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I, Trevor A Graham, conﬁrm that the work presented in this thesis is my own. Where
information has been derived from other sources, I conﬁrm that this has been indicated
in the thesis.3
For my family4Abstract
The formation of a cancer is an evolutionary process. A somatic cell may acquire an
(epi)-mutation that gives it a growth advantage relative to its neighbours. Progression
to cancer occurs as cells in the resulting mutant clone acquire additional mutations,
which may also confer a selective advantage. This thesis investigated the expansion of
mutant clones both prior to, and during, tumour growth.
First, the clonal expansion of a mutant lineage within a stem cell niche was considered.
The behaviour of mutant germline stem cells in the Drosophila testis, a remarkably
well-characterised niche, was investigated. A model was developed which identiﬁed
stem cell phenotypes that were selectively advantageous in the niche.
Crypt ﬁssion is thought to be the primary mechanism of clonal expansion in the gut.
A model of crypt ﬁssion was developed, which was used to estimate the frequency of
ﬁssion events in the normal human colon. Crypts were found to divide infrequently,
and ﬁssion was predicted to decrease the likelihood that a mutant clone would be lost
from the gut.
Next, the expansion of mutant clones during the initial growth of colorectal adenomas
was considered. Individual crypts were micro-dissected from small adenomas, and
the mutation status of the APC and K-ras genes in each crypt was determined.
Combining this information revealed how the adenoma had formed. It was found that
K-ras mutations may have occurred earlier in tumorigenesis than had been previously
established.
Last, the effect of clonal expansion on the genetic heterogeneity in a cancer was
examined. A model of microsatellite slippage during cancer growth was developed.
The model showed that clonal expansion during cancer growth, coupled with a low rate6 Abstract
of somatic mutation, can generate non-negligible amounts of genetic diversity. This
suggestedthattherewaslittleevidenceforalow-levelmicrosatellitemutatorphenotype
in colorectal cancers.Acknowledgements
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Table 1: Frequently used abbreviations.
Item
Abbreviation Description
AA amino acid
AARs 20 amino acid repeats
APC Adenomatous Polyposis Coli
BrdU Bromodeoxyuridine
cnn centrosonin
COX cytochrome c-oxidase
G6PD glucose-6-phosphate dehydrogenase
GSC germline stem cell
GI gastrointestinal
JAK-STAT Janus kinase-signal transducer and activator of transcription
K-ras Kirsten ras
LOH loss of heterozygosity
MCR mutator cluster region
MGMT O6-methylguanine-DNA methyltransferase
MS microsatellite
MSI microsatellite instability
MSI-H high level microsatellite instability
MSI-L low level microsatellite instability
MS-S microsatellite stable
MMR mis-match repair
ODE ordinary differential equation
PCR polymerase chain reaction
SSCP single strand conformational polymorphism
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Introduction
1.1 Introduction
Cancers originate from somatic cells that have acquired alterations to their DNA. These
alterations, either genetic or epigenetic, cause disruption to the cellular machinery that
regulates cell growth (HANAHAN and WEINBERG, 2000). The mutated cells can evade
normal homoeostatic control and initiate neoplastic growth.
Human bodies consist of many trillions of cells, many of which divide frequently.
Cell division requires DNA replication, so that each daughter cell is supplied with
a version of the genetic information and is able to produce proteins necessary for
cellular function. DNA replication is an imperfect process though, so each time a
cell divides, replication errors, or mutations, are introduced into the newly produced
strand of DNA. Successive rounds of division cause an accumulation of mutations.
When viewed in this manner, the eventual acquisition of a tumorigenic mutation
appears to be an inevitability. Yet cancers are relatively rare; in Britain for example,
where the average life expectancy of a female is around 81 years (UK OFFICE OF
NATIONAL STATISTICS, 2004), only about 1 in 3 people will have cancer during
their lifetime (CANCER RESEARCH UK, 2008). This is due, in part, to that fact that
the human body has evolved antitumorigenic mechanisms that limit the acquisition
of mutations and restrict their spread (KOMAROVA, 2005; PEPPER et al., 2007), or
also perhaps limit their effects. One such example of an antitumorigenic mechanism
is the hierarchical structure of tissues, notably the colonic epithelium. In the colon,22 Chapter 1. Introduction
the epithelial cell population is maintained by a small number of stem cells. The
stem cells divide infrequently to produce differentiated cell offspring. Subsequent
amplifying divisions of the differentiated cells produce the large numbers of cells in
the epithelium. Differentiated cells have a limited life-span; in the bowel of the mouse,
differentiated cells are shed from the epithelium within a week of forming (POTTEN
and LOEFFLER, 1990). Differentiated cells therefore have little opportunity to acquire
multiple tumorigenic mutations. The potential for tumour growth is thus limited, since
mutationsmayonlyaccumulateinthesmallnumberofinfrequentlydividingstemcells.
The ﬁrst part of this thesis examines how mutations can arise and spread in hierarchical
tissue structures.
To transform a normal somatic cell to a cancer cell requires alteration of the cell’s
phenotype. In their seminal review, Hanahan and Weinberg suggested that a somatic
cell had to acquire six phenotypic traits in order to become cancerous (HANAHAN
and WEINBERG, 2000). These traits, self-sufﬁciency in growth signals, the ability
to evade anti-growth signals, sustained angiogenesis, evasion of apoptosis, limitless
replicative potential and the ability to invade tissue and metastasise, were termed the
Hallmarks of Cancer. Acquisition of these six phenotypic traits appears to require
mutations in multiple genes. Thus, the somatic evolution of a particular cancer
can be viewed as the stepwise accumulation of mutations, with each mutation, or
combination of mutations, bestowing or permitting the cancer to acquire another
Hallmark behaviour. This stepwise model of tumour progression that transforms
normal somatic cells into malignant cancer cells, termed the Somatic Theory of
Carcinogenesis (MCCOMBS, 1930; EDLER and KOPP-SCHNEIDER, 2005) provides
an important conceptual framework for studying cancer genetics .
To fully understand how tumours form it is necessary to consider the phenotypic
changes induced by each genetic change. To cause tumour growth, a genetic alteration
must cause a selectively advantageous alteration to the cell’s phenotype, so that the
mutant cell clone can expand at a greater rate than other somatic cells. A subsequent
mutation acquired by a tumour cell is only likely to become dominant in the population
of tumour cells if it provides a selective advantage within the tumour population.
This tumour sub-clone can expand to the detriment of the other tumour cells. Thus,1.2. Stem cells 23
tumour progression, the stepwise transformation of normal somatic cells to malignant
cancer cells, is punctuated by repeated rounds of mutation followed by waves of
clonal expansion. This is an important observation: it is not sufﬁcient to simply
describe tumorigenesis as the simple stepwise accumulation of mutations, but rather the
acquisition of mutations should be considered in tandem with the resulting selection,
and clonal expansion, which results from each (epi)genetic change. Furthermore,
tumour growth causes a massive expansion of cell number; for example a cancer of
around 1cm3 in volume contains around 109 cells. Each of the cells in the clone has
the initial tumorigenic mutations, and so presumably most of the cells in the clone
are susceptible to additional tumorigenic mutations that cause progression towards to
cancer. In this sense, clonal expansion can drive cancer progression by increasing the
number of cells that are potential “targets” for additional mutations (MOOLGAVKAR
and LUEBECK, 2003). The second part of this thesis examines the roles of mutation,
selection and clonal expansion during tumour growth.
This introduction describes somatic stem cells and the regulatory processes that
inﬂuence their division. Particular reference is made to stem cells in the epithelium of
the colon, as these tissues are studied in detail in this thesis. Next, the process of tumour
development in the colon is described. Both the genetic and physiological processes
that underlie neoplastic growth are considered, and paradigms used to understand
tumorigenesis are discussed. In tandem with describing the biology of stem cells and
tumour growth, the complementary role of mathematical modelling for understanding
tumorigenesis is considered.
1.2 Stem cells
Adult stem cells, hereafter referred to as stem cells, are thought to be present in all
renewing tissues in the body. Stem cells are unspecialised cells, as they themselves do
not perform a specialised physiological function within the body. Stem cells however
are multi-potent, which means that they have the ability to produce progeny that are
specialised to perform a particular physiological function. These specialised cells
are termed differentiated cells. Furthermore, stem cells are thought to have a unique
ability to perform asymmetric division which results in one daughter stem cell and one24 Chapter 1. Introduction
daughter differentiated cell. Thus, asymmetric division allows a stem cell population
to self-renew, whilst still producing differentiated cell progeny.
The number of times a stem cell may divide is not thought to be restricted. This
limitless replicative potential, called immortality, is unique to stem cells. Differentiated
cells are thought to divide only a few times before becoming mitotically inactive. In the
murine colon crypt for example, differentiated cells are thought to divide only a small
number of times before becoming mitotically inactive (POTTEN and LOEFFLER, 1990;
BJERKNES and CHENG, 1999). Since stem cell lineages are immortal, they are likely
to be the precursors of cancer cells. Their lineages are long enough to have a reasonable
chance of acquiring the multiple mutations required to initiate neoplastic growth
(CAIRNS, 2002). Furthermore, the stem cell traits of multipotency and immortality
resemble the phenotype of cancer cells, suggesting that stem cells require a less radical
alteration of their phenotype to become cancerous than more specialised cells (PIERCE
and SPEERS, 1988; HANAHAN and WEINBERG, 2000). Stem cells are therefore of
great interest to researchers of oncology.
What is it that confers a stem cell phenotype, or stemness, upon a cell? Stem cell
identity could be due either to intrinsic or extrinsic properties of the cell. An intrinsic
deﬁnition of stemness suggests that some cells are simply “programmed” as stem cells,
perhaps due to the epigenetic state of their DNA, whereas others are programmed to
be differentiated cells. The extrinsic deﬁnition suggests that stemness is determined
by the environment of the putative stem cell. Stem cell identity may be conferred by
proximity to a source of a particular extra-cellular ligand that induces stemness (WATT
and HOGAN, 2000; WEISSMAN et al., 2001). The locale of such factors deﬁnes the
stem cell niche, which persists upon removal of the stem cells (SPRADLING et al.,
2001). Stemness must actually be deﬁned as a combination of both intrinsic and
extrinsic factors, since residing in the niche would not confer stemness if the internal
makeup of the cell meant it was unable to respond to the niche signal.
Thetestisofthefruitﬂy, arguablythebestcharacterisedofallstemcellniches, isaclear
example of how stemness is controlled by both extrinsic and intrinsic factors. Stem
cells are clustered around of a hub of non-dividing cells (G¨ ONCZY and DINARDO,
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KIGER et al., 2001), which stimulates the JAK-STAT pathway that maintains stem cell
identity. Proximity to the hub thus deﬁnes stemness; as cells move away from the
hub, they receive a decreased niche signal and differentiate. A cells intrinsic ability to
respond to the niche signal Upd also determines its stemness: stem cells with loss-of-
function mutations in the JAK-STAT pathway are rapidly lost from the niche (TULINA
and MATUNIS, 2001; KIGER et al., 2001).
In the human and murine colon, stem cells are thought to reside at the base of colonic
crypts, adjacent to the pericryptal myoﬁbroblasts (HUMPHRIES and WRIGHT, 2008)
(see Figure 1.2). The myoﬁbroblasts secrete some members of the Wnt family of
growth factors (GREGORIEFF et al., 2005), that are thought to maintain stemness. The
colonic crypt is discussed in detail in the following section.
1.3 The Colonic Crypt
1.3.1 Colon anatomy
The colon is the ﬁnal section of the gastrointestinal tract. The colon follows the small
intestine and ends at the rectum. The lining of the colon, the epithelium, consists of
a mono-layer of cells, pitted with millions of ﬁnger-like invaginations called crypts.
Crypts are the basic functional unit of the colonic epithelium and are responsible
for producing the bulk of the epithelial cell population. Colon cancers are likely to
originate from the crypts.
1.3.2 Crypt histology
In humans, each crypt contains around 2,000 cells. The population of each crypt is
rapidly renewing; cells ﬂow from the base of the crypt, along the crypt axis, and
are eventually lost through the lumen. This polarised ﬂow of cells from the crypt
base suggests that stem cells, the precursors of all other cell types, are located at
the crypt base. Stem cells are thought to produce semi-differentiated cells, named
transit amplifying (TA) cells (BJERKNES and CHENG, 1999). Division of the TA cells
produces the bulk of the cell population present in the crypt. The differentiated cells in
a crypt can be broadly divided into four main types (BRITTAN and WRIGHT, 2004b).26 Chapter 1. Introduction
Absorptive cells, the enterocytes, form the bulk of the columnar epithelium. Three
secretory cell lineages form the remainder of the main cell types: the mucin secreting
Goblet cells; endocrine cells that secrete hormones; and Paneth cells that have a more
speciﬁc secretory role. A Haematoxylin and Eosin (see Section 4.3.2) stained crypt
is shown in Figure 1.1. The mono-layer of cells can be clearly seen. A cartoon of a
colonic crypt, indicating the locations of the different cell types, is shown in Figure
1.2.
The mechanisms that maintain stemness in the human colon are less well understood
than in the ﬂy. The Wnt family of extra-cellular ligands form the likely niche signal.
Some Wnts, and some of the Frizzled family of receptors, show differential expression
along the crypt axis (GREGORIEFF et al., 2005). Wnts are thought to be produced
by the underlying pericryptal myoﬁbroblasts, which surround the crypt base. The
myoﬁbroblasts, in combination with the stem cells themselves, constitute the stem
cell niche. Wnt signalling appears to maintain stemness by stimulating proliferation.
Wnt initiates a signalling cascade discussed in Section 1.6.1. The Wnt pathway
is required for the maintenance of the epithelium: inhibition or deletion of Wnt
pathway components results in the loss of the stem cell compartment (FEVR et al.,
2007; KORINEK et al., 1998). Additionally, the Bone Morphogenetic Protein (BMP)
antagonists gremlin 1 and gremlin 2, the Notch signalling pathway and the binding of
Wnt factors to the ephrin receptors (KOSINSKI et al., 2007) may also inﬂuence the
maintenance of stemness (reviewed in (CROSNIER et al., 2006)). As cells migrate
up the crypt axis, away from the Wnt source, they differentiate and eventually stop
dividing.
1.3.3 Crypt clonality
A number of studies have shown that colonic crypts are clonal populations, that is, that
they are derived from a single founder cell. In-situ hybridisation for the Y chromosome
in an XO/XY chimera patient showed no crypts contained both XO and XY cells
(NOVELLI et al., 1996). X-chromosome inactivation, due to methylation, has also
been used to study crypt clonality in the human large intestine. In females, CpG island
methylation occurs at random on one or other of the two X chromosomes early in1.3. The Colonic Crypt 27
Figure 1.1: Micrograph showing normal colonic crypts that have been H&E stained.
H&E staining highlights acidic regions, such as the nucleus in red, and basic regions,
such as the cytoplasm, in purple. The architecture of the crypts can be clearly seen - the
lining of each crypt consists of a mono-layer of cells. Image taken at 10x magniﬁcation.28 Chapter 1. Introduction
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Figure 1.2: Schematic of colon crypt. Stem cells, indicated in red, are thought to reside
atthecryptbase. Directlyabovethestemcellsarethetransitamplifyingcells, indicated
in green. Terminally differentiated cells are at the crypt top, indicated in yellow. The
arrow indicates the direction of cell migration. Below the base of crypt is the location
of the pericryptal myoﬁbroblasts.1.3. The Colonic Crypt 29
development, resulting in inactivation of most genes on that chromosome, a process
termed Lyonisation. Novelli et al. examined the colon of Sardinian female patients
with a heterozygous functional polymorphism in glucose-6-phosphate dehydrogenase
(G6PD), an X-linked gene NOVELLI et al. (2003). During development, X-inactivation
led to a patchwork of crypts with either functional or non-functional G6PD expression.
Crypt clonality was conﬁrmed by the observation of only entirely wild-type or mutant
G6PD expressing crypts, whereas mixed crypts were never seen. Large patches of up
to 450 adjacent G6PD deﬁcient crypts were observed, suggesting a common ancestor
of adjacent crypts.
Although the population of cells in each colonic crypt undoubtedly has a clonal origin,
each crypt contains multiple stem cells. Each stem cell produces its own clone of
differentiated cells, so that the population of any crypt is polyclonal in the sense that
there are multiple long-lived progenitor cells in the crypt. The ﬁrst clear evidence
that crypts contained multiple stem cells was from experiments using ethylnitrosourea
(ENU) treatment to induce mutations in the intestinal crypts of heterozygous Dlb-
1a/Dlb-1b mice (WINTON et al., 1988; WINTON and PONDER, 1990). Loss of the
Dlb-1b allele could be detected by an absence of Dolichos biﬂorus agglutinin binding,
visualised by standard enzyme histochemistry techniques. Following ENU treatment,
many partially staining crypts were observed, whereas after 150 days post treatment,
only wholly staining or unstained crypts were observed. Mathematical modelling
suggested the data were most consistent with crypts that contained more than one stem
cell: ENU treatment induced mutations in only a few of the stem cells in a crypt so that
many partially mutated crypts were observed immediately after treatment. After 150
days, these crypts had converted to monoclonality, as a result of one stem cell lineage
in the crypt replacing all the others (LOEFFLER et al., 1993, 1997). The mathematical
models used to interpret the data are discussed in Section 1.4.4.
1.3.4 Crypt stem cell markers
Hampering the study of colon crypt stem cells, particularly in humans where invasive,
perturbation-based experiments are impractical, is the lack of reliable stem cell
markers. In the colon, numerous molecules have been suggested as stem cell markers.30 Chapter 1. Introduction
Of note are Musashi-1 (Msh-1), an RNA binding protein and Doublecortin and CaM
kinase-like-1 (DCAMBL-1). Evidence for Msh-1 and DCAMBL-1 as stem cell markers
is essentially coincidental: expression of these molecules tends to be restricted to cells
found in the putative location of the stem cell niche. However, some authors have
noted, for example, that in the human and murine colon Msh-1 expressing cells are
occasionally observed away from the crypt base and along the crypt axis (BARKER
et al., 2007). Does this mean that stem cells are occasionally found away from the
crypt base, or are all Msh-1+ not stem cells? Clearly, purely associative evidence is
insufﬁcient to conﬁrm the efﬁcacy of a putative stem cell marker.
In the colon, a promising candidate stem cell marker has recently been proposed:
leucine-rich-repeat-containing G-protein-coupled receptor 5 (Lgr5), a Wnt target
gene. In the colon, expression of Lgr5 appears to be restricted to the base of crypts
(BARKER et al., 2007). Transgenic mice were used to examine the dynamics of Lgr5
expressing cells (BARKER et al., 2007). In these mice, the progeny of Lgr5+ cells
were permanently labelled following induction of a reporter enzyme (LacZ) in these
cells. Following induction, labelled cells of all the lineages in a crypt were observed,
conﬁrming that Lgr5 expressing cells were multi-potent. Additionally, occasional
crypts where all cells were LacZ labelled were observed, proving that Lgr5+ cells
were capable of clonal replacement. Lgr5+ cells thus appear to have stem cell like
behaviour. It remains to determine the speciﬁcity of the marker, as not all Lgr5+ cells
are necessarily stem cells . LGr5 may identify stem-like cells, rather than just the
actively dividing stem cell population. The discovery of reliable, speciﬁc, stem cell
markers will permit direct examination of crypt stem cell behaviours.
Stem cell numbers
The lack of a deﬁnitive stem cell marker has prevented an accurate count of the number
of stem cells per crypt. Estimates of this number rely on interpreting the results of
indirect measures, such as methylation pattern analysis in humans (discussed below)
(YATABE et al., 2001; NICOLAS et al., 2007). Currently, estimates of the number of
stem cells per crypt range from around 4 to over 30 (LEEDHAM et al., 2005; NICOLAS
et al., 2007; POTTEN et al., 1997; YATABE et al., 2001). The possibility remains that1.4. Crypt dynamics 31
differentiated crypt cells retain some plasticity and so may be able to de-differentiate to
repopulate a depleted stem cell pool. Validation of the stem cell markers noted above
may permit deﬁnitive and direct determination of stem cell number.
1.4 Crypt dynamics
To study stem cell dynamics, particularly in human colon crypts where direct
observation is impractical, a number of indirect assays have been developed. The
assays all exploit the power of random infrequent replication errors, which are inherited
at cell division, to surreptitiously record cell ancestry. The pattern of replication errors
of two cells is compared: cells with similar patterns of replication errors are likely
to be closely related, whereas cells with very dissimilar patterns are unlikely to share
a recent common ancestor. Of particular note are mitochondrial DNA methods and
methylation based methods.
1.4.1 Within-crypt dynamics: stem cell behaviour
Like any population in a constrained environment, the multiple stem cells in a niche
are in competition with one another for the limited resources present in the niche. In
the colonic crypt for example, space at the base of the of crypt, proximal to the putative
niche signal, is restricted. Thus, it has been postulated that stem cell populations
are subject to genetic drift whereby one stem cell clone can replace all the others
(YATABE et al., 2001). Clonal expansion of a particular stem cell lineage is through
symmetric division. Rather than dividing asymmetrically, to produce a daughter stem
cell and a daughter differentiated cell, symmetric division results in either two daughter
stem cells, or two daughter differentiated cells. Since space in the niche is restricted,
symmetric stem cell division resulting in two daughter stem cells must be balanced by
another stem cell being displaced from the niche. The latter stem cell clone is then lost
from the crypt, whereas the ﬁrst stem cell clone has expanded.
Methylation analysis
Persuasive evidence for the dynamics turnover of stem cells in colonic crypts as
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methylationpatternsasclonalmarkerstostudywithincryptheterogeneity. Methylation
occurs at genomic regions with a high cytosine and guanine content, so called CpG
islands. Speciﬁcally, cytosine bases as the 50 position relative to a guanine base (a
CG motif) can acquire a methyl group (CH3). The methylation status of each CG
site can be determined by bisulphite treatment. Bisulphite converts all unmethylated
cytosine bases to uracil bases. The bisulphite converted DNA can then be sequenced
in the usual manner, and comparison to the wild-type (unconverted) sequence reveals
the methylation status of each CG site. The collective methylation status of all
sites in a CpG island, a binary sequence, is described as the methylation pattern
of the locus. In the colon, and in other tissues, such as the small intestine, hair
follicles and endometrium, methylation of non-expressed genes notably, biglycan
preproprotein (BGN), NK2 transcription factor related, locus 5 (CSX) and myogenic
factor 3 (MYOD1), appears to occur at random, at a relatively low rate, and be inherited
at division (KIM et al., 2004b, 2005a; CHU et al., 2007). Thus random methylation
events record a cell’s ancestry: two cells that have very similar or identical methylation
patterns are likely to be closely related.
Yatabe and colleagues looked at the diversity of methylation patterns present in
individual colonic crypts. Individual crypts were disaggregated from fresh colon
biopsies, bisulphite treated and PCR ampliﬁed. To achieve single cell resolution
again, PCR products were cloned. An example of the methylation patterns observed
is shown in Figure 1.3. Multiple distinct methylation patterns were observed in single
crypts, indicating that the crypt contained multiple stem cells that were independently
methylated. Stem cell dynamics were determined from the methylation patterns using
a mathematical model. A crypt was assumed to contain N stem cells that divided
synchronously. Each stem cell could produce 0, 1 or 2 stem cell offspring, and a
corresponding 2, 1 or 0 differentiated cell offspring, with probability p0, p1 and p2
respectively, constrained so that each crypt contained precisely N stem cells after
division. The intra-crypt variation in methylation patterns was most consistent with a
model where p1 < 1 (p1 ' 0:95), suggesting that stem cell lineages were not immortal,
and a dynamic process of stem cell clone expansion occurred within a crypt. With
p1 = 1 the model predicted more variation in methylation patterns than was observed.1.4. Crypt dynamics 33
Occasional symmetric stem cell division (p1 < 1) could lead to one stem cell clone
displacing another, so that the variation in methylation patterns was reduced.
1
2
3
4
5
6
7
8
S
equenc
e #
Figure 1.3: Methylation patterns present in a single colon crypt. Each row represents a
single methylation pattern, each column the methylation status of each methylation site
(black methylation, white unmethylated). Methylation patterns were determined by
bisulphite treatment of DNA, followed by PCR ampliﬁcation and cloning. 6 distinct
methylation patterns were present in the crypt, indicating that the crypt contained
multiple long lived progenitor cells. The crypt was from a patient aged 75. Data
were collected in the Histopathology Section, Cancer Research UK London Research
Institute, by the author.
Consecutive rounds of symmetric division can, in principle, lead to niche succession,
whereby one stem cell clone can expand to displace all the other stem cell clones in
the niche. Using their model, with p1 = 0:95 and p0 = p2 and assuming one stem
cell division per day, YATABE et al. (2001) calculated a mean niche succession time
of 8.2 years. A subsequent more sophisticated analysis of the methylation patterns
suggested a longer niche succession time of between 15 and 40 years (NICOLAS et al.,
2007).
It was not possible to estimate accurately the number of stem cells per crypt directly
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stem cells per crypt, around 20 (NICOLAS et al., 2007), but stem cell numbers between
N = 2 to N  64 were consistent with the data (YATABE et al., 2001).
Mitochondrial DNA analysis
Mitochondrial DNA (mtDNA) based assays have also been used to great effect
to study crypt stem cells. Somatic mtDNA mutations occur randomly as part of
the normal ageing process, as mitochondria have poor DNA base excision repair
mechanisms, reside in an oxidative environment and have no histones to protect their
DNA(MCDONALD etal.,2006a). ThemutationrateofmtDNAissufﬁcientlylow, soif
twocellssharetheexactsamemutationthentheyarelikelytoshareacommonancestor.
GREAVES et al. (2006) used mtDNA mutations that result in cytochrome-c-oxidase
(COX) deﬁciency, an enzyme encoded in the mitochondrial genome, to study clonality.
COX-deﬁcient cells can be readily recognised by an enzyme histochemistry technique,
which also allows the extent of the clone to be easily visualised. Clonality of two COX-
deﬁcient cells can be conclusively conﬁrmed by the presence of the same mtDNA point
mutation in both cells, identiﬁed by sequencing the entire mtDNA genome.
Greaves et al. found the number of entirely COX-deﬁcient crypts increased in colons
from patients aged about 40 or more. Laser capture micro-dissection was used to
isolate individual cells from a mutated crypt and sequencing conﬁrmed that each cell
carried the same mtDNA point mutation (GREAVES et al., 2006). This showed that
a single mutated stem cell could repopulate an entire colonic crypt. Partially mutated
crypts were occasionally observed, suggesting that crypts contain multiple stem cells.
Alternatively, partially mutated crypts could be evidence that a mtDNA mutation had
been acquired by a transit amplifying cell, so that only the progeny of the TA cell were
COX deﬁcient.
mtDNA mutations illustrate the phenomenon of monoclonal conversion. If an
expanding stem cell clone happens to be mutated, niche succession of the clone results
in a crypt where every cell in the crypt carries the mutation. The mutation is described
as ﬁxed in the niche.1.4. Crypt dynamics 35
OAT staining
PatientsheterozygousforO-acetyltransferase(OAT)activity, asialicacidglycoprotein,
have also proved informative to study crypt stem cell dynamics. Routine radiotherapy
treatment for colorectal cancer induced loss of wild-type OAT function in some colon
crypt cells, which was detectable using a routine histochemical technique (CAMPBELL
etal.,1994a,b). Inbiopsiestaken withinafew monthsofradiationtherapy, manycrypts
that showed a mixture of OAT+ and OAT  cells (mixed crypts) were seen. One year
post-irradiation, the number of mixed crypts fell to the background level observed in
biopsies from non-irradiated patients. Thus, the clonal stabilisation time of the colon,
the average of the time taken by a mutated lineage to become dominant in a crypt
or be lost from the crypt, was about one year (CAMPBELL et al., 1996). This study
was additional evidence for the dynamic turnover of stem cells in the human colon
crypt.
1.4.2 Anti-tumorigenic properties of the niche
Niche succession limits the accumulation of mutations within a niche, so may have
evolved as an anti-tumorigenic mechanism. Suppose a stem cell niche contains N stem
cells, all of which are equally likely to undergo niche succession and repopulate the
entire niche with their progeny. A neutral mutation acquired by one of the stem cells
has a 1=N chance of becoming ﬁxed in the niche, and so most neutral mutations are
lost from the niche. Agent-based modelling by PEPPER et al. (2007) compared the
robustness of hierarchal structured cell populations that permit niche succession, to
self-renewing cell populations that do not permit niche succession. Permitting niche
succession limited the rate of somatic evolution and reduced the rate at which faster
dividing cells, or cells with a reduced tendency to apoptosis, invaded the niche. Using
a differential equation model, KOMAROVA (2005) showed that the niche construction
within a colon crypt that permitted competition between stem cell lineages reduced the
likelihood of stem cells acquiring multiple mutations in the niche.
If cancers do indeed originate from stem cells (PIERCE and SPEERS, 1988; CAIRNS,
2002), then the initial mutations which lead to neoplastic growth are likely to confer
a selective advantage in the stem cell pool. This would increase the likelihood that a36 Chapter 1. Introduction
tumorigenic mutation is able to evade the anti-tumorigenic mechanisms in the niche,
and be retained in the body. Understanding how mutations can form and spread in a
niche is therefore of importance to understanding the initial development of tumours.
Evidence that pre-tumour, pro-oncogenic mutations, may alter stem cell dynamics in
the niche is provided by the study of the colonic crypts of patients with Familial
Adenomatous Polyposis (FAP), who carry a germline mutation in the APC tumour
suppressor gene (see Section 1.6.1). In these patients, the diversity of methylation
patterns in a crypt was increased (KIM et al., 2004b), which could be explained by an
increase in stem cell number or a reduced tendency for symmetric division (p1 < 5%).
The crypts from FAP patients also showed greatly increased ﬁssion rates (see Section
1.4.3). Therefore, it appeared that the heterozygous APC mutation had a phenotypic
effect on stem cells in the crypt. It is unclear whether a sporadic heterozygous APC
mutation would be selectively advantageous within a crypt - but establishing this would
provide insight into the genesis of sporadic colorectal adenomas.
1.4.3 Crypt-level dynamics: crypt ﬁssion
Crypts themselves are also capable of clonal expansion. The mechanism of clonal
expansion is believed to be crypt ﬁssion, whereby a parent crypt divides to form two
daughter crypts by bifurcating from the base upward. The bifurcation presumably splits
the stem cell population at the base of the crypt between the new daughter crypts.
mtDNA mutations have provided the strongest evidence for crypt ﬁssion. GREAVES
et al. (2006) observed adjacent COX-deﬁcient crypts, that shared identical mtDNA
mutations (see Figure 3.2). Sequencing conﬁrmed that the adjacent crypts shared the
same point mutation, indicating that they had a common precursor. The patches must
have formed through successive division of the ﬁrst mutated crypt. The mean number
of crypts per patch increased with patient age: by age 80 the mean patch size was
around four crypts, suggesting that ﬁssion occurs throughout life.
Previously, it had been suggested that crypts that were apparently in ﬁssion may
actually have been in fusion. Using the methylation assay described above, KIM et al.
(2004b) found that the diversity of methylation patterns within a branching crypt was
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the diversity within a single crypt. This suggests perhaps that the methylation pattern
diversity is generated by the mixing of two independent stem cell populations from the
fusingcrypts. Alternatively, thiscouldbeinterpretedas evidencethatﬁssionitselftakes
a long time to complete, so that the methylation patterns in the stem cells of each arm
of a bifurcating crypt have sufﬁcient time to diverge. It should be noted though that in
this study, only 8 bifurcating crypts were analysed, 7 of which were sourced from the
normal appearing colon of a single Ulcerative Colitis (UC) patient. UC patients show
increased incidence of crypts in ﬁssion, so may not be representative of normal colonic
crypts.
Crypt ﬁssion rate
In the 1980s, Bjerknes and Cheng suggested that crypts had a natural life-cycle, that
they termed the crypt cycle (CHENG et al., 1986a; TOTAFURNO et al., 1987). The
duration of the crypt cycle is deﬁned by the duration of time between successive crypt
ﬁssion events. By counting the frequency of crypts in ﬁssion in the human colon
and making extrapolations about crypt dynamics that were based on mouse data (see
Chapter 3), they estimated that the time taken for the number of crypts in the human
colon to double was between 9-18 years (CHENG et al., 1986a). This gave a crypt cycle
duration between 13-22 years. Analysis of methylation patterns from pairs of crypts
from the colon suggested that crypts that were adjacent appeared as unrelated to each
other as those that were more than 15cm apart (KIM et al., 2004b). This is additional
evidence perhaps that ﬁssion is a rare event, so that the time between successive ﬁssion
events is sufﬁcient to allow the methylation patterns of adjacent sister crypts to diverge.
In Chapter 3 of this thesis, the crypt ﬁssion rate in the human colon is estimated directly
from data on the frequency of mtDNA mutated crypts.
Initiation of ﬁssion
Crypt ﬁssion appears to be the primary mode of crypt-level clonal expansion in the
colon. Understanding how ﬁssion is induced could therefore reveal a mechanism to
retard aberrant growth in the colon. Crypts in ﬁssion tend be larger than average
(TOTAFURNO et al., 1987, 1988; WONG et al., 2002). The mathematical models of
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number could stimulate ﬁssion (LOEFFLER et al., 1993, 1997). The models assume
that the stem cell population is in a constant state of growth, and ﬁssion is induced
when the number of stem cells per crypt surpasses a threshold value. This formulation
was consistent with the formation rate of adjacent mutated crypts in Dlb-1a/Dlb-1b
mice following ENU treatment (WINTON et al., 1988). Bio-mechanical mathematical
modelling suggests that ﬁssion could occur due to buckling of the epithelial sheet,
induced by increased cell numbers (EDWARDS and CHAPMAN, 2007).
The frequency of crypts in ﬁssion also appears to be increased in the normal appearing
colon of patients with FAP (CHENG et al., 1986a; WASAN et al., 1998; BJERKNES
et al., 1997), suggesting a possible role for APC and the Wnt pathway in the direct
regulation of crypt ﬁssion events. Alternatively, the heterozygous APC mutation in
FAP patients may alter the number of stem cells per crypt (KIM et al., 2004b), and so
inﬂuence the rate of ﬁssion.
1.4.4 Modelling colon crypt dynamics
A number of computational models of the colon crypt have been developed. The
models have attempted to infer the biological processes that regulate crypt cell
dynamics, such as stem cell number, and the rate of niche succession.
A series of iterations of stochastic crypt models by the Loefﬂer group are particularly
noteworthy (see LOEFFLER et al. (1993, 1997)). They created an auto-regulatory model
of crypt dynamics where the balance between stem cell symmetric or asymmetric
divisionwasregulatedbythesizeofthestemcellpool. Symmetricdivision(probability
p(S), where S is the number of stem cells size) to produce two new stem cells is
likely when there are few stem cells and asymmetric division (q(S)) is likely when
there are many stem cells. Stem cells died at a constant rate r. Crypt division (see
Section 1.4.3) occurs where the size of the stem cell pool exceeds a threshold value,
and cells are randomly assigned to each of the two new crypts. To test the ﬁtness of
theirmodel, themodelwascomparedtotheformationofDlb 1bdeﬁcientcryptsinthe
murine colon following ENU treatment (see Section 1.3.3). The distribution of crypt
sizes observed in the model matched the distribution observed in mice, but the rate of
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weakness of the model is the number of free parameters that cannot be estimated
directly from biological data. Nevertheless, the work by Loefﬂer et al. represents the
ﬁrst successful attempt to develop a theoretical model to explain crypt cell behaviour.
The modelling provides a convincing argument that crypts contain multiple competing
stem cells.
Later revisions by the Loefﬂer group yielded a lattice-free model of crypt dynamics
(MEINEKE et al., 2001). In this model, the crypt was modelled as a 2D sheet, with
periodic boundary conditions. Cell positions were determined by a physical model that
approximated cell adhesive forces and visco-elastic properties by a series of springs
connecting the nucleus of a cell with its neighbours. A Voroni tessellation was then
used to approximate the position of the cell boundaries. This rather sophisticated model
was able to reproduce the ribbons of mutated cells that were observed in the crypts of
Dlb   1a=Dlb   1b mice following NEU treatment (WINTON and PONDER, 1990).
However, the ability of the model to produce predictions about crypt dynamics was
again restricted by the number of free parameters in the model which could not be
estimated from biological data. Extensive work is still required to produce a model that
can reproduce the range of phenomena seen in a colon crypt. Such Systems Biology-
style modelling attempts are restricted by the availability of biological data from which
parameter values can be inferred. In the colon crypt for example, data on cell adhesion,
stem cell number, stem cell division rate, transit amplifying cell division rate and
mechanisms of cell propulsion along the crypt axis are all lacking. In this thesis, a more
reductionist approach is taken. Intentionally simple, hopefully parsimonious, models
are developed and used to investigate particular phenomena.
Another model of colon crypt dynamics that is particularly noteworthy is that of
NICOLAS et al. (2007). Their model attempts to infer crypt properties, such as the
stem cell number and niche succession rate from methylation pattern data (described
above in Section 1.4.1). Their model is stochastic, and in contrast to previous models
of methylation data, their model describes the accumulation of methylation patterns
as continuous functions of time. The model is ﬁtted to the methylation data using
a Markov Chain Monte Carlo technique. The model suggests that crypts contain a
relatively large number of stem cells, around N = 20, and that niche succession takes40 Chapter 1. Introduction
as long as forty years.
1.5 Tumorigenesis
Tumorigenic mutations bestow a selective advantage relative to the normal somatic
cells, which leads to aberrant growth. In the colon, how does this growth occur?
1.5.1 Bottom-up growth
The primary mode of aberrant growth in the colon appears to be bottom-up (PRESTON
et al., 2003). This model of tumorigenesis suggests that a mutant cell ﬁrst forms in a
colonic crypt, presumably in a stem cell. The mutated cell then expands to repopulate
the entire crypt, and subsequent expansion of the mutated clone is then through crypt
ﬁssion (see Figure 1.4). Repeated rounds of ﬁssion form the large number of dysplastic
crypts present in an adenoma.
Preston and colleagues provided evidence of bottom-up spread in sporadic adenomas
and in adenomas from FAP patients (PRESTON et al., 2003). In both groups of
adenomas, they observed that the nuclear accumulation of -catenin, a marker of
proliferation, was restricted to the bottom portion of dysplastic crypts, suggesting
that cell growth occur occurs primarily at the crypt base. Proliferative cells along
the entire crypt axis was only observed in more developed adenomas. Furthermore,
the proportion of crypts in ﬁssion was increased in adenomas (WONG et al., 2002;
PRESTON et al., 2003), and also in dysplastic monocryptal adenomas, the precursors
of larger colorectal adenomas (BJERKNES et al., 1997).
Further evidence for bottom-up growth, using point mutations in the APC gene as
clonal markers, is presented in Chapter 5 of this thesis.
1.5.2 Top-down growth
Aberrantcryptgrowthviatop-downspreadhasbeensuggestedbytheVogelsteingroup.
In contrast to the results of Preston et al. , Shih and colleagues observed proliferating
cells at the tops of crypts dissected from small adenomas, whilst proliferation appeared
to decrease towards the crypt base (SHIH et al., 2001). This suggests that the dysplastic1.5. Tumorigenesis 41
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Figure 1.4: Cartoon illustrating bottom up growth in the colon. A mutated cell
(coloured blue) forms in the base of a colonic crypt (panels 1-2), and expands to
repopulate the entire crypt (panels 3-4). Subsequent expansion of the mutated clone
is then through crypt ﬁssion (panels 5-8).42 Chapter 1. Introduction
cells form, or at least reside, at the top of crypts. Presumably tumour growth is by
luminal invasion of normal crypts by the mutant clone.
Top-down spread appears to be generally restricted to later neoplastic growth.
PRESTON et al. (2003) occasionally observed dysplastic tissue growing down into
an adjacent normal appearing crypt. No evidence for top-down spread was observed
in very small adenomas or mono-cryptal adenomas. In the same study, in-situ
hybridisation for the Y chromosome in the adenomas of an XO/XY chimeric patient,
who also had FAP, showed that some adenomas were composed of a mixture of crypts
that were either XO or XY. However, no crypts were observed that were a mixture
of both XO and XY cells, suggesting that mixing of the crypt populations, through
top-down spread, was a very rare event.
1.5.3 Field cancerisation
The ﬁeld cancerisation theory proposes that a large patch, or ﬁeld, of epithelial cells
may be mutated by exposure to a carcinogen (SLAUGHTER et al., 1953). The ﬁeld
is then predisposed to subsequent neoplastic development. Thus, ﬁeld cancerisation is
a form of pre-tumour progression, whereby mutations that contribute to carcinogenesis
can accumulate in a large number of cells prior to any overt tumour growth. Evidence
for ﬁeld cancerisation is seen in the colon. In the colon, colorectal tumours with
methylation of the O6-methylguanine-DNA methyltransferase (MGMT), a DNA repair
enzyme, were often found in a ﬁeld of histologically normal epithelium that also
showed MGMT methylation (SHEN et al., 2005), although the role of MGMT in
tumorigenesis is unclear. In the colons of patients with ulcerative colitis, a chronic
inﬂammatory disease, DNA ﬁngerprinting methods revealed large regions that were
clonal for somatic genetic changes (CHEN et al., 2005).
Expansion of the mutated clone, which is presumably through crypt ﬁssion in the
colon, can increase the size of the mutated ﬁeld (BRAAKHUIS et al., 2003). Thus it
is arguable that crypt ﬁssion mediated growth is responsible both for the expansion of
pre-malignant lesions, and for early adenomatous growth. Increasing the rate of crypt
ﬁssion may therefore by a crucial early event in tumorigenesis. This is discussed in
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1.6 Genetic alterations in the development of colorectal
cancers
The genetics of colon cancer is probably the best understood of all cancer types.
Much of this knowledge has been derived from careful study of patients that
have a family history of cancer (FEARON and VOGELSTEIN, 1990; KINZLER
and VOGELSTEIN, 1996). Neoplastic growth is usually initiated by mutation the
Adenomatous Polyposis Coli (APC) tumour suppressor gene (LAMLUM et al., 1999;
KINZLER and VOGELSTEIN, 1996). Subsequent changes involve mutations to
the Kirsten-Ras (K-ras) oncogene (VOGELSTEIN et al., 1988), to the p53 tumour
suppressor (BAKER et al., 1989), and loss of the 18q chromosome arm which is the
location of the tumour suppressor genes Deleted in Colon Cancer (DCC) and SMAD4
(mothers against decapentaplegic homolog 4) (VOGELSTEIN et al., 1988). Many other
changes may also be important in progression, such as loss chromosome arm 1p and
loss on chromosome 8 (reviewed in (HOULSTON, 2001)).
Attempts have been made to relate particular genetic changes with histological
variables that describe the state of the neoplasm. Tumour growth begins by the
formation of a small adenoma. APC mutations are extremely common in these
early neoplasms, whereas other alterations are much less frequent (LAMLUM et al.,
2000; KINZLER and VOGELSTEIN, 1996), suggesting that APC is the gatekeeper of
initial neoplastic growth in the colon (KINZLER and VOGELSTEIN, 1997). Adenomas
increase in size and tend to be benign. Eventually, the adenoma may become invasive
and is termed an adenocarcinoma, or just a carcinoma. Invasiveness presumably results
from the acquisition of a particular genetic change, or set of changes. Rather than
being restricted to the colonic epithelium, adenocarcinomas can grow, or invade, the
underlying stroma. Finally, cells from the adenocarcinomas may acquire the ability
to metastasise, presumably through the acquisition of additional genetic changes.
Metastatic tumour cells can leave the original primary tumour and spread to other
parts of the body via the blood or lymphatic system. The transformation of normal
tissue to invasive carcinoma, observable as a series of histological changes in the
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and VOGELSTEIN, 1990; KINZLER and VOGELSTEIN, 1996).
In the following sections, these genetic alterations are discussed in more detail.
ParticularattentionisgiventoAPC,K-ras, andthegeneticalterationspresentincancers
that show microsatellite instability. APC is thought to be the ﬁrst genetic change that
occurs in neoplastic development in the colon. The role of APC in tumorigenesis is
referred to throughout this thesis. K-ras is mutated in around 40% of colon cancers
(ANDREYEV et al., 2001; JONES et al., 2008a). K-ras mutations are associated with
an increase in tumour size (VOGELSTEIN et al., 1988). Clonal expansion of APC
and K-ras mutant clones in small adenomas is considered in Chapter 5 of this thesis.
Microsatellite instability is a type of genetic instability that is associated with colon
cancer development. Microsatellite instability is investigated in Chapter 6 of this
thesis.
1.6.1 APC
In the late 1980s, genetic linkage studies showed that colorectal cancer patients with
Familial Adenomatous Polyposis (FAP), a disease of the bowel characterised by the
presence of numerous polyps, tended to have a heterozygous alteration on the distal arm
of chromosome 5 (5q) (LEPPERT et al., 1987; BODMER et al., 1987). Subsequently,
Adenomatous Polyposis Coli (APC), was implicated as the gene on chromosome 5q
responsible for tumour growth (GRODEN et al., 1991). APC is a tumour suppressor,
and both allelic copies of the gene must be mutated for neoplastic growth to occur. FAP
patients are thus much more likely to develop cancer, as they already have one defective
copy of APC, so only a single somatic mutation, or hit, on the second allele is required
for tumour growth.
APC mutations are found in upwards of two thirds of all colorectal cancers (MIYOSHI
et al., 1992). However, the true mutation frequency may be much higher, as the
large size of the APC gene makes screening more than a small region of the gene
for mutations technically difﬁcult. In most colon cancers, if not all, mutation of APC
results in the initial tumour growth (LAMLUM et al., 2000).1.6. Genetic alterations in the development of colorectal cancers 45
Wnt-signalling
The tumour suppressing behaviour of APC is certainly to do with its involvement in
the canonical Wnt signalling pathway (see Figure 1.5). Wnts, the human homologs of
the Drosophila Wingless proteins, are a family of secreted proteins that stimulate cell
proliferation. In the absence of Wnt, in the cytoplasm of the cell, APC forms the so
called destruction complex, along with Axin and Glycogen Synthase Kinase 3 (GSK-
3). The destruction complex recruits the intra-cellular signalling molecule -catenin.
Whilst bound to the destruction complex, -catenin is phosphorylated, marking it for
subsequent degradation.
The Wnt ligands bind to the Frizzled family of cell surface receptors. The Frizzled
receptors usually interact with adjacent LRP transmembrame proteins. Binding of
Wnts to the Frizzled receptors results in the recruitment of the protein Dishevelled
to the plasma membrane. In turn, this results in the recruitment of Axin, and possibly
the entire destruction complex, to the membrane, causing inhibition of the destruction
complex. Thus, -catenin is no longer degraded and so can accumulate in the nucleus,
where it stimulates proliferation through binding of transcription factors. For a detailed
review of canonical Wnt signalling see KLAUS and BIRCHMEIER (2008).
Mutation locations
Most APC mutations are found between codons 1250-1450, and this region
is correspondingly termed the mutation cluster region (MIYOSHI et al., 1992).
Furthermore, most mutations in APC that are observed in colon cancers result in a
stable truncated protein product. The truncated protein appears necessary for cell
proliferation: in cancer cells that express only a truncated APC protein, inhibition of
the protein product reduces cell proliferation (SCHNEIKERT and BEHRENS, 2006).
Knudson’s famous two-hit hypothesis states that tumour suppressor genes require
two inactivating mutations, one on each allele, to permit tumour growth (KNUDSON,
1971, 2001). It appears that APC is not a classical tumour suppresor gene in this
sense, since removal of all the APC protein is very rare, probably because this does
not provide an optimal growth advantage. Presumably then, the spectrum of APC
mutations observed in colon cancers is the spectrum of mutations which provide an46 Chapter 1. Introduction
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Figure 1.5: Canonical Wnt signalling pathway. A: In the absence of Wnt, -catenin is
marked for degradation by the destruction complex involving APC.
B: In the presence of Wnt, Axin is localised to the cell surface, leading to inactivation
of the destruction complex. -catenin is then able to accumulate in the nucleus where
it stimulates cell proliferation through transcription factor binding.1.6. Genetic alterations in the development of colorectal cancers 47
optimal growth advantage to tumour cells.
The spectrum of APC mutations selected in cancers must be related to the function
of the resulting mutated protein. The middle of APC, at codons 1266, 1379 and
1495 respectively, is the location of the so called 20 amino acid repeats (20 AARs)
(SEGDITSAS and TOMLINSON, 2006). The 20AARs are responsible for -catenin
binding. Thus, truncation of the protein between codons 1250-1450 affects the
efﬁciency of APC to bind -catenin and presumably affects the concentration of -
catenin in the nucleus. The ﬁrst SAMP (serine alanine methionine proline) repeat in
APC is located at codon 1580. SAMP repeats bind Axin, and so are required for the
formation of the destruction complex. Nearly all mutations in APC truncate the protein
before the ﬁrst SAMP repeat.
Just-right mutations
The two hits at APC are non-random (SEGDITSAS and TOMLINSON, 2006), in that the
location of the mutation on the ﬁrst allele will tend determine the type or location of
the mutation on the second allele. In this sense, the type of ﬁrst hit selects the second
hit. The combination of hits appears to select for the retention of an “optimal” number
of 20AARs. The association between ﬁrst and second hits is most clear in the colonic
tumours from FAP patients, where the ﬁrst “hit” is in the germline (LAMLUM et al.,
1999; ALBUQUERQUE et al., 2002; CRABTREE et al., 2003). A germline truncation
between the ﬁrst and second 20AARs is strongly associated with a second hit via
loss of heterozygosity (LOH). LOH is usually the result of mitotic recombination.
A germline truncation before the ﬁrst 20AAR is usually associated with a somatic
mutation between the second and third 20AAR. A germline mutation after the second
20AAR usually results in a somatic mutation before the ﬁrst 20AAR. Combinations
of mutations in APC thus select for retention of between 1 and 2 20AARs. Similar
associations are seen in sporadic colon cancers (ROWAN et al., 2000).
Disease severity
In FAP patients, germline mutations around codon 1309 are associated with the
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associated with less severe disease than mutations in the MCR (CRABTREE et al.,
2002). These differences may be due to variations in the efﬁcacy of Wnt signalling in
the mutated cells. Mutant APC proteins that retain the ﬁrst 20AAR -catenin binding
repeat are able to modulate the recruitment of -catenin to the nucleus (SCHNEIKERT
and BEHRENS, 2007), suggesting that the just-right combinations of APC mutations
select for an “optimal” level of Wnt-signalling.
Additionally, APC mutations around 1309 seem to require LOH, a relatively more
frequent event than a truncating mutation, to achieve a ‘just-right’ combination of
mutations. Thus, the rate of polyp formation in the bowel of an 1309-FAP patient
may be higher than in other FAP genotypes, which may explain the increased disease
severity.
1.6.2 K-ras
Mutations in the K-ras oncogene are a frequently observed alteration in colorectal
cancer, occurring in around 40% of all cancers (WOOD et al., 2007; ANDREYEV et al.,
1998). K-ras mutations are associated with an increase in tumour size (VOGELSTEIN
et al., 1988). Unlike APC, K-ras mutations tend to be restricted to just two codons, 12
and 13. In a wild-type sequence, codons 12 and 13 both code for glycine. Mutations
resulting in a change to a valine or aspartine at codon 12 (G12V and G12D mutations
respectively) are most common.
Wild-type K-ras proteins are located against the inner cell membrane layer and maybe
either in an active or inactive state. Activation of K-ras can initatiate multiple signalling
cascades that can promote cell proliferation, angiogenesis and suppress apoptosis,
through pathways including the RAS/RAF, RAS/PI3-K and RAS/RAL (reviewed in
CASTAGNOLA and GIARETTI (2005)). Wild-type K-ras remains activated for only
a short time before hydrolysis reverts the protein to its inactive state. Oncogenic
mutations in K-ras cause a constitutively active protein product, presumably causing
sustained activation of pathways that promote cell proliferation and angiogenesis, and
suppress apoptosis.
As with mutations in APC, certain K-ras mutations are associated with a worse
prognosis. A large meta-analysis showed that K-ras G12V mutation is associated with1.7. Genetic instability in tumorigenesis 49
the worse clinical outcome than any other mutation type, increasing both the risk of
mortality and remission (ANDREYEV et al., 2001).
K-ras is also implicated in Wnt signalling. Transfection of a mutant K-ras G12V
allele into cancer cell lines with wild-type K-ras alleles caused an increased in the
nuclear accumulation of -catenin and inhibited the activity of GSK-3, and appeared
to act through the PI3-K pathway (LI et al., 2005). Other in-vitro work on colorectal
cancercellcultureshasshownthattheover-expressionof-catenincancauseincreased
activity of downstream targets of the RAS-MEK-ERK pathway, and conversely, over-
expression of APC inhibits the activity of the targets (PARK et al., 2006). Thus, the
signaling pathways controlled by K-ras and APC may overlap, and so the mutational
spectrum of the two genes may be linked. This idea is considered in Chapter 5 of this
thesis.
1.7 Genetic instability in tumorigenesis
Tumorigenesis requires alterations to a number of genes. If the rate of mutation per
gene is  per cell division, then, asymptotically, in a static population, the rate at
which n genes are mutated is proportional to n (ARMITAGE and DOLL, 1954). If
the rate of gene mutation is small, and a number of genes are required for cancer
formation, then this rate is vanishingly small. Thus, genetic instability has been
suggested as an important driving force in tumorigenesis (RAJAGOPALAN et al., 2003;
KOMAROVA et al., 2002). Consequently, many groups have investigated the role
of genetic instability in tumorigenesis. Much work has been focused on estimating
the proportion of cancers that show genetic instability, and at which stage of tumour
development instability arises.
Genetic instability can be broadly classiﬁed into two main types: chromosomal
instability (CIN) and microsatellite instability (MSI). Evidence for chromosomal
instability is discussed brieﬂy in the following section, but chromosomal instability
is not considered in this thesis and so a detailed discussion is beyond the scope of
this introduction. Instead the reader is referred to the reviews of RAJAGOPALAN et al.
(2003) and SIEBER et al. (2003). Microsatellite instability is considered in detail in
Chapter 6 and correspondingly, is considered in more detail here.50 Chapter 1. Introduction
1.7.1 Chromosomal instability
CIN+ cancers tend to be deﬁned by their having frequent gross chromosomal
alterations, usually aneuploidy or polyploidy. In contrast to MSI tumours (discussed
below), CIN has not been established as a dynamic process representative of the
cell having acquired a mutator phenotype, and, correspondingly, deﬁnitive genetic
alterations that cause CIN have not yet been established.
A minority of cancers show frequent large scale part-chromosome deletions, regarded
as evidence of chromosomal instability (JONES et al., 2007). Apc =+ 1638N mutant
mice show evidence of aneuploidy in small adenomas, suggesting that some kind
of genetic instability occurs early in tumour development (ALBERICI et al., 2007).
Apc is involved in mitotic spindle orientation, and germline defects in Apc cause
chromosome misalignment in mouse embryonic stem cells (FODDE et al., 2001). In
Apc =+ 1638N mice which also had loss of p53, a more severely disrupted karyotype
was observed, suggesting chromosomal instability may be a more prominent feature of
later cancer development (ALBERICI et al., 2007). On the other hand, SIEBER et al.
(2002) found little evidence for CIN in 55 human colorectal adenomas: most adenomas
were diploid and showed no evidence of chromosome karyotypic aberrations when
examined with comparative genomic hybridisation. SHIH et al. (2001) used single
nucleotide polymorphisms to identify allelic imbalance in small colorectal adenomas.
They identiﬁed frequent LOH on chromosomes 1, 5, 8,15 and 18, which they suggested
was due to chromosomal instability, although the possibility that the pattern of LOH
could simply be due to allelic loss, followed by reduplication, rather than gross genetic
instability, cannot be discounted. Gross karyotypic abnormalities undoubtedly occur
in a large number of colorectal cancers. It remains unclear though, whether these
alterations are an indication of an underlying unstable genome, or the result of a
one-off selectively advantageous event that, for example, removes a functional tumour
suppressor gene or causes polyploidy.
1.7.2 Microsatellite instability
Microsatellites consist of a short, repeated, motif of bases and are found throughout the
genome(DE LA CHAPELLE,2003). Forexample, thesequenceCACACACACACACACA1.7. Genetic instability in tumorigenesis 51
forms a dinucleotide microsatellite of length eight motif repeats.
Microsatellite instability (MSI) is a particular form of genetic instability that is
relatively common in colorectal cancer. MSI is characterised by somatic alteration of
the number of motif repeats at many microsatellite (MS) loci. The somatic alterations
are due to slippage, whereby the DNA replication enzyme polymerase can “slip” a
number of motif repeats when synthesising the repetitive microsatellite regions (DE LA
CHAPELLE, 2003).
Whilst it is unlikely that the microsatellite instability has any selective effect upon
a cell per-se, microsatellite slippage in a MS locus within a tumour suppressor or
oncogene can cause a change in the protein structure, often a truncated protein product.
In this manner, the acquisition of an MSI phenotype accelerates tumour progression.
Indeed, patients with Hereditary Non-Polyposis Colorectal Cancer (HNPCC), who
have inherited defects in their mis-match repair machinery, causing MSI, will tend
to be diagnosed with a tumour around twenty years prior to the general population
(KINZLER and VOGELSTEIN, 1996). HNPCC is discussed further below.
Detection of microsatellite slippage is via routine polymerase chain reaction (PCR)
techniques. MS loci are ﬁrst PCR ampliﬁed. Somatic alteration of the MS in the
tumour, relative to the germline, can be identiﬁed by gel electrophoresis as changes, in
the allele length affect the motility of the PCR product through the gel.
MSI-H
Around 15% of tumours have extensive MS slippage at many of the loci examined
(DE LA CHAPELLE, 2003). Accordingly, these cancers are labelled high-level
microsatellite unstable (MSI-High, or MSI-H). MSI-H cancers have genetic or
epigenetic defects in their mismatch repair (MMR) machinery (DE LA CHAPELLE,
2004; HOEIJMAKERS, 2001), a mechanism that proof-reads and corrects errors in
DNA replication (IYER et al., 2006). Thus in MMR deﬁcient cancers, MSI results
from a persistent inability of the cancer cells to identify and repair replication errors
(PARSONS et al., 1993).
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MMRgenes, andsoexhibitMSI-H(KINZLER and VOGELSTEIN,1996). Thedominant
germline mutations are typically in MLH1 (PAPADOPOULOS et al., 1994) and MSH2
(FISHEL et al., 1993). Sporadic cancers identiﬁed as MSI-H often have somatic
mutations in these genes, or, more often, show hyper-methylation of the hMLH1
promoter which is associated with protein loss (KANE et al., 1997; VEIGL et al.,
1998).
MSI-L
In addition to the MSI-H cancers, it has been suggested that there is a second distinct
group of cancers that are characterised by a low-level of microsatellite instability
(termed MSI-Low cancers or MSI-L). Identiﬁcation of MSI-L cancers is inherently
problematic. Microsatellite loci are prone to slippage: estimates of the meiotic MS
slippage rate per MS locus range from 10 9 to 10 6 (BHATTACHARYYA et al., 1994;
HANFORD et al., 1998; KRUGLYAK et al., 1998; LAI and SUN, 2003), compared to
a baseline point mutation rate which may be as low as 10 10 per base per division
(ELMORE et al., 1983; SJ¨ OBLOM et al., 2006). Tumour growth involves many rounds
of cell division, providing ample opportunity for MS slippages to accumulate in tumour
cells. Thus, apparent low level microsatellite instability in a tumour may be attributable
to normal somatic slippage that is expected during tumour growth. Accordingly, a
large study, that genotyped 90 non MSI-H cancers at 377 loci, showed that if enough
loci were examined, an unstable locus would nearly always be found (LAIHO et al.,
2002).
Nevertheless, many groups have attempted to characterise the group of putative MSI-
L cancers. MSI-L status is usually identiﬁed by slippage by at least one locus, and
usually less than 30% of the loci, examined (reviewed in TOMLINSON et al. (2002)).
KETS et al. (2006) showed a weak association between MSI-L cancers and lymphocyte
invasion. WHITEHALL et al. (2001) showed an association between methylation of O
6-Methylguanine DNA Methyltransferase a DNA repair enzyme, although a subsequent
study failed to repeat this observation (HALFORD et al., 2005). Suggestions that MSI-L
was associated with K-ras mutation by JASS et al. (1999) again could not be veriﬁed in
a subsequent study by LAIHO et al. (2002). MSI-L has not been shown to correlate1.7. Genetic instability in tumorigenesis 53
strongly with worse prognosis or any other clinico-pathological variable (WRIGHT
et al., 2005; HALFORD et al., 2002).
MSI-L is considered in detail in Chapter 6. A mathematical model that predicts the
degree of MSI expected in cancer from normal somatic slippage is developed, and used
to assess the evidence for MSI-L in a cohort of colorectal cancers.
1.7.3 Clonal expansion versus genetic instability
Whilst genetic instability (GI) undoubtedly occurs in some colorectal cancers, such
as in the tumours of HNPCC patients as noted above, it is hotly debated whether GI
is necessary for tumorigenesis. Mathematical modelling has been used to attempt to
answer this question. TOMLINSON et al. (1996) used a simple argument to suggest
that GI was unlikely early event in tumorigenesis. They showed that if tumour
growth required just two hits, and the acquisition of genetically unstable phenotype
also required two hits, then cancers that formed rapidly were unlikely to have genetic
instability, since this required the cancer to acquire four hits in a short period of time. If
the number of mutations required for tumour growth was increased, then GI was more
likely to be an early event in tumorigenesis.
A more sophisticated model was developed by Nowak and colleagues. Their stochastic
modelconsideredtheAPCmutationinacoloncrypt(NOWAK etal.,2002; KOMAROVA
et al., 2002). Wild-type cells could acquire a ﬁrst APC hit at a low basal and the
second hit occurred via LOH event or second point mutation. Alternatively, a wild-
type cell could acquire mutations that caused chromosomal instability, which increased
the rate of LOH in an APC =+ cell. In contrast to the previous work of Tomlinson
and colleagues, Nowak’s model also considered the dynamics of the stem cell niche in
a colon crypt. Mutations had only a ﬁnite probability of ﬁxation in the niche, and so
could be lost from the niche. Using this framework, they showed that if the number of
cells in a crypt susceptible to cancerous mutation was small, then CIN could precede
APC inactivation. A caveat of this conclusion was that LOH occurs at a similarly low
frequency to point mutations. If the rate of LOH was greater than the rate of point
mutations, as may well be the case, then CIN was unlikely to be a initial event in
tumorigenesis.54 Chapter 1. Introduction
In their seminal work, ARMITAGE and DOLL (1954) attempted to estimate the number
of mutations required to transform a somatic cell into a cancer cell. The modelling
framework introduced by Armitage and Doll has subsequently been adapted to study
the competing roles of mutation and clonal expansion in tumour growth. Armitage and
Doll noted that a log-log plot of the number of cancer related mortalities against age
followed an approximately straight line, for many cancer types. Thus the frequency
of cancer related deaths was roughly proportional to the nth power of age. For many
cancer types, including colorectal cancer, the gradient of this line was about n = 6.
Armitage and Doll showed that a multistage model of tumour progression, which
required n + 1 changes to transform a normal cell to a cancer cell, was consistent
with this data. In their model, the rate of acquiring a single mutation in time t was t,
and so the rate of at which a cell acquired n + 1 mutations was then asymptotically
proportional to nth power of age:
formation rate  123 :::n+1t
n (1.1)
AdaptingtheframeworkprovidedbyArmitageandDoll, LUEBECK and MOOLGAVKAR
(2002) described the effect of clonal expansion in a multistage model of tumorigenesis.
After acquiring a pre-determined number of mutations, a mutant cell lineage could
then initiate tumour growth. Tumour cells acquired additional mutations to become
cancerous. The model was compared to age-incidence data on colorectal cancer
formation. Fitting of the model suggested that the rate of the initial (APC) mutations
was low - so genetic instability was unlikely to be an early event in tumorigenesis.
All but one of the subsequent changes were also predicted to occur at a low rate, so
that it was not necessary to invoke genetic instability to explain the cancer incidence
data. In fact, models that use incidence data to infer the number of mutations required
for malignant transformation depend strongly on underlying assumptions about clonal
expansion. HORNSBY et al. (2008) demonstrated that including clonal expansion in a
multistage model strongly affected the estimate of the number of alterations that occur
during tumour growth. Furthermore, the clonal expansion considered in their model
was minimal; a clone of size of around 150 cells was assumed to form after 50 years.
This highlights the need for better understanding of the role of clonal expansion in
tumour growth. In particular, understanding the role that clonal expansion plays in1.7. Genetic instability in tumorigenesis 55
determining the spectrum of mutations present in a cancer is important for determining
the initial events in tumorigenesis. This is considered in Chapters 5 and 6 of this
thesis.
Clear evidence for the importance of clonal expansion in driving tumour progression
was demonstrated by BEERENWINKEL et al. (2007). Their model attempted to explain
the presence of the large number of mutations observed in colon and breast cancers
(SJ¨ OBLOM et al., 2006; JONES et al., 2007). In their model, tumour growth began
following APC inactivation. The tumour was assumed to grow at a constant rate, but
the rate of subclone growth (or retardation) was determined by the relative ﬁtness of
the subclone, as speciﬁed by the subclone’s genotype. A cancer was formed after
at least one subclone had acquired k = 20 mutations. The authors found that it
was not necessary to invoke an increased mutation rate in the model to explain the
genetic diversity observed in cancers. Instead, it was sufﬁcient to assume that each
additional mutation in a subclone bestowed an additional selective advantage of around
just 1%. Increasing the mutation rate accelerated cancer progression. Thus, selection,
not mutation, drove cancer progression.
Whilst genetic instability may accelerate tumour progression, through increasing the
rate of tumorigenic mutations, it is conceivable that it may also have a deleterious
effect on the tumour cell population. Genome wide genetic instability presumably
increases the rate of mutations in genes necessary for cell function, so called house-
keepinggenes. Thusageneticallyunstablecellmaybemorelikelytoacquiremutations
that make it less ﬁt relative to the other cells in the tumour, and so in this manner,
geneticinstabilitymaybeselectedagainst. Usingacontinuummodel, wherecellﬁtness
was described as a continuous function of the mutation rate, Sole et al. predicted that
a genetically unstable tumour population would be maintained by a few genetically
stable cancer stem cells. However, the robustness of this conclusion is confounded by
the fact that the authors did not permit mutation in the cancer stem cells, so it is unclear
whether the stratiﬁcation of the tumour population by genetic instability is a natural
consequence of tumorigenesis, or an artefact of the model. The relationship between
the mutation rate and the balance between positive and negative selection warrants
further study.56 Chapter 1. Introduction
Since mutations tend to occur during DNA replication and chromosome segregation,
the large number of divisions involved in tumour growth can generate genetic diversity
in a population of tumour cells. In this sense, the genetic diversity generated by clonal
expansion may be analagous to the genetic diversity generated by a mutator phenotype.
Chapter 6 of this thesis assesses the degree of genetic diversity that can be generated in
a population of tumour cells, without an elevated mutation rate.
1.8 Conclusion
This chapter has described the basic biology of stem cells and of the colonic epithelium.
The joint roles of mutation and selection in transforming normal somatic cells to
invasive cancer cells have been discussed. The need to understand how mutations can
arise and spread, both prior to and during tumour growth, has been highlighted. This
need is addressed in the remainder of this thesis.
In Chapter 2, a model of the stem cell niche in the Drosophila testes is developed. This
model is used to demonstrate how a sporadically mutated stem cell can be selectively
advantageous in the niche.
In Chapter 3, clonal expansion in the human colon is considered. The rate of crypt
ﬁssion, the probable primary mechanism of mutant clone expansion in the colon, is
estimated. The importance of crypt ﬁssion in ﬁxing mutations in single crypts is also
explored.
In Chapter 4, the laboratory techniques used to analyse the clonal structure of small
colorectal adenomas are described.
In Chapter 5, the clonal structure of a number of small colorectal adenomas is reported.
The mutation status of the APC and K-ras genes was determined on a crypt-by-crypt
basis in 12 sporadic adenomas. The implications of this clonal mapping for the order
of, timing of, and relationship between APC and K-ras mutations is discussed.
In Chapter 6, a mathematical model of somatic microsatellite slippage during cancer
growth is developed. The model is used to analyse the evidence for low-level
microsatellite instability in a cohort of colorectal cancers.1.8. Conclusion 57
Finally, in Chapter 7, the implications of this thesis for future research are
discussed.58 Chapter 1. IntroductionChapter 2
Stem cell division in the Drosophilia
Testis
2.1 Aims
 Examine stem cell division in the Drosophila testis as a case study for examining
stem cell regulation and survival in human tissues.
 Predict the behaviour of sporadically occurring mutant stem cells in the
Drosophila testes, which have acquired mutations in speciﬁc genes.
 Demonstrate that some mutations, that are insufﬁcient to initiate tumour growth,
can still rapidly reach ﬁxation within a stem cell niche.
2.2 Chapter Summary
Stem cell regulation is critical for development and tissue homoeostasis. Further, most
cancers are likely to originate from stem cells, since only stem cells have lineages
that are long enough to be likely to acquire the multiple genetic mutations required
for the initiation of neoplastic growth (CAIRNS, 2002; CALABRESE et al., 2004).
Stem cells have the self-renewing properties required for tumour growth, whereas
more specialised cell types would require a more redical alteration of their phenotype
to become oncogenic (PIERCE and SPEERS, 1988). Therefore, understanding the
mechanisms responsible for stem cell regulation, and therefore stem cell survival, is60 Chapter 2. Stem cell division in the Drosophilia Testis
essential for understanding the initial events in tumour formation.
Stem cells are thought to be spatially deﬁned by physical interactions with a local
extra-cellular environment or niche (WATT and HOGAN, 2000). Multiple stem cells
are present in a niche (BARKER et al., 2007; YATABE et al., 2001; G¨ ONCZY and
DINARDO, 1996), and potentially one stem cell may acquire a selective advantage
from a sporadic mutation that allows its progeny to become dominant in the niche.
In this manner, oncogenic mutations, which by themselves are insufﬁcient to initiate
tumour growth, can accumulate in a stem cell population. Studying stem cell survival
inhumansisdifﬁcult; therearefewreliablestemcellmarkers(MOLOFSKY etal.,2003;
LESSARD and SAUVAGEAU, 2003; BARKER et al., 2007; SANGIORGI and CAPECCHI,
2008) and time course experiments are usually impractical.
In this Chapter, stem cell survival in the Drosophila testis was studied. The Drosophila
testes is a relatively well characterised niche, and so provided an excellent model
system to investigate stem cell survival. In particular, there were sufﬁcient data to
permit investigation of the behaviour of phenotypically altered stem cells within the
niche. In the ﬂy testis, stem cells are clustered around a hub of non-dividing cells
(G¨ ONCZY and DINARDO, 1996). The hub secretes a niche-signal which maintains cell
stemness (TULINA and MATUNIS, 2001; KIGER et al., 2001). As cells move away
from the hub, the strength of the niche signal decreases, causing cells to differentiate.
Stem cell numbers are controlled by regulation of the angle of the mitotic spindle
during cell division (YAMASHITA et al., 2003, 2007). New daughter cells are produced
away from the hub, so that they receive a reduced niche-signal and subsequently
differentiate.
I have developed and analysed a mathematical model of stem cell survival in the
Drosophila testes. The model was used to investigate the behaviour of phenotypically
abnormal stem cells in an otherwise wild-type niche. The parameters of the model were
estimated from published data (YAMASHITA et al., 2007; WALLENFANG et al., 2006)
and veriﬁed against a third published data set (TULINA and MATUNIS, 2001). The
model was then used to predict the selective advantage of sporadically mutated stem
cellclonesintheniche. Simulationsofstemcellsthathadhomozygousmutationsinthe
apc1 and apc2 genes, which caused an impaired ability to correctly align their mitotic2.3. Introduction 61
spindle (YAMASHITA et al., 2003, 2007), revealed that these mutations were selectively
advantageous in a niche composed of otherwise wild-type cells. Further, the mutant
cells were predicted to rapidly displace wild-type cells from the niche. Additionally,
the simulations predicted that cells with mutations in the cetrosonin (cnn) gene, which
also resulted in an impaired alignment of the mitotic machinery (YAMASHITA et al.,
2003, 2007), were also selectively advantageous.
Analysis of the model revealed properties of a stem cell that conferred a survival
advantage in the Drosophila testes stem cell niche. The model demonstrated that stem
cell mutations that may have oncogenic potential, but are insufﬁcient to initiate tumour
growth, can rapidly become ﬁxed in a stem cell niche, and so predispose to further
oncogenic development.
2.3 Introduction
2.3.1 Tissue structure and role of stem cells
Many tissues in the human body are rapidly renewed. For example, the cells that form
the epithelium of the large intestine have a life-time of around one week until they are
replaced (BRITTAN and WRIGHT, 2004b). Tissue renewal is driven by the division
of stem cells (BRITTAN and WRIGHT, 2004a). Stem cells have the ability to divide
either symmetrically or asymmetrically, producing, respectively, either two daughter
stem cells or two differentiated cells, or a stem cell, and a differentiated cell (WATT
and HOGAN, 2000). The differentiated cell can undergo further amplifying divisions,
which produce the specialised cells that form the majority of a tissue or organ.
Understanding the behaviour of stem cells is therefore crucial to understanding
development and homoeostasis. Dysregulation of stem cell division is also likely to
be the initiating event in tumorigenesis, since only stem cells have a high replicative
potential, and lineages that are long enough to be likely to acquire oncogenic mutations
(PIERCE and SPEERS, 1988; CAIRNS, 2002). Knowledge of stem cell dynamics and
crucially, stem cell survival within a niche, is therefore necessary to understand the ﬁrst
events in neoplastic growth.
Studying stem cell and niche interactions is difﬁcult. There are few available stem cell62 Chapter 2. Stem cell division in the Drosophilia Testis
markers (reviewed in (WEISSMAN et al., 2001)), and notably none which have been
conclusively shown to identify stem cells in the human or murine colon (BARKER
et al., 2007; LEEDHAM et al., 2005; SANGIORGI and CAPECCHI, 2008). Further,
stem cells appear to be spatially deﬁned by the location relative to the stem cell niche
(WATT and HOGAN, 2000; WEISSMAN et al., 2001). In human colonic crypts for
example, stem cells are thought to reside near to the base of each crypt, proximal to the
pericryptal myoﬁbroblasts. The myoﬁbroblasts are thought to secrete some members of
the Wnt family of growth factors which reportedly promotes stemness (GREGORIEFF
et al., 2005). Cells differentiate as they migrate away from the crypt base, along the
crypt axis. The inter-dependency of a stem cell and its niche means that, to study
stem cell survival, observations must be made in vivo (THEISE, 2004), which makes it
impractical to observe stem cell survival in humans.
A cell’s intrinsic properties also affect its stemness. For example, germline loss of Tcf4,
an integral component of the Wnt signalling pathway (see Introduction section 1.6.1),
leads to the loss of all intestinal crypts in mice (KORINEK et al., 1998), presumably
because the cells can no longer respond to niche survival signals.
2.3.2 Stem cells in the Drosophila Testes
One well-studied stem cell compartment is in the Drosophila testis. In male fruit ﬂy
testis, aboutninegermlinestemcells(GSCs)areclusteredaroundahubofnon-dividing
cells that express a niche-signal, the ligand Unpaired (Upd). Upd stimulates the JAK-
STAT (Janus kinase-signal transducer and activator of transcription) signalling cascade
that causes cells to retain their stem cell identity (KIGER et al., 2001; TULINA and
MATUNIS, 2001). Thus, proximity to the hub maintains stemness. As GSCs move
away from the hub, the niche signal decreases and the cells differentiate (see Figure
2.1).
In the Drosophila testes, stem cell numbers are regulated by a simple mechanism that
preferentially distributes daughter cells to speciﬁc locations in the niche. Positioning
of daughter cells is controlled by the angle of the mitotic plane. YAMASHITA et al.
(2003) showed that the stem cells usually align their mitotic spindle perpendicular to
the hub surface, so that one daughter cell is produced close to the hub niche whereas2.3. Introduction 63
testes ( 2% of total stem cells) in 0- to
2-day-old adults. Spindles were not oriented
toward the hub in gonialblasts (Fig. 1C).
Drosophila male GSCs maintained a fixed
orientation toward the hub throughout the cell
cycle, unlike Drosophila embryonic neuro-
blasts or the Caenorhabditis elegans P1 cell,
in which spindle orientation is established
during mitosis by a programmed rotation of
the spindle (5, 6). The single centrosome in
early interphase GSCs was consistently locat-
ed adjacent to the hub (Fig. 1D, arrow). After
centrosome duplication, one centrosome re-
mained adjacent to the hub, whereas the other
migrated to the opposite side of the nucleus
(Fig. 1, D to F). The mechanisms responsible
for Drosophila GSC spindle orientation may
differ between sexes. In female GSCs, the
spectrosome, a spherical intracellular mem-
branous structure, remains localized next to
the apical cap cells, where it may help anchor
the spindle pole during mitosis (7). In inter-
phase male GSCs, in contrast, the spectro-
some was often located to the side, whereas at
least one centrosome held the stereotyped
position adjacent to the hub (Fig. 1G).
To investigate centrosome function in orien-
tation of male GSCs, we analyzed males that
were null mutant for the integral centrosome
component centrosomin (cnn)( 8, 9), which is
required for normal astral microtubule function
(10). In cnn mutant males, mitotic spindles were
not oriented toward the hub in 30% (n   100)
of the dividing GSCs examined (Fig. 2A). In an
additional 10 to 20%, spindles were properly
oriented, but the proximal spindle pole was no
longer closely associated with the cell cortex at
the hub-GSC interface and the entire spindle
was displaced away from the hub (Fig. 2B). The
frequency of spindle orientation defects was
highest in metaphase (Fig. 2C). Loss of function
of cnn also partially randomized the interphase
centrosome positioning in male GSCs. In more
than 35% of the cnn mutant GSCs with dupli-
cated centrosomes that were scored (table S1),
neither centrosome was positioned next to the
hub (Fig. 2, D and E).
The number of germ cells associated with
the hub was increased 20 to 30% in cnn
mutant males, from an average of 8.94 GSCs
per hub in the wild type to 11.89 GSCs per
hub in cnnHK21/cnnHK21 (P   1.3   10–8)
and 10.69 GSCs per hub in cnnHK21/cnnmfs3
(P   7.2   10–6) (Fig. 2F and table S1). Hub
size was not significantly different in cnn
compared with wild-type males (table S1). In
cnn testes with many stem cells, GSCs ap-
peared crowded around the hub and often
seemed attached to the hub by only a small
region of cell cortex (Fig. 2, G to J). Finite
available physical space around the hub may
limit the increase in stem cell number in cnn
mutant males.
As suggested by the increased stem cell
number, there were several cases in both live
and fixed samples from cnn males in which a
stem cell that had recently divided with a
mitotic spindle parallel to the hub-GSC inter-
face produced two daughter cells that re-
tained contact with the hub (Fig. 2K), a find-
ing that was not observed in the wild type.
We also observed GSCs dividing with a mis-
oriented/detached spindle that lost attachment
to the hub (Fig. 2L), probably explaining the
mild increase in stem cell number relative to
the frequency of misoriented spindles.
The normal close attachment of one spindle
pole to a region of the GSC next to the hub and
the effects of cnn mutants on centrosome and
spindle orientation suggest that a specialized
region of the GSC cell cortex touching the hub
mightprovideapolaritycuetowardwhichastral
microtubules from the centrosome and spindle
pole orient. High levels of DE-cadherin (fly
epithelial cadherin) and Armadillo (Arm; fly
 -catenin) colocalized at the hub-GSC interface
(Fig. 3, A to C), as well as at the interface
between adjacent hub cells, marked by high
levels of Fas III (Fig. 3C). High levels of DE-
cadherin and Arm were not detected around the
rest of the GSC surface. Forced expression of
DE-cadherin–GFP specifically in early germ
cells (4) confirmed that DE-cadherin in GSCs
colocalized to the hub-GSC interface (Fig. 3D).
DE-cadherin and Armadillo at the hub-
GSC interface may provide an anchoring
platform for localized concentration of
Apc2, one of two Drosophila homologs of
the mammalian tumor suppressor gene Ad-
enomatous Polyposis Coli (APC)( 11, 12),
which in turn may anchor astral microtu-
bules to orient centrosomes and the spindle.
Immunofluorescence analysis revealed Apc2
Fig. 1. Male GSCs orient toward the hub throughout the cell cycle. (A) In the apical tip of a Drosophila
testis, male GSCs are visualized with nos-gal4-VP16/upstream activating sequence (UAS)–GFP– -
tubulin (4). GSCs form a rosette of GFP-positive cells around and touching the GFP-negative hub (*).
(Arrowhead) A GSC undergoing mitosis. (B) A schematic of GSCs (green) surrounding the hub (orange).
The proximal spindle pole in GSCs always associated with the hub-GSC interface (red line), with the
other pole on the opposite side. (C) Spindles oriented perpendicular to the hub in GSCs but not
gonialblasts. Pro, prophase; prome, prometaphase; meta, metaphase; and, anaphase; tel/later, telophase
or later phase. (D and E) Oriented centro-
some position in interphase male GSCs
around the hub. GFP– -tubulin (green);
antibody to  -tubulin (red). [(D), arrow]
Early interphase cell with a single centro-
some. [(E), arrows] A recently duplicated
centrosome pair adjacent to the hub of a
midinterphase cell. [(D) and (E), arrow-
heads] Later interphase cells with one
centrosome adjacent to the hub and the
other migrating around the nucleus. Cen-
trosomes are marked only when all cen-
trosomes in a cell were visible in a single
confocal microscope plane. (F) Centro-
some position in male GSCs during the
cell cycle, with the approximate percent-
age of cells that were observed for each
indicated centrosome position (n   300).
The hub (blue), centrosomes (red), and
microtubule (green) are shown. (G) The
spectrosome (blue, arrowhead, antibody
to  -spectrin) was not consistently ori-
ented toward the hub in interphase. An-
tibody to Centrosomin (red, arrow); GFP–
 -tubulin (green). Scale bar, 10  m.
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Figure 2.1: Micrograph of Drosophila testes hub and GSCs. The asterisk marks the
position of the hub cells, and clustered around the hub are GSCs. The arrow indicates
a dividing cell. The image is from a transgenic ﬂy where -tubulin content has been
ﬂuorescently labelled with green ﬂuorescent protein (GFP). The mitotic spindle, with
a high -tubulin content is clearly visible in the dividing cell. Perpendicular alignment
of the spindle to the surface of the hub is observed. Image reproduced with permission
from YAMASHITA et al. (2003).
the other is produced at a distance and subsequently differentiates. In this manner, stem
cell numbers remain constant within a niche.
Disruption to the mitotic machinery alters stem cell survival in the Drosophila testes.
The testes of ﬂies that were mutants for the integral centrosome component centrosonin
(cnn) showed frequent misalignment of the mitotic spindle, causing both daughter stem
cellstoremainincontactwiththehubaftermitosis, withanoverallincreaseinstemcell
numbers (YAMASHITA et al., 2003). Similar behaviour was observed in ﬂies carrying
mutations in apc1 and apc2 genes (YAMASHITA et al., 2003). apc1 and apc2 are
ﬂy-homologues of the human APC gene (see Introduction 1.6.1), and are involved in
anchoring microtubules which in turn orientate the centrosomes and the mitotic spindle
(YAMASHITA et al., 2003; ETIENNE-MANNEVILLE and HALL, 2003).
Another factor important for stem cell survival in the Drosophila testes is the ability
of a stem cell to respond to niche signals. Disruption to components in the JAK-STAT
signalling pathway that maintains GSC identity in the Drosophila testes causes loss of
the stem cell population, whereas ectopic expression of the niche ligand Upd maintains64 Chapter 2. Stem cell division in the Drosophilia Testis
stem cell identity even when a cell is detached from the hub (KIGER et al., 2001;
TULINA and MATUNIS, 2001).
In this chapter, the importance of niche location and responsiveness to niche signals on
stem cell survival in a model of the Drosophila testes stem cell niche is investigated.
A mathematical model is developed which describes clonal evolution in the stem cell
niche. The model is used to examine the ability of a mutant stem cell to completely
displace wild type stem cells, and hence invade a niche. Using data on the behaviour
of wild-type and mutant stems cell (TULINA and MATUNIS, 2001; YAMASHITA et al.,
2003, 2007; WALLENFANG et al., 2006), predictions are made about how stem cells
with speciﬁc types of mutation will behave in the niche.
2.4 Methods
2.4.1 Mathematical model of stem cell division
The model described N stem cells that were clustered around a central hub that secreted
an attractive niche-signal. It was assumed that cells were adequately represented in two
dimensions by circles of radius r. The strength of the niche signal was described by the
function w(h), where h was the distance of a cell from the hub. It was assumed that the
strength of the niche signal decreased linearly with distance from the hub so that:
w(h) = 1  
h
hmax
(2.1)
where hmax was a normalising factor. At h = 0 a cell was just touching the surface of
the hub and had a niche signal of 1.
At division, each stem cell produced a daughter cell at an angle  to the radial line from
the hub, so that the vertical distance of the daughter cell from the hub was 2rcos()
(see Figure 2.2). The niche signal for this daughter was then:
w(h) = 1  
2rcos()
hmax
= 1   scos() (2.2)
where s was a spatial scaling factor.
Each cell had a sensitivity  for the niche signal. A cell with a large value of  was
inﬂuenced strongly by the niche signal. A cell with a large value of  was likely to be
able to attach successfully to the hub.2.4. Methods 65
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Figure 2.2: Cartoon of mathematical model construction. The hub of non-dividing cells
secretes a niche signal, the ligand Unpaired. Stem cells in close proximity to the hub
receive a strong niche signal, which stimulates the JAK-STAT pathway, and maintains
stemness. Stem cells that move away from the hub receive a decreased niche signal and
so differentiate.
The attraction A of a cell to the hub was then deﬁned as the product of the sensitivity
of the cell to the niche signal and the magnitude of the signal:
A = w(h) (2.3)
Hence the attraction of the cell to the hub depended upon the distance of the cell from
the hub.
After division, a daughter cell could occupy the position in the niche that was occupied
by its nearest neighbouring stem cell. Competition for a place in the niche was decided
by comparison of the attraction of the two competing cells for the hub. The cell that
had the greatest attraction remained in the niche, whereas the other cell was lost from
the niche and differentiated. After division, and the competition for spaces in the niche,
precisely N cells remained in the niche.
The distribution of values of  was modelled using a von-Mises distribution with
mean 0 = 0 and concentration parameter . Von-Mises distributions are the circular
analogue of the normal distribution, periodic for theta in the range [0;2], so are
appropriate for describing an angle. Then the probability density of  was given
by:
P(j0 = 0;) =
1
2I0()
e
 cos (2.4)66 Chapter 2. Stem cell division in the Drosophilia Testis
where I0 was a modiﬁed Bessel function of the ﬁrst kind. The concentration parameter
 controlled how peaked the distribution was. Large values of  gave distribution that
was strongly peaked around 0, whereas smaller values of theta gave a more uniform
distribution. A cell with a larger value of  therefore tended to align its mitotic
machinery perpendicular to the surface of the hub and so produce a daughter cell at
angle  close to 0. Conversely, a cell with a small value of  frequently misaligned its
mitotic spindle.
2.4.2 Estimation of spindle alignment parameter H
The mitotic spindle alignment tendency parameter for wild-type cells, H, was
estimated. To do this, it was assumed that each GSC would produce two GSC offspring
at the same frequency that misaligned centrosomes were observed. The frequency of
mis-orientated centrosomes observed in wild-type GSCs ranged between 1.3-12.2%
(YAMASHITA et al., 2003, 2007), but misaligned mitotic spindles were never observed
in wild-type GSCs (YAMASHITA et al., 2003). Therefore it was assumed that spindle
alignment is difﬁcult to score reliably and so underestimated the rate at which one
GSC produced two GSC offspring. It was assumed that 6.1% of GSCs divisions
produced two GSC offspring, according to the frequency of misorientated centrosomes
in cnnHK21=+ ﬂies reported in YAMASHITA et al. (2007). Then, to estimate the
corresponding value of H, the model was repeatedly simulated, with increasing values
of H, to approximate the function P(correctly aligned centrosomes) = f(H) (see
Figure 2.3). Values of H were then calculated from this function. Additionally,
without loss of generality, wild-type cell sensitivity was normalised to 1.
2.4.3 Estimation of stem cell division rate
Stem cell division rates were estimated by analysis of BrdU labelling data from
WALLENFANG et al. (2006). Brieﬂy, ﬂies were fed on a yeast paste which had been
mixed with Bromodeoxyuridine (BrdU). BrdU is incorporated into cells during DNA
replication, and can be detected by immunohistochemistry. At t =12, 24, 36, and 48
hours of BrdU exposure, 10 ﬂies were culled, and the mean proportion of BrdU labelled
GSCs per testis was recorded. The proportions were labelled Obs
12 , Obs
24 , Obs
36 and Obs
48
respectively (see Table 2.1).2.4. Methods 67
Hours of BrdU Exposure Proportion of labelled stem cells
12 0.127
24 0.324
26 0.628
48 0.887
Table 2.1: Proportion of BrdU labelled GSCs against time. Data published in
WALLENFANG et al. (2006).
A priori minimum (tmin) and maximum (tmax) durations of the cell-cycle were deﬁned.
tmin represents the minimum time required for cell division, whereas tmax represented
an upper limit so that 99% of GSC cell divisions had a cell-cycle duration less than
tmax. Estimates for tmin and tmax were 12 and 60 hours respectively.
The distribution of cell-cycle times for T > tmin was then assumed to follow a log-
normal distribution. In the absence of knowledge about the true distribution of cell-
cycle times, the log-normal distribution was chosen because it has a Gaussian like
shape, so that most cells had similar cell-cycle times, and also because the distribution
was deﬁned on the semi-inﬁnite plane [0;1) so that cell-cycle times were always at
least as long as tmin.
The log-normal distribution has two parameters:  and . Making the substitution
t0 = t   tmin, then the probability of a cell having a maximum cell-cycle duration of t
was:
P(cell-cycle duration T  t) = P(T
0  t
0) =
1
2
+
1
2
erf

ln(t0)   

p
2

(2.5)
Applying the a priori limits on the duration of the cell-cycle gave P(T  tmax) = 0:99.
Hence equation 2.5 could be solved with t = tmax to ﬁnd:
 = f() =
ln(48)   
p
2erf
 1(0:98)
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Hence the distribution of GSC cell-cycle durations (T) was deﬁned as:
P(T < t) =0 where t < tmin
P(T < t) =
1
2
+
1
2
erf

ln(t   tmin)   
p
2f()

where t  tmin (2.7)
It remained to estimate the value of  from the BrdU labelling data. When BrdU
containing yeast paste was ﬁrst made available to the ﬂies, they did not immediately
feed. In the absence of better knowledge, it was assumed that the duration between
the availability of BrdU labelled yeast paste and the time when a ﬂy began feeding
was uniformly distributed on [0;24] hours. When ﬂies were ﬁrst exposed to BrdU,
each GSC in a ﬂy’s testes could be at any point in its cell-cycle. Assuming that cell
division was not synchronous, then the position in the cell-cycle of a GSC with cell-
cycle duration T was described with a uniform distribution on [0;T]. The half-life
of BrdU was neglected: the BrdU yeast paste was assumed to label cells with ﬁxed
efﬁcacy.
A niche was initialised with N = 9 wild-type GSCs which had H as estimated above.
The time at which the ﬂy ate the BrdU labelled food (A hours), was sampled from the
uniform distribution on [0;24]. For cell i = 1;:::;9, the cell-cycle duration (Ti) was
sampled from the distribution deﬁned in equation 2.7 above. The position of cell i in
the cell-cycle (Ci) was then sampled from a uniform distribution on [0;Ti]. Hence the
division time of the cell was Di = Ti   Ci. If Di  A then the labelling time of the
cell was Di, since the ﬂy had consumed BrdU prior to the GSC division. Otherwise
the labelling time was Di + c Di, where c Di was a second sample from the distribution of
cell-cycle times in equation 2.7.
An Approximate Bayesian Computation method was then used to estimate 
(BEAUMONT et al., 2002). For each repeat of the simulation, a value of  was
sampled from a uniform prior distribution on [0;10]. This sampled value was labelled
S. Following the experimental method of Wallenfang et al. ten niches were then
initialised as described above, using the sampled S, and then simulated until t = 48
hours had elapsed. At t =12, 24, 36 and 48 hours the mean proportion of labelled cells
in the ten niches was computed. These proportions were labelled 
Comp
1 , 
Comp
2 , 
Comp
3
and 
Comp
4 respectively. The value of S was then accepted as an observation from the2.4. Methods 69
posterior distribution of  if
 
4 X
j=1
j
Comp
j   Obs
j j
Obs
j
(2.8)
where  was a suitably small value. The simulation was repeated 106 times to form
a posterior distribution for est (see Figure 2.4). 95% credible intervals for est were
approximated by calculating the 2.5% and 97.5% percentiles of this distribution.
To evaluate the value of  that provided an appropriately stringent acceptance threshold,
themeanvalueand95%crediblepointsofwereplottedasafunctionof. For < 0:2
the mean and 95% credible points were approximately constant in value (see Figure
2.5), so did not depend strongly on the value of . Hence an acceptance threshold of
 = 0:2 was used.
The estimated value of  was est = 3:23 (2 dp) with 95% credible intervals 2.74
- 3.61 (2 dp). The ﬁt of the model to the Wallenfang data is shown in Figure 2.6.
This corresponded to a mean GSC division rate as one division every 39.4 hours (95%
credible intervals 31.6 - 49.4 hours).
2.4.4 Veriﬁcation of wild-type cell parameters
Using the parameters estimated above, the rate of loss of labelled wild-type cells, as
reported in TULINA and MATUNIS (2001), was computed (displayed in Table 2.2).
In TULINA and MATUNIS (2001), wild-type cells were labelled by heat shock at day
0. After 2 days, 55% of niches contained at least one labelled cell. It was assumed
that the number of labelled cells per niche two days post labelling followed a Poisson
distribution. Maximum likelihood estimation of the Poisson distribution parameter
gave  = 0:7985. Then, to compute the proportion of labelled niches after 2 days,
the model was initialised at t = 2 days post-labelling, with L labelled cells in the
niche, where L was sampled from the Poisson distribution estimated above. The model
was then simulated and the fate of the labelled cells was recorded. The proportion of
niches that contained a labelled cell after t was calculated by repeated simulation of
the model (R = 106 repeats), and then counting the proportion of these R repeats that
resulted in a niche containing a labelled cell at t = 2;:::;10 days post-labelling.
Credible intervals for the proportion of labelled niches at t days post-labelling were70 Chapter 2. Stem cell division in the Drosophilia Testis
Days after induction Proportion of testes with
at least one labelled GSC
2 0.55
3 0.32
5 0.48
9 0.38
Table 2.2: Data from Tulina et al. on the proportion of labelled niches after heat shock
induced labelling. Data reproduced from TULINA and MATUNIS (2001)
calculated using a bootstrap method. Following the experimental method of TULINA
and MATUNIS (2001), at t = 2, 3, 5 and 9 days post-labelling, 105 sets of n = 20 niches
were sampled, with replacement, from the R = 106 simulation repeats. The proportion
of labelled niches in each set was then computed. These proportions approximated the
sampling distribution of the number of niches containing a labelled cell at t days post
labelling. 95% credible intervals were determined by calculating the 2.5% and 97.5%
quantiles of the sampling distribution.
The ﬁt of the model to the data from TULINA and MATUNIS (2001) is displayed in
Figure 2.7.
2.4.5 Mutant Cells
Two types of mutant cells were possible in the model. Mutant cells could have a
sensitivity to the niche signal, M, or a tendency to align their mitotic spindle M,
that was different to the wild-type stem cell population.
To examine the behaviour of mutant stem cells, a niche of host cells with parameters
H and H was constructed. At time t = 0 a single mutant cell with parameters M and
M was introduced into the niche by mutating one of the host cells. The lineage of this
mutant cell was then tracked. For a given set of parameters the simulation was repeated
many times (R = 106 repeats) and the proportion of runs where the mutant lineage
successfully displaced all other cells in the niche was recorded. Also, the average2.4. Methods 71
time to invasion and loss, and the clonal stabilisation time were computed. The clonal
stabilisation time was the average time taken to either invasion or loss of the mutant
cells.
Speciﬁc mutant genotypes
To predict the behaviour of a sporadic mutant stem cell with a speciﬁc mutation in
either the cnn, apc1 or apc2 genes, the mitotic spindle alignment parameter M for
each mutant cell type was estimated. This was done according to the method for wild-
type cells described above, using the centrosome misalignment frequencies reported in
YAMASHITA et al. (2003). Estimated values of M are shown in Tables 2.3 and 2.4,
and are indicated on Figure 2.3. Additionally the simplifying assumption that mutant
GSCs have the same sensitivity to the niche signal as wild-type cells was made. A
niche that contained a single mutant cell at time t = 0 was then simulated, and the rate
and likelihood of mutant cell invasion was examined. The likelihood and rate of mutant
invasion for each mutant genotype are displayed in Tables 2.3 and 2.4.72 Chapter 2. Stem cell division in the Drosophilia Testis
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2.5 Results
2.5.1 Wild-type stem cell parameters
Stem cell division rate
The stem cell division rate  and mitotic spindle alignment tendency parameter H of
wild-type cells was inferred. Each stem cell was estimated to divide once every 39.4
hours (95% credible intervals 31.6 - 49.4 hours) (see Figures 2.6 and 2.4).
Mitotic spindle alignment tendency
The alignment tendency of wild-type cells was estimated at H = 2:188 (see Figure
2.3).
Fit to data of Tulina et al.
To conﬁrm the estimation of these parameters, the model with these fuitted parameters,
was compared to data from TULINA and MATUNIS (2001) on the loss of labelled wild-
type cells from the niche (see section 2.4.4). Figure 2.7 shows the ﬁt of the model,
with parameters as stated above, to the data from TULINA and MATUNIS (2001).
The model approximated the observed loss of wild-type cells well, although slightly
over-estimated the number of labelled cells per niche two days post-labelling. This
was likely to be because the number of GSCs per niche declines slowly with age
(WALLENFANG et al., 2006), but this phenomenon was not described in the model.
Also, stem cells that had undergone recombination as a result of the heat shock
treatment may have been less ﬁt than other GSCs, so prone to loss from the niche.
This was not considered in the model.
2.5.2 Invasion of mutant cells
The behaviour of sporadic mutant stem cells in the niche was investigated by exploring
the behaviour of the model in M, M parameter space. Mutant cells with a high
sensitivity for the niche signal (M > H) were likely to invade, and correspondingly
mutants with a low sensitivity for the niche (M < H) were unlikely to invade (see
Figure 2.8A). Mutants invaded faster as their sensitivity to the niche signal increased2.6. Discussion 81
(seeFigure2.8C).Cellswithdisruptedmitoticmachinery, whichreducedthelikelihood
that they would successfully align their mitotic spindle perpendicular to the hub, were
more likely to invade the niche than cells with their mitotic machinery intact. Invasion
was most likely when there was no tendency for a mutant to align its mitotic spindle
perpendicular to the niche (M ! 0) (see Figure 2.8B). Mutants invaded faster as the
mitotic spindle machinery became increasing disrupted (see Figure 2.8D).
2.5.3 Predictedinvasionrateofstemcellswithspeciﬁcmutations
The behaviour of sporadic mutant GSCs with speciﬁc mutations in the apc1, apc2 or
centrosonin (cnn) genes in an otherwise wild-type niche was investigated. For each
mutantstrainofstemcell, thetendencyofthemitoticspindletoaligncorrectly, M, was
estimated. The behaviour of a sporadic mutant stem cell in a niche was then simulated,
and the likelihood and rate of mutant invasion were calculated (see Tables 2.3 and 2.4).
cnnHK21/cnnHK21 and apc1Q8/Df mutants, both of which had severely disrupted mitotic
machinery, were most likely to invade, with predicted mean invasion times of 53.4
(25.5-99.0) and 47.5 (23.5-86.9) days, respectively. Other mutant strains invaded more
slowly, so that predicted invasion times were much longer than the average lifetime of
a ﬂy. Hence, these invasion times cannot be measured directly in a ﬂy and therefore
must be inferred.
2.6 Discussion
In this chapter, a mathematical model that describes the propagation of sporadic mutant
stem cells in the Drosophila testes was developed. The model predicted that stem cells
that had acquired mutations which disrupted the alignment of the mitotic machinery
during cell division were likely to displace wild-type cells and hence become ﬁxed
in the niche. As the tendency of the mitotic spindle to align with the hub surface
decreased, the likelihood that a mutated cell would invade increased. When the mitotic
machinery was disrupted, a stem cell often produced a daughter cell close to the surface
of the hub. The proximity to the hub provided the daughter cell with a strong attractive
niche signal, so that the cell could compete favourably for a place in the niche.
Previously published work has shown that germline inactivation of apc1, apc2 or cnn82 Chapter 2. Stem cell division in the Drosophilia Testis
genes in the Drosophila testes results in stem cells with misaligned mitotic spindles
(YAMASHITA et al., 2003). The model developed in this chapter predicted that sporadic
mutations of apc1, apc2 or cnn in a germline stem cell were selectively advantageous
for the cell and increased the likelihood of the mutant cell invading the stem cell niche.
The rates of invasion of cells with speciﬁc sporadic mutations were also predicted (see
Tables 2.3 and 2.4). These predictions could be tested by experiment in a chimeric ﬂy
where apc1, apc2 or cnn could be selectively inhibited. The predictions were based on
a niche which initially contained a single mutant stem cell, and the other cells in the
niche were wild-type. In practice, induction of mutant cells in adult ﬂies would tend to
produce niches that initially contained more than one mutant cell per niche. It would
be straightforward to modify the model to describe that situation.
The model also predicted that mutant stem cells that had acquired an increased
sensitivity for the niche signal were likely to invade, as they were better able to compete
with their neighbouring stem cells for a position in the niche. The adenomatous
polyposis coli gene (APC), the mammalian homologue of apc1 and apc2, is implicated
in cell migration and cell-cell adhesion (MAHMOUD et al., 1997; FAUX et al., 2004)
so it is conceivable that mutations to apc1 and apc2 could confer increased sensitivity
to the niche signal in ﬂy testes. Correspondingly, in the testes of apc1 and apc2 mutant
ﬂies, increased numbers of stem cells are seen clustered around the hub (YAMASHITA
et al., 2003), which is indicative of an increased sensitivity to the niche signal, and
correspondingly in testes where the niche signal ligand Unpaired was over-expressed
stem cell numbers increased (TULINA and MATUNIS, 2001; KIGER et al., 2001). Thus
the actual selective advantage of apc1 and apc2 mutants (Tables 2.3 and 2.4) may be
greater than predicted. Conversely, the model predicts cells with a low sensitivity to
the niche signal are rapidly lost from the niche, which agrees with the observation that
induced Stat92E mutant cells in adult ﬂies, which cannot effectively transduce the Upd
niche signal, are lost from the niche within a week (TULINA and MATUNIS, 2001;
KIGER et al., 2001).
Many mutations found in tumour cells may occur before visible tumorigenesis since
some oncogenic mutations do not initiate tumour growth (KINZLER and VOGELSTEIN,
1997; JONES et al., 2008b). This pre-tumour progression must occur predominately in2.7. Conclusion 83
stem cells, since only stem cells have lineages long enough to be likely to accumulate
the necessary multiple oncogenic mutations (CAIRNS, 2002; CALABRESE et al., 2004).
Stem cell niches contain multiple stem cells, and like any ecological niche that has an
upper limit on the number of cells it can support, selection or drift is expected between
similar but non-identical daughter cells. It is impossible to know a priori which
stem cells will acquire oncogenic mutations before initiating tumour growth, therefore
studying pre-tumour progression is prohibitively difﬁcult. The model presented in
this chapter illustrated how studying the behaviour of mutant cells in a simple model
system can reveal stem cell phenotypes that promote stem cell survival. Stem cells in
human niches may acquire mutations that are insufﬁcient to initiate neoplastic growth,
but which provide the stem cell with a selective advantage, which causes increased
longevity of the mutant lineage. The model presented in this chapter illustrates how
stem cells may acquire pro-oncogenic mutations which then become ﬁxed in the niche.
Therefore, the mutant stem cell lineage is more likely to acquire further mutations that
may promote, and eventually prompt, cancer growth.
2.7 Conclusion
A simple mathematical model was developed that described the behaviour of sporadic
mutant stem cells in the Drosophila testes. The model predicted that mutations
which caused misalignment of the mitotic machinery of a stem cell were selectively
advantageous in the niche, as were mutations which increased a cell’s ability to respond
to the niche signal and so compete favourably with other stem cells for a position in the
niche. The model illustrated how mutations which may have oncogenic potential, but
were insufﬁcient to initiate tumour growth, could become rapidly ﬁxed in a niche, and
so predispose to subsequent progression to cancer.
2.8 Future work
2.8.1 Additional model complexity
The model developed in this chapter was designed to be a basal description of stem
cell dynamics in the Drosophila testes, developed in order to investigate the behaviour84 Chapter 2. Stem cell division in the Drosophilia Testis
of sporadic mutant cells in a niche. In order to describe more precisely the true
behaviours of germline stem cells in the Drosophila testes, additional behaviours could
be introduced into the model. For example, the number of germline stem cells per
niche decreases with age (WALLENFANG et al., 2006), but this is not described in the
model. Also, recent research suggests that the strength of the niche-signal is decreased
in older ﬂies (BOYLE et al., 2007); this could also be described in the model. Further,
mutations in apc1, apc2 and cnn genes alter the number of stem cells per niche. In the
model presented in this chapter, the number of stem cells per niche is ﬁxed. The model
could be modiﬁed to allow ﬂuctuations in stem cell numbers.
2.8.2 Experimental systems
In this chapter, the likelihood and rate of invasion of several sporadically occurring
mutations have been predicted. The predictions could be tested in a suitable ﬂy
model, where speciﬁc mutations could be induced in adult ﬂies. Speciﬁcally, ﬂies
with inducible mutations in apc1, apc2 or cnn should be created. Standard Flp-
FRT is a suitable technology for induction of mutant clones, and could be used in a
manner similar to the induction of STAT92E mutant clones described in (TULINA and
MATUNIS, 2001).Chapter 3
Crypt ﬁssion in the human colon
3.1 Aims
 Describe the spread of mutant clones in the human colon
 Estimate the duration of the crypt cycle.
 Examine the effect of crypt ﬁssion on the expansion of mutant clones.
3.2 Chapter Summary
Cancer can be considered a stem cell disease, since it is argued that only stem
cells have lineages long enough to be likely to accrue sufﬁcient mutations to initiate
tumorigenesis. Understanding how mutations can arise and spread in a stem cell
population is therefore crucial to understanding the early events in tumour formation.
In this chapter, the spread of mutations in the stem cell population of the human colonic
epithelium is examined.
The lining of the colon is covered in small invaginations called crypts. Each crypt is
maintained by a number of stem cells that are thought to reside close to the crypt base,
in the SC niche (POTTEN and LOEFFLER, 1990; SPRADLING et al., 2001).
Recently, the mechanism of clonal expansion of colonic stem cells has been elucidated
(GREAVES et al., 2006). Using mitochondrial DNA mutations as clonal markers, it
was demonstrated that a mutant stem cell can displace the other, wild-type, stem cells
from the niche, and so become dominant in the niche. This clonal expansion process is86 Chapter 3. Crypt ﬁssion in the human colon
termed niche succession (YATABE et al., 2001; CAMPBELL et al., 1996). Subsequent
clonal expansion is through crypt ﬁssion, whereby one parent crypt divides to produce
two daughter crypts. The period of time between ﬁssion events deﬁnes the crypt life-
cycle, termed the crypt cycle (TOTAFURNO et al., 1987). The duration of the crypt
cycle is of considerable interest, particularly because crypt ﬁssion is the primary mode
of expansion of colorectal adenomas (PRESTON et al., 2003; BJERKNES et al., 1997).
The previous estimate of the duration of the crypt cycle in humans was based on a
heuristic comparison between murine and human crypts, and suggested that the number
of crypts in the colon doubles every 9-18 years (CHENG et al., 1986a).
In this Chapter, the duration of the crypt cycle is inferred from data on the spread
of cytochrome-c-oxidase (COX) deﬁcient crypts through the colonic epithelium
((GREAVES et al., 2006) and unpublished data) using a parsimonious ordinary
differential equation (ODE) model of the clonal expansion in the colon. Some mtDNA
mutations cause a cell to become COX-deﬁcient. COX-deﬁciency is readily detected
usingahistochemicalstain(TAYLOR etal.,2003). ACOX-deﬁcientcellcanrepopulate
an entire crypt through niche succession. Observations show that COX-deﬁcient crypts
form at a low rate throughout adult life (TAYLOR et al., 2003). Since the rate at which
entire crypts become COX-deﬁcient is low, spatially adjacent COX-deﬁcient crypts are
likely to share a common ancestor. This was conﬁrmed by direct sequencing of the
entire mitochondrial genome: adjacent COX-deﬁcient crypts shared identical mtDNA
mutations that were not seen in the surrounding wild-type crypts (GREAVES et al.,
2006).
Fitting the model to the data suggested that the mean duration of the crypt cycle is
23.6 years (CI: 17.3-32.6 years). This estimate is longer than the previous available
estimate of 13-26 years (calculated from an estimated crypt doubling time of 9-18
years) (CHENG et al., 1986a). Further, the model suggests that crypt ﬁssion increases
the likelihood that a mutant cell will become ﬁxed in the epithelium. Therefore, ﬁssion
causes oncogenic mutations, which themselves may be insufﬁcient to initiate tumour
growth, to become ﬁxed in a crypt. This predisposes to subsequent adenomatous
growth. The low rate of ﬁssion in wild-type crypts may be an anti-tumorigenic
mechanism designed to restrict the spread of mutant clones in the colon. The increase3.3. Introduction 87
in the ﬁssion rate in adenomatous growths is therefore likely to be a pivotal event in
colorectal tumorigenesis.
3.3 Introduction
The colon, the last section of the gastrointestinal tract, has a rapidly renewing
epithelium. Estimates suggest that cells on the epithelium have a lifetime around one
week in the mouse large bowel (POTTEN and LOEFFLER, 1990). The surface of the
colon is lined with millions of small invaginations called crypts (see Introduction,
Section 1.3). Each crypt contains stem cells which are thought to be located
towards the crypt base (BRITTAN and WRIGHT, 2004b). Stem cells can undergo
asymmetric division to produce a daughter stem cell and a daughter differentiated
cell. Subsequently amplifying divisions of the differentiated cells maintain the crypt
population (BJERKNES and CHENG, 1999). No deﬁnitive marker for colonic stem cells
has, as yet, been identiﬁed, and various indirect assays have been used to estimate the
number of stem cells per crypt; estimates range from 4 to around 30 (see Introduction,
Section 1.3.4).
Within a crypt, stem cell division must be tightly regulated to ensure homoeostasis, and
like any constrained population in an ecological niche, stem cells undergo random drift,
whereby one stem cell lineage will replace all the others (YATABE et al., 2001). This
replacement process is termed niche succession. A neutral mutation arising in the stem
cell pool, which results in a partially mutated crypt, can reach ﬁxation in the crypt via
this process, and so produce a wholly mutated crypt.
Cryptsaredynamicstructures. Cryptscandividethroughaprocesstermedcryptﬁssion,
which is analogous to cell division. Fission begins at the base of the crypt, splitting the
stem cell pool between the two daughter crypts, and proceeds along the vertical crypt
axis (see Figure 3.1). Presumably, subsequent rounds of stem cell divisions restore the
normal complement of cells in each daughter crypt.
Colonic cancers are thought to originate in colonic crypts (see reviews (POTTEN and
LOEFFLER, 1990; PRETLOW and PRETLOW, 2005)). Adenomatous growth follows the
inactivation of the APC tumour suppressor gene (KINZLER and VOGELSTEIN, 1996;88 Chapter 3. Crypt ﬁssion in the human colon
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Figure 3.1: Cartoon showing process of crypt ﬁssion. Red cells represent stem cells.
A-B: Fission begins at the base of the crypt and proceeds vertically along the crypt axis.
C: Stem cells are divided between the two daughter crypts. D: Subsequent rounds of
cell division restore the stem cell complement of each daughter crypt. Two complete
crypts are formed.
LAMLUM et al., 2000). The mutant APC =  cell lineage is thought to repopulate
the entire crypt. Two theories have been suggested for the subsequent expansion of
the mutant crypt, top-down expansion, whereby cells from a mutant crypt invade a
neighbouring crypt by downward migration from the crypt lumen (SHIH et al., 2001),
and bottom-up expansion (PRESTON et al., 2003) whereby mutant clones form at
the crypt base, and subsequent expansion of the mutated clone is by crypt ﬁssion.
Both mechanisms of expansion do occur (see examples in Chapter 5 of this thesis).
However, it appears that the initial expansion of colorectal adenomas is predominately
through crypt ﬁssion, and later growth also involves top-down spread (PRESTON et al.,
2003). The number of crypts in ﬁssion is increased around sixteen-fold in adenomas
(PRESTON et al., 2003; WONG et al., 2002), which is indicative that an increase
in the rate of crypt ﬁssion in a mutated crypt is an important early development in
tumorigenesis in the colon. Thus the regulation of crypt ﬁssion in a healthy bowel is
likely to be a crucial homeostatic control.
The method responsible for the initiation of ﬁssion is unknown. TOTAFURNO et al.
(1987) noted that crypts in the murine colon had a Gaussian-like distribution of sizes,
and that crypts in ﬁssion tended to be larger than average. Subsequent observations
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crypt ﬁssion occurs in response to changes in the stem cell number in the crypt. A
mathematicalmodelwhereﬁssionoccursifthenumberofstemcellspercryptexceeded
athresholdvalue(Sf)couldexplaintheformationofadjacentmutantcryptsinresponse
to chemical induced damage in the mouse bowel (LOEFFLER et al., 1993, 1997).
Biomechanicalmodellingsuggeststhattheincreasedcellnumbercouldcausesbuckling
of the epithelial cell layer of the crypt relative to the underlying lamina propria, which
could be the trigger to initiate ﬁssion (EDWARDS and CHAPMAN, 2007).
The distribution of crypt sizes, and the fact that around 3% of crypts in the murine
colon are branching at any instant (TOTAFURNO et al., 1987), led Bjerknes and Cheng,
in their series of seminal papers, to suggest that crypts had a natural life-cycle, termed
the crypt cycle (CHENG et al., 1986b,c; BJERKNES, 1986; TOTAFURNO et al., 1987).
The crypt cycle deﬁnes the period of time between successive ﬁssion events in a
single crypt. To estimate the duration of the crypt cycle in humans, CHENG et al.
(1986b) assumed that the number of crypts in the colon was growing exponentially
such that:
N(t) = A0e
t (3.1)
(where N(t) was the number of crypts in the colon at time t,  was the growth rate of
crypts, and A0 the number of crypts at t = 0). Setting  = log(2)=C they had that the
number of crypts doubles in time C. The time C was deﬁned as the mean duration of
the crypt cycle. Rearranging equation 3.1 for C gave:
C =
tlog(2)
log

N(t)
N(0)
 (3.2)
Then to estimate the crypt doubling time, it remained to estimate the change in the
number of crypts in the interval [0;t]. Examination of the colons of 11 patients
suggested that the percentage of crypts in the human colon that were in ﬁssion at any
one time was 0.44%. Observations of the murine colon suggested that duration of a
ﬁssion event in the mouse was between 5 and 10 days, and that the crypt stem cell
cycle duration was between 15-23 hours. Cheng and Bjerknes estimated the frequency
of stem cell division was four-fold greater in the murine colon than in the human, and so
assumed that the duration of crypt cycle would also be four-fold greater in the human.
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colon would increase by 0.44%. Inserting these numbers into equation 3.2 yielded an
estimateofthedurationofthe cryptdoublingtime asbetween9-18years. Thisheuristic
estimate has remained the de facto estimate of the crypt cycle duration in the human
colon.
Crypt extinction or death is not thought to occur. Observations over a three week period
of the same section of murine colon in three mice showed no evidence of crypt loss
(BJERKNES, 1986), although the reliability of these experiments is questionable. It is
difﬁcult to conﬁrm reliably the identity of individual crypts in the malleable bowel,
and also extinguished crypts may have been rapidly replaced so that dying crypts may
not have been observed. Given the large number of crypts in the colon, around 107,
it seems very unlikely that occasional stochastic crypt death does not occur, especially
since inﬂammation is associated with increased levels of oxidative stress (reviewed in
PAVLICK et al. (2002)) which can cause cell apoptosis (reviewed in KANNAN and JAIN
(2000)).
In this chapter, the duration of the crypt cycle is inferred from the data on the spread
of mutated clones through the epithelium. Cytochrome-c-oxidase (COX) deﬁciency,
which usually results from a mutation in the mitochondrial genome, was used as a
lineage marker to trace the spread of mutated clones. COX-deﬁciency is not thought to
confer a selective advantage on a cell (MCDONALD et al., 2006b).
COX deﬁciency is readily detected using two-colour histochemical staining (TAYLOR
et al., 2003). After staining, COX-deﬁcient cells appear blue, and wild-type cells
appear brown. Greaves et al. used COX-deﬁciency to trace the expansion of
mutated clones through the colonic epithelium. COX-deﬁcient cells could form in
a crypt, producing a partially mutated crypt (PMC), and then repopulate the entire
crypt, forming a wholly mutated crypt (WMC). A WMC could then undergo ﬁssion,
producing a patch of WMCs. Patches expanded through subsequent ﬁssion events.
The mean patch size increased with age, which was taken as evidence of the crypt-
cycle.
COX mutations occurred relatively infrequently, and were very rarely in seen patients
agedlessthan40years. COX-deﬁcientcryptsthatwerespatiallyadjacentwerelikelyto3.3. Introduction 91
share a recent common ancestor. This was conﬁrmed by direct sequencing of the entire
mitchondrial genome in single cells dissected from adjacent mutated crypts. Adjacent
crypts shared the exact same mutation; the probability of this happening at random
was estimated to be 2:48  10 9 (GREAVES et al., 2006). A micrograph of a patch of
COX-deﬁcient crypts is shown in Figure 3.2.
Figure 3.2: A patch of COX-deﬁcient crypts in a section of human colonic mucosa.
COX-deﬁciency is revealed as a patch of blue crypts, surrounding wild-type crypts are
stained brown. Picture supplied by Dr Stuart McDonald, Cancer Research UK London
Research Institute.
In this chapter, data on the spread of COX-deﬁcient clones through the human colon
wasusedtoestimatethedurationofthecryptcycle. Incontrasttothepreviousestimate,
the inference of the crypt ﬁssion rate in this Chapter is basely solely of data from the
human bowel. A parsimonious mathematical model of mutation, ﬁxation and crypt
ﬁssion was developed. The model predicted the incidence of COX-deﬁcient crypts
with patient age. Fitting the model to the data yielded an estimate of the crypt ﬁssion
rate. This estimate was conﬁrmed using a more simpliﬁed model which produced a
similar estimate. Subsequent analysis was performed to assess the importance of crypt
ﬁssion in ﬁxing mutations in the colonic epithelium.92 Chapter 3. Crypt ﬁssion in the human colon
3.4 Method
3.4.1 COX-deﬁciency data
Data were collected from colon specimens from 62 patients aged between 25 and 85
years. Data on 48 of these patients had been previously published (GREAVES et al.,
2006), and data on the remaining 14 patients were collected by Stuart McDonald
(CRUK, Histopathology Laboratory, Lincoln’s Inn Fields). COX deﬁciency was
identiﬁed using an histochemical method as described in GREAVES et al. (2006)
and TAYLOR et al. (2003). Brieﬂy, colonic sections were cut to a thickness of
4m and slides were dewaxed as described in Section 4.3.1. Antigen retrieval was
performed by pressure cooking the slides for 3 min in boiling 0.1 M sodium citrate
buffer (pH 6.0). Non-speciﬁc staining was blocked by adding protein block serum-
free ready-to-use buffer (DAKO) for 15 min, then slides were washed three times
in Tris-buffered saline with 0.1% Triton X-100. A 1:100 dilution of mouse anti-
human cytochrome c oxidase subunit I was made in Tris/Triton X-100 and applied
to the sections for 30 min in a humid chamber. Next, slides were washed three
times in TBS/Triton, and then incubated in neat CheMate (Envision) anti-rabbit/anti-
mouse conjugated with horseradish peroxidase (DAKO) and developed in 4 mM
diaminobenzidene tetrachloride (DAKO). The sections were lightly counterstained in
haematoxylin, dehydrated through increasing ethanol washes, cleared with xylene, and
mounted in DPX.
In each specimen, the total number of crypts, and the frequency of wholly-mutated
crypts (COX-deﬁcient in a part of the crypt), and patches of mutated crypts (wholly
COX-deﬁcient), classiﬁed according to the size of the patch, was recorded. This data
are displayed in the Appendix, Section 8.1.
Counts of partially mutated crypts were also occasionally recorded. These counts are
considered unreliable and were neglected from this analysis for the following reasons.
Firstly, distinguishing between a partially mutated crypt and a crypt which contained
cells with a varying level of heteroplasmy for COX-deﬁciency was not possible.
Secondly, conﬁdent identiﬁcation of a partially mutated crypt was not necessarily
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have been acquired by a long-lived commited progenitor cell which would eventually
be lost from the crypt (see examples in HUMPHRIES and WRIGHT (2008)). Thus,
including these partially mutated crypts would confound the analysis of crypt stem cell
dynamics.
3.4.2 Summary statistics
To describe those data, two summary statistics were used: the proportion of counted
crypts that were COX-deﬁcient (1(t)), and the mean number of mutated crypts in
a patch (2(t)). For patient j, aged tj, there were j crypts counted, Mj of which
were COX-deﬁcient. The total number of patches in the sample was denoted by Pj.
Therefore:
1(tj) =
Mj(tj)
j(tj)
2(tj) =
Mj(tj)
Pj(tj) (3.3)
3.4.3 Deterministic model to estimate crypt ﬁssion rate
An ordinary differential equation (ODE) model (Model 1) was used to describe the
propagation of mutations in the colon. Crypts containing a COX-deﬁcient cell were
assumed to form from wild-type crypts at a constant rate of m per crypt per year, in
colons aged more than T years. These partially mutated crypts became wholly mutated
at a rate of c per crypt per year. All crypts divided at a constant rate of f per crypt
per year: thus it was assumed that a crypt becoming COX-deﬁcienct did not alter its
ﬁssion rate.
It was assumed that all partially mutated crypts would become wholly mutated; thus
the parameter m represented the formation rate of COX-deﬁcient crypts that were
destined to become wholly mutated. The true rate at which COX-deﬁcient cells formed
in a crypt would have been higher than m, since some COX-deﬁcient cells would not
havesuccessfullyinvadedthestemcellniche, andthereforewouldhavebeeneventually
lost from the crypt. The assumption that COX-deﬁcient cells formed at a constant rate
from wild-type crypts was almost certainly an over-simpliﬁcation (see Section 3.3),
but was used as an adequate ﬁrst approximation in the absence of information on the
mutation and expansion rate of mtDNA strands containing COX mutations.94 Chapter 3. Crypt ﬁssion in the human colon
The dynamics of the stem cells in the niche were described by the single rate parameter
c. More sophisticated models of niche dynamics have been proposed (see for example
YATABE et al. (2001); LOEFFLER et al. (1997, 1993); MEINEKE et al. (2001)), but the
basal model here was assumed to be sufﬁcient to reasonably describe the conversion
from a partially mutated to a wholly mutated crypt. The dependence of the results on
the value of c was examined.
Under the assumptions of the model, the number of crypts in the colon grew
exponentially at a rate of f per crypt per year. Previous modelling attempts have
speculated that crypt ﬁssion occurs in response to increased stem cell numbers in the
crypt (TOTAFURNO et al., 1987; LOEFFLER et al., 1997; EDWARDS and CHAPMAN,
2007). In this model, the process that initiates ﬁssion was neglected, and it was
assumed that ﬁssion events occur at a constant rate. This basal model allows the
straightforward estimation of the crypt cycle duration, without requiring the postulation
of the mechanism responsible for initiating ﬁssion.
Since relatively few partially mutated crypts are observed, the value of c is likely to be
much greater than f or m. Accordingly, a simpler model (Model 2) was developed
which neglected the process of monoclonal conversion. In this second model, wholly
mutated crypts were formed at a rate m per crypt per year from wild-type crypts. All
crypts underwent ﬁssion at a rate of f per crypt per year. This second, simpler, model
was used to evaluate the results of the ﬁrst model and indicate the independence of the
ﬁtted value of f to the monoclonal conversion rate c.3.4. Method 95
Table 3.1: Deﬁnition of variables and parameters
Variable Deﬁnition Units
N(t) number of wildtype crypts
Q(t) number of partially mutated crypts
M(t) number of wholly mutated crypts
P(t) number of patches of mutated crypts
(t) total number of crypts
m rate of formation of partially mutated crypts per crypt per year
c monoclonal conversion rate per crypt per year
f rate of crypt ﬁssion per crypt per year
T time of formation of ﬁrst wholly mutated crypts years
t transformed time years
1(t) proportion of mutated crypts
2(t) mean patch size
Parameter Deﬁnitions
3.4.4 Model 1: Deﬁnition
The model described above was deﬁned by the following equations:
dN
dt
= fN   mN (3.4)
dQ
dt
= mN + fQ   cQ (3.5)
dM
dt
= cQ + fM (3.6)
dP
dt
= cQ (3.7)
d
dt
= f (3.8)
with the initial conditions:
(0) = N(0) = N0;Q(0) = M(0) = P(0) = 0 (3.9)
Time t = 0 was a transformed time, such that t = t0   T, where t0 was the true age,
in years, of the colon. Equations 3.4 - 3.8 describe the average behavior of the model.96 Chapter 3. Crypt ﬁssion in the human colon
The growth rate of each population of crypts (wild-type, partially mutated, or wholly
mutated) is f per crypt per year. Accordingly, the total number of crypts in the colon,
(t), increases at rate f per crypt per year (Equation 3.8). Wild-type crypts, N(t),
become partially mutated at rate m per crypt per year (Equation 3.4). Monoclonal
conversion of partially mutated crypts, Q(t), occurs at rate c per crypt per year - these
crypts are then wholly mutated, M(t), (Equations 3.5 and 3.6). Since each partially
mutated crypt that is converted to wholly mutated is assumed to form a distinct (new)
patchofCOX-deﬁcientcrypts, theincreaseinthenumberofpatchesovertimeissimply
therateatwhichpartiallymutatedcryptsconverttowhollymutated(Equation3.7). The
initial conditions state that at time t = 0 there are N0 crypts in the colon, and all crypts
are wild-type and so there are no mutated crypts or patches of mutated crypts.
The number of wholly mutated crypts was calculated as the total number of crypts
minus the number of wild-type and partially mutated crypts:
M(t) = (t)   N(t)   Q(t) (3.10)
Expressions for 1(t) and 2(t)
Integrating (3.4) gives:
N(t) = N0 exp[(f   m)t] (3.11)
Similarly, integrating (3.8) gave:
(t) = N0 exp[ft] (3.12)
Substituting N(t) into equation (3.5) and integrating gave:
Q(t) = N0
m
c   m

exp[(f   m)t]   exp[(f   c)t]

(3.13)
Using the expression for M(t) given in equation (3.10):
M(t) = N0 exp[ft]

1   exp[ mt]  
m
c   m
exp[ mt] +
m
c   m
exp[ ct]

(3.14)
Then, dividing by the expression for (t) gave the expression for the proportion of
wholly mutated crypts:
1(t) = 1   exp[ mt]  
m
c   m
exp[ mt] +
m
c   m
exp[ ct] (3.15)3.4. Method 97
Calculation of the mean patch size, 2(t) = M(t)=P(t), required the integration
of equation (3.7). Substituting the expression for Q(t) into (3.7) and integrating
gave:
P(t) = N0
mc
c   m

exp[(f   m)t]
f   m
 
exp[(f   c)t]
f   c
+
c   m
(f   c)(f   m)

(3.16)
Then, after some simpliﬁcation:
2(t) =
(c   m)(f   m)(f   c)
mc

1(t)
(f   c)exp[ mt]   (f   m)exp[ ct] + (c   m)exp[ ft]
(3.17)
Parameter estimation
Values of m, f, c and T were estimated by minimising the error function:
1(m;c;f;T) = (3.18)
P
i
h
b i
1(ti)   1(ti;m;c;f;T)
i2
+
h
b i
2(ti)   2(ti;m;c;f;T)
i2
where b i
1(ti) and b i
2(ti) refer to the data collected on patient i, aged ti. Minimisation
wascarriedoutinRusingthedefaultNealder-Meldsimplexmethod(R DEVELOPMENT
CORE TEAM, 2007).
Conﬁdence intervals were computed using a case resampling bootstrap (RICE, 1994).
For each bootstrap, a new data set b D was constructed by sampling, with replacement,
62 samples from the original data of 62 patients. The value of 1(m;c;f;T)
was then minimised using the data set b D, and the computed values of f, m, c
and T were recorded. Repeated bootstraps ( 104 repeats) gave approximations to
the underlying sampling distributions of the parameters. Conﬁdence intervals for the
parameter estimates were computed by calculating the 2.5 and 97.5 percentiles of the
sampling distributions.
Estimated parameter values, with bootstrap conﬁdence intervals, are displayed in Table
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3.4.5 Model 2: Deﬁnition
Model 2 was a simpliﬁed version of Model 1 that neglected to describe monoclonal
conversion. In Model 2, wholly mutated crypts were produced from wild-type crypts
at a rate of m per crypt per year. The equations for this modiﬁed model were:
dN
dt
= fN   mN (3.19)
dM
dt
= mN + fM (3.20)
dP
dt
= mN (3.21)
d
dt
= f (3.22)
with the initial conditions:
(0) = N(0) = N0;M(0) = P(0) = 0 (3.23)
As before, the total number of mutant crypts was computed as the total number of
crypts minus the number of wild-type crypts:
M(t) = (t)   N(t) (3.24)
Integrating equations (3.19) and (3.22) gave:
N(t) = N0 exp[(f   m)t] (3.25)
and
(t) = N0 exp[ft] (3.26)
Substituting these results into (3.24) gave an expression for M(t):
M(t) = N0 exp[ft](1   exp[ mt]) (3.27)
Finally, integrating (3.21) gave:
P(t) = N0
m
f   m
exp[ft](exp[ mt]   exp[ ft]) (3.28)3.4. Method 99
The two statistics 1(t), the proportion of mutated crypts at time t, and 2(t) the mean
patch size at time t, were used to ﬁt the model to the data.
By deﬁnition:
1(t) =
M(t)
(t) = 1   exp[ mt] (3.29)
2(t) =
M(t)
P(t) =
f   m
m
1   exp[ mt]
exp[ mt]   exp[ ft]
(3.30)
Estimate of m and T
Taking logs of equation (3.29) gives:
log[1   1(t)] =  mt (3.31)
And since t = t0   T, this gives:
log[1   1(t)] =  mt
0 + mT (3.32)
which is of the form y = mx + c. Fitting (3.32) to the data fb i
1(ti)g, using the
default least-squares method in R (R DEVELOPMENT CORE TEAM, 2007), provided
an estimate of T as T = c=m.
Estimate of f
By deﬁnition, for t0  T (t  0), 2(t) = 1. For t0 > T (t > 0), 2(t) is as speciﬁed in
(3.29). The value of f was estimated by minimising the square error:
1(f) =
X
i
h
b 
i
2(ti)   2(ti;f)
i2
(3.33)
using the value of m was computed in 3.4.5. As before, b i
2 refers to the data for
patient i. Conﬁdence intervals were computed using the bootstrap approach described
above.
3.4.6 Stochastic model of mutant clone expansion
To investigate how crypt ﬁssion affected the ﬁxation of mutant cells in the colon it was
necessary to describe the dynamics of stem cells in the niche. To do this, the model
of Yatabe et al. was adapted (for full model deﬁnition see supplementary materials of100 Chapter 3. Crypt ﬁssion in the human colon
YATABE et al. (2001)). In their model, Yatabe and colleagues deﬁned the probabilities
p0, p1 and p2 of a stem cell having 0, 1 or 2 stem cell offspring in a niche that contains
a constant N stem cells. The N stem cells were assumed to divide synchronously, at
rate of one division every 48 hours. Crypt sizes are normally distributed (TOTAFURNO
et al., 1987) so it was assumed that a crypt containing N stem cells represented the
mean stem cell pool size. Division probabilities were constrained so that precisely N
stem cells remained in the niche following ﬁssion. Yatabe et al. estimated the value
of p0, p1 and p2 by comparing their model to data on methylation at neutral loci (see
Introduction, Section 1.4.1), and suggested that p1 = 0:95, and p0 = p2 = 0:025.
Yatabe and colleagues also described the differentiated cell population in their model;
here non-stem cells were assumed to remain in the crypt for only a short time, and so
were neglected.
In this Chapter, the model of Yatabe et at was modiﬁed to describe crypt ﬁssion.
At the initiation of crypt ﬁssion, stem cells were divided randomly between the two
daughter crypts. “Symmetrical ﬁssion”, whereby the N stem cells were divided
evenly between the two daughter crypts, and “asymmetrical ﬁssion” which resulted
in non-even segregation of stem cells, were considered. Without loss of generality,
the number of the original stem cells that were found in the ﬁrst daughter crypt (n1)
after division was n1 = 1 + binomial(N   2;). The number of parent cells in the
second daughter crypt was then n2 = N   n1. For symmetrical ﬁssion,  = 0:5,
and increasingly asymmetrical ﬁssion was represented by decreasing . After ﬁssion,
the full complement of stem cells in the daughter crypts was restored by selecting at
random an appropriate number of stem cells to divide symmetrically to produce two SC
offspring. In this manner, crypt ﬁssion could lead to a partially-mutated crypt becoming
wholly-mutated. For example, a partially mutated crypt could undergo ﬁssion in such a
way that one of the daughter crypts contained only COX-deﬁcient cells. It was assumed
that COX-deﬁcient cells were randomly distributed between the two daughter crypts.
Given that a parent crypt contained M COX-deﬁcient stem cells before ﬁssion, the
number of COX-deﬁcient stem cells found in the ﬁrst daughter crypt after ﬁssion (k)
followed a hypergeometric distribution with parameters N, M and n1, where n1 is
the number of parent stem cells that are segregated to the ﬁrst daughter crypt during3.5. Results 101
ﬁssion.
Simulations began with a crypt that contained a single COX-deﬁcient stem cell. The
niche dynamics model for the crypt was then run, with a ﬁssion rate of f and ﬁssion
symmetry parameter , until the COX-deﬁcient clone was lost from all crypts, or until
a crypt containing only COX-deﬁcient stem cells was formed. The probability that a
mutant cell would succeed in the niche after a given time, with a ﬁssion rate of f, was
approximated by repeatedly running the model and recording the proportion of runs
where the mutant stem cell succeeded in the niche, or was lost from the niche.
3.5 Results
3.5.1 Crypt doubling time
The rate of crypt ﬁssion events, f per crypt per year, was estimated as described above.
f had to be co-estimated with m, the formation rate of COX-deﬁcient cells, c, the
rate at which partially mutated crypts became wholly mutated, and T, the age at which
the ﬁrst COX-deﬁcient cells formed.
Estimated values of the parameters for Model 1 and Model 2 are displayed in Tables
3.2 and 3.3 respectively. The estimated value of f in Model 1 was 0.042 (CI: 0.031-
0.058). This corresponded to a mean crypt cycle duration of 23.6 years (CI: 17.3-32.6
years). The ﬁt of Model 1 to the data is displayed in Figure 3.3.
The estimated value of f from Model 2 (f = 0:042, CI: 0.024-0.058) compared
favourably to Model 1 (f = 0:042, CI: 0.031-0.058), indicating that the value of c
(in Model 1) was indeed larger than the other rate parameters and did not signiﬁcantly
inﬂuence the estimation of f. Correspondingly, the 95% conﬁdence intervals for
c were very wide, as illustrated in Figure 3.4, again illustrating that the estimate
of the rate of crypt ﬁssion did not depend signiﬁcantly on the rate of monoclonal
conversion.
The estimated value of T was around 35 years in both models, consistent with the
observation that few COX-deﬁcient crypts are observed in patients aged less than 40
years.102 Chapter 3. Crypt ﬁssion in the human colon
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Figure 3.3: Fit of Model 1 to mean patch size and proportion of mutated crypts data.
A: Mean patch size vs age. Mean patch size of zero implies no mutated crypts were
observed in the colon biopsy. B: % of colon mutated vs age. The model was computed
with the estimated parameter values as displayed in Table 3.2.3.5. Results 103
0 10 20 30 40 50 60
0
.
0
0
0
.
0
2
0
.
0
4
0
.
0
6
0
.
0
8
0
.
1
0
0
.
1
2
T
T
r
e
l
a
t
i
v
e
 
d
e
n
s
i
t
y
0.000 0.005 0.010 0.015 0.020
0
1
0
0
2
0
0
3
0
0
4
0
0
5
0
0
lm
lm
r
e
l
a
t
i
v
e
 
d
e
n
s
i
t
y
0.02 0.04 0.06 0.08 0.10 0.12
0
5
0
1
0
0
1
5
0
lf
lf
r
e
l
a
t
i
v
e
 
d
e
n
s
i
t
y
10 20 30 40 50
0
.
0
0
.
1
0
.
2
0
.
3
Crypt cycle time
1 lf
r
e
l
a
t
i
v
e
 
d
e
n
s
i
t
y
0 100 200 300 400 500 600 700
0
.
0
0
0
.
0
2
0
.
0
4
0
.
0
6
lc
lc
r
e
l
a
t
i
v
e
 
d
e
n
s
i
t
y
l
l
l
l
l
l
l
l
l
l
Figure 3.4: Histograms showing bootstrapped parameter estimates for Model 1. From
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Table 3.2: Estimated parameter values for Model 1
Parameter Estimate Median 95% limits of estimated parameters
T 35.8 35.2 (26.3-44.2)
m 0.004 0.004 (0.003-0.006)
f 0.042 0.042 (0.031-0.058)
1=f 23.6 23.6 (17.3-32.6)
c 6.9 23.3 (0.054-1708.6)
Table 3.3: Estimated parameter values for Model 2
Parameter Estimate Median 95% limits of estimated parameters
T 35.5 34.8 (18.1-41.8)
m 0.003 0.003 (0.001-0.007)
f 0.042 0.041 (0.024-0.058)
1=f 23.8 24.6 (17.2-42.4)
3.5.2 Fixation of mutations
Using the stochastic model described above, the rate at which ﬁssion ﬁxed mutations
in the epithelium was examined. Mutations were assumed to have no selective beneﬁt
or detriment in the stem cell niche. The ﬁxation of mutations due to ﬁssion depended
upon two parameters: , which controlled the probability of even distribution of stem
cells between the two daughter crypts, and f, the rate of crypt ﬁssion.
A tendency for “symmetrical crypt ﬁssion” ( ' 0:5), such that each daughter crypt
was likely to receive half the total number of stem cells in the parent crypt, increased
the likelihood that a mutation would eventually become ﬁxed in a crypt (see Figure
3.5). When  = 0:5, both daughter crypts were most likely to receive N=2 of the parent
stem cells. To reach the total complement of N stem cells in each daughter crypt,
each of the parent cells underwent a symmetric division which caused the number of3.6. Discussion 105
mutant cells to double. This increased the numbers of mutant cells, and meant that
eventual ﬁxation of the mutant clone was more likely. Immediately after the formation
of a mutant clone, the likelihood of ﬁxation of the clone was highest for values of
 ' 0 (see Figure 3.5.2). This was because for small , shortly after clone formation,
daughter crypts could be formed which contained only a single parent stem cell. The
full complement of the crypt was restored by repeated divisions of this founder cell.
If the founder cell happened to be a mutant cell, this would result in the crypt formed
entirely of mutant cells. For larger values of , this crypt puriﬁcation through ﬁssion
was very unlikely to occur.
Mutant stem cells were increasingly likely to become ﬁxed in a crypt (displace all wild-
type cells) as the rate of ﬁssion increased (see Figure 3.5). The rate at which a clone
becomes ﬁxed in a crypt increased as the ﬁssion rate increased (see Figure 3.5.2). This
is because ﬁssion causes an increase in stem cell number, and so an increased ﬁssion
rate tends to increase the number of mutant cells which makes ﬁxation of a mutant
clone more likely.
3.6 Discussion
In this chapter, the duration of the crypt cycle was estimated at 23.6 years (CI: 17.3-
32.6). The time taken for the number of crypts in the colon to double, termed the crypt
doubling time (C) by Bjerknes and Cheng (CHENG et al., 1986a; TOTAFURNO et al.,
1987) was C = ln(2)=f. Using the estimate of the crypt ﬁssion rate estimated in the
ﬁrst model presented in this chapter, the estimated crypt doubling time is 16.4 years
(CI: 12.0 - 22.6), slightly longer than the previous estimate of 9-18 years. This is the
ﬁrst estimate of the crypt ﬁssion rate in the normal human colon inferred directly from
human data.
Supposing that an individual lives to around 75 years of age, each original crypt will
undergo approximately three ﬁssion events in the lifetime of the individual, implying
that the number of crypts will increase eight-fold in an average human lifetime. How is
this large increase in the number of crypts manifested in the appearance of the colon?
BHATNAGAR et al. (2004) and HOUNNOU et al. (2002) looked at changes in the length
and width of the colon with age, and observed that there was no signiﬁcant ﬂuctuation106 Chapter 3. Crypt ﬁssion in the human colon
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Figure 3.5: Probability of eventual mutant clone ﬁxation as a function of the crypt
ﬁssion rate f and degree of symmetry in crypt ﬁssion . A mutant lineage was more
likely to become ﬁxed in the epithelium as the crypt ﬁssion rate increased. As the
tendency for a symmetric crypt ﬁssion event increased (increasing ), the likelihood of
eventual mutant ﬁxation also increased. Increasing the crypt ﬁssion rate had a more
marked effect than increasing the likelihood of symmetric ﬁssion events. Eventual
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Figure 3.6: Rate of mutant clone invasion and loss for different values of the crypt
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Simulations results are shown for N = 8 stem cells per crypt, 182 rounds of cell
divisions per year,  = 0:5, and f = 1 per year unless otherwise stated.108 Chapter 3. Crypt ﬁssion in the human colon
in size with age. Thus, if the number of crypts in the colon does indeed increase eight-
fold over an average human lifetime, then this change is not manifested by the growth
of a bigger colon. How then, could the colon accommodate a larger number of crypts?
Casual observations suggest that colon becomes increasingly folded as it ages. The
folds increase the surface area and so more crypts can be accommodated. Further,
casual observations suggest that crypts are more densely packed in older people; the
average crypt diameter may be reduced and so more crypts ﬁt in a smaller area of
the colonic epithelium. If it is supposed that, in early life, each crypt has an average
diameter of r micrometres, then the area occupied by n crypts is proportional to nr2.
Thus, slight decreases in the mean crypt diameter permit many more crypts to ﬁt in the
same area of epithelium. For example, if the mean diameter of the n crypts were to
halve, the area of the epithelium occupied by the crypts would be reduced to a quarter
of the original area. The suggestions that the colon shows increased folding and the
mean crypt size reduces as a person ages are speculative but merit investigation (see
Section 3.8.1).
Alternatively, the absolute number of crypts in the colon may remain roughly constant
with age. The rate of “crypt birth”, through ﬁssion of parent crypts, may be balanced
by an equal rate of crypt death. Crypt death, however, has not been observed: no crypts
that appear to be in process of “crypt apoptosis” have been identiﬁed. In the murine
colon, BJERKNES (1986) looked for evidence of crypt death. Sections of colon from 3
mice were repeatedly observed over a period of three weeks, by exorcising the colon,
and no crypts were lost during the period of observation. However, the reliability of
these ﬁndings are doubtful, as it is practically very difﬁcult to conﬁrm the identity
of a crypt, as reference points such as tissue folds or blood vessels do not provide
consistent markers. Further crypt replacement would have gone unnoticed. Given the
large number of crypts in the colon, around 107, it seems inconceivable that there is not
occasional crypt death. Further, it is reasonable to speculate that certain regions of the
colon are more susceptible to crypt death, due to environmental differences between
regions of the colon. Thus, crypt expansion in one area of the colon, which causes the
expansion of a COX-deﬁcient crypt to form a patch, may be balanced by crypt death
elsewhere in the colon.3.6. Discussion 109
The idea that crypts have a natural life cycle, analogous to the cell cycle, was ﬁrst
suggested by Bjerknes and Cheng in 1986 (CHENG et al., 1986a), after they noted
that crypts in ﬁssion tended to be larger than crypts that were not in ﬁssion. Fission
was proposed as a mechanism that occurred in response to periodic ﬂuctuations in
the stem cell pool (TOTAFURNO et al., 1987). This idea has become prevalent in the
literature (LOEFFLER et al., 1997; EDWARDS and CHAPMAN, 2007). However, the
possibility remains that crypts may have no characteristic life time. Crypt ﬁssion may
simply be a “healing” response to epithelial damage, analogous to skin growth after
injury, whereby a crypt divides to replace a neighbour that is no longer viable due to
some environmental or internal stress. Stem cell numbers may still ﬂuctuate in crypts,
and inﬂuence the timing of a ﬁssion event. The oscillations in stem cell number may
not be periodic though, but rather be a response to another signal which causes the
initiation of ﬁssion or cell growth in the colon. To corroborate this idea, many authors
have noted that the frequency of crypts in ﬁssion is greatly increased in regions of
inﬂammation (WANG, 2006; CHEN et al., 2005; CHENG et al., 2000). Inﬂammation is
associated with increased levels of oxidative stress (GRISHAM, 1994; PAVLICK et al.,
2002; RACHMILEWITZ et al., 1995; SINGER et al., 1996) which would presumably
increase the rate of crypt death, due to increased rates of cell death inside the crypts
(KANNAN and JAIN, 2000). The presence of COX-deﬁcient patches can be explained if
a COX-deﬁcient crypt formed adjacent to a region of local inﬂammation, so that crypt
ﬁssion was induced in the COX-deﬁcient crypt to replenish the depleted crypt pool.
This model for the initiation of crypt ﬁssion could be tested by a suitable stochastic
model of inﬂammation and crypt ﬁssion (see Section 3.8.5).
In this chapter, cytochrome-c-oxidase deﬁciency in cells has been used as a marker
of clonality. COX-deﬁciency is undoubtedly an excellent lineage marker, as it occurs
relatively infrequently and is readily detectable by routine methods. However, using
COX-deﬁcient cells as a model to study normal homoeostatic processes assumes
that COX-deﬁcient cells behave as wild-type cells do. There are three characteristic
length scales at which selection for COX-deﬁciency could occur in the colon: in the
mitochondrial pool of a single cell, between cells in a crypt, and between crypts in the
colon.110 Chapter 3. Crypt ﬁssion in the human colon
At the sub-cellular level, mathematical modelling of mtDNA dynamics suggests that
the clonal expansion of a neutral mutation in the mtDNA pool, through genetic drift, is
probably a slow process (ELSON et al., 2001). Simulations suggest that it can take
around 50 years for 1% of cells to become COX-deﬁcient given that new mtDNA
strands are generated at a rate of 10 5 per mtDNA replication. Higher mutation rates
lead to greater numbers of cells becoming COX-deﬁcient earlier in life. The data
analysed in this chapter shows that a COX-deﬁcient crypt is observed in most biopsy
sections from patients over the age of 40. This relatively high frequency of COX-
deﬁcient crypts in the colons of young adults suggests either that COX mutant mtDNA
rapidly reaches homoplasmy in the mtDNA pool, and so has a selective advantage in
the mitochondrial pool, or that the rate of COX mutations is relatively high. A precise
estimate of the mtDNA error rate is required to determine whether a high mutation
rate or selection for the mutated mtDNA generates the large number of COX-deﬁcient
crypts observed in the colon. Deep re-sequencing of the entire mtDNA genome in
patients of varying ages could be used to accurately estimate somatic mtDNA mutation
rate.
Selection may also occur at the cell level. By analysing the accumulation of
methylation in the promoter region of a gene that is not expressed in the colon, YATABE
et al. (2001) suggested that the niche-succession time, the time taken for a single cell
clone to become dominant in a crypt through random drift, was around 8.2 years.
Thus, given this slow niche succession rate, if COX-deﬁcient cells had no selective
beneﬁt compared to their neighbours, many partially mutated crypts would have been
observed. In order to investigate the expansion of COX-deﬁcient cells in an otherwise
wild-type crypt, combining mtDNA and methylation analysis may be informative. The
diversity of methylation patterns within the cells in a COX-deﬁcient clone could be
used to infer the expansion rate of the mutated clone.
Given that selection for COX-deﬁciency may well occur at the mtDNA and cell levels,
do COX-deﬁcient crypts also have a growth advantage compared to their wild-type
counterparts? Determining this is crucial if the estimate of the crypt ﬁssion rate derived
in this Chapter is to be used as the estimate of wild-type colonic crypts. Selection at
the crypt level is difﬁcult to infer, since no comparison can be made with the expansion3.6. Discussion 111
rate of non-COX-deﬁcient crypts. If COX-deﬁcient crypts did have a growth advantage
compared to wild-type crypts, patches of COX-deﬁcient crypts would be larger than
patches of related wild-type crypts. Correspondingly, the duration of the crypt cycle in
wild-type crypts would be longer than estimated in this chapter.
Crypt ﬁssion increases the likelihood that a mutation will become ﬁxed (see Section
3.5.2), and further ﬁssion events facilitate the spread of mutations through the
epithelium (GREAVES et al., 2006). The low ﬁssion rate estimated in this Chapter, of
a ﬁssion event in each crypt once every 23.6 years (CI: 17.3-32.6 years), is perhaps
an adaptive anti-tumourigenic mechanism which prevents the spread of mutations
through the GI tract. The primary expansion of colorectal adenomas is through crypt
ﬁssion (PRESTON et al., 2003). The genetic event(s) which cause the increase in
the crypt ﬁssion rate must be a crucial early step in the development of a colorectal
adenoma.
The number of crypts in ﬁssion is signiﬁcantly increased in adenomas compared to the
wild-type epithelium (WONG et al., 2002). A sixteen-fold increase in the number of
crypts in ﬁssion was observed by PRESTON et al. (2003) in early sporadic adenomas
(3% of crypts in ﬁssion in normal mucosa, 48% of crypts in the adenoma), which
conﬁrmed the earlier observations of WONG et al. (2002). If the sixteen-fold increase
in the number of crypts in ﬁssion in an adenoma is indicative of a sixteen-fold increase
in the ﬁssion rate, the duration of the crypt cycle would be reduced to 1.5 years (CI 1.1
- 2.0 years) in colorectal adenomas. The rate of ﬁssion may be much higher than this if
the time taken for each ﬁssion event is also decreased in adenomas.
The frequency of crypts in ﬁssion is increased in patients with FAP (WASAN et al.,
1998; BJERKNES et al., 1997). These patients carry a heterozygous germline mutation
in the APC gene (see Introduction, Section 1.6.1), which suggests that APC maybe
involved in the regulation of crypt ﬁssion. This involvement of APC could be direct,
for example by stimulating or repressing a particular genetic pathway that regulates
crypt ﬁssion. More likely though, is that the action of APC is indirect. Phenotypic
characteristics of a crypt, that are under the control of APC, may in turn cause the
initiation of ﬁssion. Mathematical modelling by BOMAN et al. (2001) suggests that the
number of stem cells per crypt is increased in FAP patients, and similar conclusions112 Chapter 3. Crypt ﬁssion in the human colon
have been drawn from the analysis of methylation patterns by KIM et al. (2004c).
Crypts in ﬁssion tend to be larger than average (BJERKNES, 1986; WONG et al., 2002),
so are likely to contain a greater number of stem cells. Thus the frequency of crypt
ﬁssion events in FAP colons may be a result of an increased number of stem cells
per crypt. This hypothesis suggests that the single remaining wild-type copy of APC
is insufﬁcient to regulate crypt cells in a wild-type fashion. However in contrast to
this theory, BJERKNES et al. (1997) suggested that the increased frequency of crypts
in ﬁssion in FAP colons was due only to an increased number of crypts in ﬁssion in
aberrant crypt foci (ACF). Given that, in FAP colons, mono-cryptal adenomas tend
to have bi-allelic APC mutations (TAKAYAMA et al., 2001), the increase in the crypt
ﬁssion rate in FAP colons would not then be due to haploinsufﬁciency. The increase in
the number of crypts in ﬁssion in FAP colons and adenomas could also be indicative
of an increase in the time taken for a crypt to undergo ﬁssion, or even of a systemic
failure to complete crypt ﬁssion. Crypts from FAP colons that are undergoing ﬁssion
often show multiple “buds”, each of which may be a precursor to a new crypt, so it
appears that in colons new ﬁssion events can occur before previous crypt divisions
have ﬁnished.
Fission appears to take a reasonably long time to complete in the normal colon: by
using methylation at non-expressed promoters as a lineage marker, KIM and SHIBATA
(2004) found that cells from the two arms of a bifurcating crypt were no more closely
related than cells from two non-adjacent crypts. This suggests that the time taken for
a crypt to divide is long enough to allow the methylation patterns of the cells in each
arm of the dividing crypt to diverge. This work could be extended to estimate the
duration of a ﬁssion event. A mathematical model could be developed which predicted
the expected degree of dissimilarity between the methylation patterns from cells from
the two arms of the bifurcating crypt, given that the ﬁssion event takes  years to
complete (see Section 3.8.2). Comparing the model to data on the methylation patterns
onbifurcatingcryptswouldallow tobeestimated. Thisanalysiscouldthenbeapplied
to determine whether the observed increase in the number of crypts in ﬁssion in an
adenoma is due to an increase in the ﬁssion rate or a failure to complete ﬁssion.3.7. Conclusion 113
3.7 Conclusion
Crypt ﬁssion is a rare event in the normal human colon. In this Chapter, it was
estimated that each crypt divides once every 23.6 years (CI: 17.3-32.6 years). Fission
increases the likelihood that a mutant stem cell will become ﬁxed in a crypt, and
facilitates the expansion of mutations through the epithelium. Fission is the primary
method of expansion of colorectal neoplasms. Therefore understanding the mechanism
responsible for increasing the ﬁssion rate is necessary for understanding the mechanism
of tumorigenesis.
3.8 Future work
3.8.1 Changes in colon with age
The number of crypts in the colon may ﬂuctuate with age. Mechanisms that may
facilitate the colon to house a greater number of crypts are: increased folding of the
colonic epithelium, or a decrease in the mean crypt size. These factors should be
examined. Sections of colon biopsies of uniform area should be examined from a large
number of patients of different ages. The number of crypts in each unit area should be
counted. These counts should then be examined to see if the mean number of crypts
per unit area depends upon the age of the patient at biopsy. Sections should also be
examined for folds to see if the number of folds increases with age.
3.8.2 The duration of a ﬁssion event
The duration of a crypt ﬁssion event is another parameter of interest, which may be
altered in neoplastic development. The duration of a ﬁssion event could be estimated by
examining the diversity of methylation patterns in crypts that were undergoing ﬁssion.
Methylation of CpG islands in the promoters of non-expressed genes has been shown to
be a high ﬁdelity lineage marker, which can be used to distinguish closely related cell
lineages (YATABE et al., 2001; KIM et al., 2004c; KIM and SHIBATA, 2004; KIM et al.,
2005d,c,b, 2006; CHU et al., 2007). A stochastic model of the change in diversity of
methylation patterns during a ﬁssion event should be developed (see Figure 3.7). The
model should be compared to the methylation patterns observed in crypts in ﬁssion.114 Chapter 3. Crypt ﬁssion in the human colon
This comparison would allow the duration of a crypt ﬁssion event to be inferred.
An outline of a suggested model is as follows: suppose the crypt in ﬁssion was removed
from the colon of a patient of age A. The parameter of interest in the model is , the
duration of a ﬁssion event. At the time when the crypt was removed, the crypt was part
way through the ﬁssion event. Denote this time by , where  < . Thus the ﬁssion
event began at age A   .  is a nuisance parameter in the model, which follows some
distribution on [0;).
The diversity of methylation patterns in a crypt is described by a statistic S. Using
a model of stem cell dynamics and crypt ﬁssion (such as described above in Section
3.4.6), coupled with a model of methylation (such as that of YATABE et al. (2001)), the
value of S in a crypt which began ﬁssion at time A  could be simulated. A rejection
method could then be used to estimate . For each run of the model, a value of b  should
be sampled from a reasonable prior distribution, then a corresponding value of  should
be sampled from the appropriate distribution on [0;). The value of the statistic S at
time A could then be computed using these parameter values. b  would be accepted
into the posterior distribution if the computed value of S was sufﬁciently similar to the
value of S observed in a crypt in ﬁssion.
3.8.3 Inﬂammation induced crypt ﬁssion
Crypt ﬁssion occurs in response to inﬂammation in the colon (WANG, 2006; CHEN
et al., 2005; CHENG et al., 2000). Therefore, crypts may not have a characteristic
life-cycle duration, but instead divide in response to local inﬂammation. To examine
the plausibility of this hypothesis, predictions from a suitable stochastic model of
inﬂammation-driven crypt ﬁssion could be compared to the data on COX-deﬁcient
patches of crypts presented in this chapter. Inﬂammation driven crypt ﬁssion may better
explain the large variation in patch size and frequency seen in different patients.
3.8.4 Modelling mtDNA dynamics
For a cell to have detectable COX-deﬁciency, a signiﬁcant proportion of the mtDNA
pool inside the cell must carry the mutation in the COX gene. COX mutations occur
frequently in colonic crypts (see above), thus it appears that the expansion of a COX 3.8. Future work 115
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Figure 3.7: Model to estimate the duration of a crypt ﬁssion event.  is the duration a
ﬁssion event, indicated by the red line, and is the parameter of interest. , the time since
ﬁssion began, is a nuisance parameter, and is denoted by indicated by the green line.
Methylation accumulates in the crypt from birth. The diversity of methylation patterns
in a crypt that is part way through ﬁssion could be compared to the model to estimate
.116 Chapter 3. Crypt ﬁssion in the human colon
mtDNA strand inside a cell occurs rapidly. Mathematical modelling of the clonal
expansion of the COX  mtDNA might allow the selective advantage conferred by the
mutation in the mtDNA pool to be inferred. Also, the rate at which COX mtDNA
mutations occur could be estimated. Published models of mtDNA dynamics, such as
those of ELSON et al. (2001) and COLLER et al. (2001) could be adapted for this
purpose.
3.8.5 Stochastic model to estimate crypt ﬁssion rate
In this chapter, a deterministic model of the mutation and clonal expansion of COX-
deﬁcient cells was used to estimate the frequency of crypt ﬁssion events. This data may
be better described by a stochastic model where the duration of crypt ﬁssion follows
some underlying probability distribution. This could be incorporated into a model. The
timing of the ﬁrst COX mutation is likely to be a stochastic event, and this could be
described in the model.Chapter 4
Laboratory methods
4.1 Aims
 Establish tissue preparation protocol.
 Establish macro-dissection protocol.
 Establish laser capture micro-dissection protocol for single crypt dissection.
 Optimise sequencing methods for DNA extracted from a single crypt.
4.2 Introduction
The laboratory experiments presented in this thesis were designed to examine genetic
heterogeneity in a colorectal adenoma or cancer. Most previous work on colorectal
cancers has involved needle macro-dissection of a broad section of tumour tissue (see
for example GONZ´ ALEZ-GARC´ IA et al. (2002); JONES et al. (2007)). Although studies
like these could distinguish macro-scale heterogeneity, such as genetic differences
between the left side and the right side of the tumour, determining micro-scale
heterogeneity, such as difference between neighbouring crypts, was not possible.
Micro-scale descriptions of the genetic composition of an adenoma, termed a clonal
map, are necessary to examine the development of tumour sub-clones. Genotyping
micro-dissected tissue from formalin ﬁxed parafﬁn embedded samples is technically
difﬁcult. Micro-dissection of single crypts yields only small quantities of DNA, which
is also often of poor quality. Highly optimised genotyping techniques are required to118 Chapter 4. Laboratory methods
analyse adenomas on a crypt-by-crypt basis.
In this chapter, methods for the dissection and genotyping of individual crypts
from parafﬁn embedded tissue are presented. Reﬁned laser-capture micro-dissection
techniques are described. Optimised genotyping methods for detection of APC and
K-ras mutations in individual crypts are presented.
The methods described here were developed with Simon Leedham and Christina
Thirwell at the Cancer Research UK London Research Institute.
4.3 Histology
4.3.1 Slide preparation
Formalin ﬁxed, parafﬁn embedded tissue was used in this study. Ethical permission to
use this tissue was granted by the Oxfordshire Research Ethics Committee B.
De-waxing
Slides were de-waxed by incubation in sulphur free xylene (VWR, UK). After de-
waxing, tissue was rehydrated by sequential incubations in decreasing concentrations
of ethanol (100%, 95%, 80%, 70% and 50%) and ﬁnally in distilled water.
4.3.2 H&E
Tissue histology was assessed with the aid of Hematoxylin and Eosin staining (H&E
stain). Hematoxylin, a basic dye, colours acidic structures, such as the nucleus and
ribosomes, with a blue-purple hue. Eosin, an acidic dye, colours basic structures, such
as the cell cytoplasm, bright pink or red.
For H&E staining, slides were ﬁrst de-waxed according to the protocol above. Harris
Hematoxylin and Eosin stains (VWR, UK) were applied to the de-waxed slides, and
then stained tissue was rehydrated as described above. Prepared slides were then
mounted in DPX (VWR, UK). De-waxing and H&E preparation was automated using
a Tissue-Tek Prisma automated slide stainer machine (Sakura, USA).4.4. Dissection and DNA Extraction 119
4.3.3 Dysplasia
Dysplastic tissue was identiﬁed by examination of the H&E slides. Dysplastic crypts
could be identiﬁed by malformed crypt structure, multiple layers of cells in the
crypt, and increased nuclear (Hematoxylin) staining. Dysplasia identiﬁcation was
conﬁrmed by at least one expert pathologist (Dr Maesha Deheragoda or Prof. Nicholas
Wright).
4.4 Dissection and DNA Extraction
Both macro and micro dissection were performed.
4.4.1 Macro-dissection
Macro-dissection digestion buffer
Digestion buffer for macro-dissection was made from 4.45ml distilled H20, 500l 10x
magnesium-free PCR buffer, at pH8 with 50l proteinase K (VWR, UK) at 200g/ml.
Between, 30-100l of digestion buffer was used per sample, depending on the mass of
tissue being digested.
Macro-dissection process
Parafﬁn embedded tissue was cut onto non-coated glass slides (Thermo Shandon
Colorfrost), at thickness of 6m using a Jung Biocut 2035 microtome. Tissue was
typically cut into six serial sections, although fewer slides were used for larger
adenomas. Slides were de-waxed as described above (Section 4.3.1). De-waxed
tissue was then lightly stained with tolonium chloride (0.2% ppm, VWR, UK) to aid
identiﬁcation of regions of interest. Stained tissue was then air dryed in an incubator at
37C for approximately one hour.
Macro-dissection was then performed using a sterile needle under a dissecting
microscope (Nikon Eclipse E400, Nikon Europe, The Netherlands). The needle was
dipped in the digestion buffer, as the buffer aided detachment of the tissue from the
slide. Tissue was transferred to a sterile Eppendorf tube containing an appropriate
volume of digestion buffer for the mass of tissue dissected, typically a 0:5cm2 area of120 Chapter 4. Laboratory methods
tissue would be digested in 50ml of digestion buffer. Dissected tissue was transferred
to a 55C incubator (Techne Hybridsier HB-1D, Techne, UK) for a minimum of 24
hours and agitated frequently (RotaMixer, Hook and Tucker Instruments, UK). After
incubation, the proteinase K was deactivated by heating to 95C for 10 minutes and
then centrifuged at 12000 rpm for 15 minutes (Eppendorf centrifuge 5154 D). The
DNA rich supernatant was removed, and the protein rich precipitate was discarded.
DNA was stored by freezing at-18C or lower, or if required for immediate use, was
held in a standard refrigerator at 2-8C.
4.4.2 Micro-dissection
Laser capture micro-dissection
Micro-dissection was perform with the aid of a laser capture dissecting microscope
(PALM, Carl Zeiss). Laser capture micro-dissection permits extremely precise
dissection, allowing homogeneous cell populations can be collected (ESPINA et al.,
2006). Here, laser capture micro-dissection was used to extract speciﬁc regions of
tissue, usually single crypts. This dissection technique is performed robotically, so the
risk of contamination is reduced.
Laser capture micro-dissection required the use of PALM Membrane Slides (PALM
micro-laser technologies AG, Germany), which had a thin plastic coating on one side
of the slide. Cut tissue is transferred onto this plastic coating. The plastic ﬁlm provides
support for the tissue and prevents fragmentation during laser cutting and transfer of
tissue from the slide to a capture tube. PALM slides were 254 nm wavelength UV light
pre-treated for 30 minutes to improve section adhesion. Parafﬁn embedded tissue was
cutatathicknessof6montoPALMslidesusingaJungBiocut2035microtome(Leica
Instruments, Germany). The tissue was cut as ordered serial sections according to the
following protocol: sections 1-3 were the PALM slides, section 4 was H&E stained
to provide a histological reference, and slides 5-7 were PALM slides. Additionally,
sections 0 and 8 were occasionally made into additional H&E slides to aid histology
identiﬁcation.
PALM slides were dried overnight at 37C (Windsor Incubator, Windsor, UK). After4.5. APC mutation screening 121
drying, slides were de-waxed according to the de-waxing protocol described above
(Section 4.4.1). After de-waxing, slides were lightly stained with methyl green (0.1%
ppm, VWR, UK), and dried at 37C for at least 1 hour. A PALM laser micro-dissection
microscope and associated PALM Robo software (PALM, Carl Zeiss, UK) was used to
perform micro-dissection. Using the microscope, the H&E was examined to identify
a crypt, or part crypt, of interest, then each of the six PALM slides were examined to
conﬁrm that the same crypt could be identiﬁed in each slide. The crypt was cut from
each section, and cut tissue was catapulted into a sterile collection tube.
Digestion of micro-dissected tissue
A single crypt was digested in 10l of proteinase K digestion buffer (PicoPure DNA
Extraction Kit, Arcturus Bioscience) incubated at 65C (Techne Hybridsier HB-1D,
Techne, UK) for a minimum of twelve hours. Prior to digestion, proteinase K digestion
buffer was kept on ice to optimise digestion yield. An aliquot of pure digestion buffer
was also digested, and was subsequent used as to conﬁrm that the buffer was not
contaminated. After digestion, proteinase K was deactivated by heating to 95C for
10 minutes and then spun at 5000 rpm for 3 minutes (Eppendorf centrifuge 5154 D). A
small volume of distilled water, typically 5l, was added to the sample to replace the
buffer lost due to evaporation during the digestion and deactivation process.
4.5 APC mutation screening
Tumorigenic mutations in APC tend to cluster in the region between codons 1250-
1450, termed the mutator cluster region (SEGDITSAS and TOMLINSON, 2006). The
MCR has been divided into 12 overlapping regions, each of around 100-200 base
pairs, to facilitate PCR ampliﬁcation (see Appendix Section 8.2). Sequencing of APC
was performed on the small quantity of DNA extracted from a single crypt. Due to
the small quantity of DNA available, direct sequencing of the entire MCR of each
crypt was impractical. Hence, prior to direct sequencing, single strand conformation
polymorphism (SSCP) was performed on macro-dissected tissue to identify which of
the 12 MCR sub-divisions harboured a mutation. Then only these mutated regions
needed to be directly sequenced in each crypt.122 Chapter 4. Laboratory methods
4.5.1 Single strand conformation polymorphism
SSCP was used to screen for mutated regions of the APC gene (HAYASHI, 1991).
To perform SSCP, the genomic region of interest was ampliﬁed in both tumour and
controlsamples, usingstandardPCRwithﬂuorescentlylabelledprimers. PCRproducts
were then denatured, and the resulting single strands of DNA naturally folded to form
a tertiary structure. Mutations alter the conformation of this structure. Differences
between samples could then be resolved by gel electrophoresis, or an analogous
capillary system, since a sample’s conformation determined its motility through the
gel.
Method
Macro-dissection and DNA extraction was performed on whole polyp sections
according to the protocol above (section 4.4.1). Twelve individual PCRs, one for
each of the MCR regions, were then performed on the extracted DNA. Details of the
primers for each MCR region are given in Table 4.1. Reagent quantities and reaction
conditions for each MCR subdivision are shown in Table 4.2. Reagent concentrations
and manufacturer’s details are shown in Table 4.3. To conﬁrm that PCR master mix
was not contaminated, blank (master mix only) reactions were always performed.
Reactions were performed in 96 well plate that had been sealed with adhesive PCR
ﬁlm (Thermo Scientiﬁc, UK). The reaction was carried on a Peltier Thermal Cycler
(PTC-225, MJ Research, USA) according to the protocol in Table 4.13.
PCR efﬁciency was examined by gel electrophoresis (see Section 4.7). Concentrated
reactions products, identiﬁed by the presence of a strong band on the electrophoresis
gel, were diluted with double distilled H20 to an appropriate concentration between
1:2 - 1:100. 4l of diluted PCR products were aliquotted to a new 96 well plate.
Ampliﬁed DNA was denatured with Hi-Di (Applied Biosystems, USA) according
to manufacturer’s instructions. An ABI 3100 16 capillary DNA analyser (Applied
Biosystems, USA) was used to resolve the samples. Results were analysed in the
Genotyper software (Applied Biosystems, Perkin Elmer), using the “view by scan”
option. Mutated regions were identiﬁed by visually comparing tumour to wild-type
DNA (see Figure 4.5.1).4.5. APC mutation screening 123
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Table 4.3: PCR reagent concentrations and manufacturer’s details.
Reagent Manufacturer Working Concentration
Primers Sigma-Aldrich, UK 20mM
Taq Qiagen, UK 5 units / l
dNTP Promega,UK 10 mM each dNTP
Mg2+ Qiagen, UK 25mM
Buffer Promega, UK as supplied
Q Qiagen 5x solution (as supplied)
Table 4.4: Thermal cycling protocol for PCR reactions.
Step Description
1 94C for 4 minutes
2 94C for 1 minute
3 annealing temperature C for 1 minute
4 72C for 1 minute
5 Repeat steps 2-5 34 more times
6 72C for 10 minutes
7 8C forever (holding temperature)
4.5.2 Direct sequencing from laser-captured tissue
APC sequencing was performed on the very small volumes of DNA extracted from a
single micro-dissected crypt. Nested PCR reactions, which used DNA from the ﬁrst
round PCR reaction as a template for the second, were used to produce sufﬁcient DNA
yield for sequencing. First round primers were designed to amplify a region containing
both the MCR and the target sequence for the second round primers (see schematic
in Figure 4.5.2). Primer details are shown in Tables 4.5 and 4.6, and the location of
the target sequence in the gene for each primer is shown in the Appendix, Section126 Chapter 4. Laboratory methods
8.2.
DNA ampliﬁcation
Prior to each reaction, all reagents, excluding primers, and all sequencing apparatus
including PCR plates, lids, tips and pipettes were sterilised by 45 minutes of 254
nm wavelength UV treatment, and then PCR reactions were prepared in the sterilised
UV hood (ASTEC Microﬂow, UK). Reaction master mixes were prepared according
to the protocol in Tables 4.7 an 4.8, and aliquoted into a 96-well plate (AB gene,
UK). Reagent concentrations and manufacturer’s details are shown in Table 4.3. To
conﬁrm that PCR master mix was not contaminated, additional blank (master mix only)
reactions were always performed. Plates were sealed with adhesive PCR ﬁlm (Thermo
Scientiﬁc, UK). Prepared plates were immediately transferred to a Peltier Thermal
Cycler (PTC-225, MJ Research, USA), using the annealing temperatures indicated
in Table 4.7 and Table 4.8, and according to the thermal cycling protocol in Table
4.4.
Reaction efﬁciency was tested by agarose gel electrophoresis of PCR products (see
Section 4.7). Successful ampliﬁcation was identiﬁed by the presence of a single strong
band of appropriate length (see Figure 4.3).4.5. APC mutation screening 127
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Figure 4.1: SSCP result analysis in Genotyper. The ﬁgure shows the output from
Genotyper of a typical SSCP result. Lanes A and B are SSCP scan results for APC
MCR 11 wild-type and tumour DNA respectively. A clear difference is observed
between the scan results in lanes A and B (extra peaks are observed in lane B),
indicating the presence of a mutation in this region. The position of a peak on the x-axis
indicates the speed, relative to a size standard, at which the sample moved through the
capillary system, and the y-axis indicates the signal intensity, normalised against the
size standard.
5'  3' 
Figure 4.2: Schematic of nested primer construction. First round primers (coloured
green) were designed to amplify a region containing both the sequence of interest
(coloured red) and the target sequence for the second round primers (coloured blue).128 Chapter 4. Laboratory methods
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Figure 4.3: Electrophoresis gel showing successful PCR ampliﬁcation. In the top row,
lanes 1-7 contain successfully ampliﬁed products, identiﬁed by the presence of a bright
band at around 200bps. Lane 8 has no band, corresponding to no PCR product. Lane
8 contained the blank (no template DNA) control PCR product. In the bottom row, the
PCR failed for the sample in lane 4.
Sequencing
APC MCR reaction products were puriﬁed, sequenced, and analysed as described in
Section 4.8.
4.6 K-ras mutation screening
Oncogenic K-ras mutations tend to occur at codons 12 and 13, and occasionally
codon 61 (ANDREYEV et al., 1998; WELLCOME TRUST SANGER INSTITUTE, ????).
Therefore, K-ras mutation screening of micro-dissected material could be performed
using only a single set of nested PCRs. Nested K-ras primers are shown in Table 4.9.
Reactions were prepared according to the reagent volumes in Table 4.10. Reactions4.6. K-ras mutation screening 133
were performed on a Peltier Thermal Cycler (PTC-225, MJ Research, USA), using the
annealing temperatures indicated in Table 4.10, and according to the thermal cycling
protocol in Table 4.4. Reaction efﬁciency was tested by agarose gel electrophoresis
of PCR products. After successful ampliﬁcation, reaction products were puriﬁed,
sequenced, and analysed as described in Section 4.8.134 Chapter 4. Laboratory methods
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Table 4.10: K-ras nested sequencing PCR reagent quantities and annealing
temperatures. All volumes in l and temperatures in C. Volumes listed are for a single
25l reaction.
First Round Second Round
Forward primer 0.25 0.25
Reverse primer 0.25 0.25
dNTP 0.5 0.5
buffer 2.5 2.5
Mg 2 2
H20 12.3 12.3
Q 5 5
Taq 0.2 0.2
DNA 2 2
Annealing temp 60 55
4.7 Agarose Gel Electrophoresis
Agarose gel electrophoresis separates DNA molecules according to their size. The
migration rate of DNA molecules through the gel during electrophoresis depends upon
the molecule size and the density of the gel. 2% agarose gels were used as they resulted
in a resloving power of about 100bp in reasonable time. The addition of ethidum
bromide to the gel, which intercalates between DNA base pairs and ﬂouresces under
302nm UV light, allows the location of DNA in the gel to be visualised.
Gels were prepared by boiling an appropriate mass of agarose power in 1X TBE buffer
(CRUK central services), and allowing the mixture to cool to 60C. Ethidium bromide
(Sigma, UK) was added to a ﬁnal concentration of 0.25g/ml. The gel solution was
poured into a casting tray (Biorad, UK) and a comb added. The gel was allowed to set,
then transferred to an electrophoresis chamber (Biorad, UK) and covered with 1X TBE136 Chapter 4. Laboratory methods
buffer. 5l of PCR products with mixed with 2l of Orange G loading dye (Sigma,
UK) and loaded into the gel. 10l of 1kbp ladder (Invitrogen, UK) was also loaded to
provide a size reference. The chamber was connected to a DC current device (Biorad,
UK) and run for 20 minutes at 120V, 400mA. DNA bands were identiﬁed using a 302
nm UV transilluminator (UVP, UK). An example of an electrophoresis gel showing
successful sequencing is shown in Figure 4.3.
4.8 Sequencing
4.8.1 Puriﬁcation of reaction products
Successfully ampliﬁed reaction products were ﬁrst treated with EXoSAP-IT(USB,
Germany). EXoSAP-IT contains exonuclease I, which removes unincorporated
primers, and Shrimp Alkaline Phosphatase which removes leftover dNTPs. 2l
of EXOSAP was added to 5l of reaction product, and then placed on a Peltier
Thermal Cycler (PTC-225, MJ Research, USA), using the protocol described in Table
4.11.
Table 4.11: EXOSAP thermal cycling programme
Step Description
1 37C for 15 minutes
2 80C for 15 minutes
3 15C forever (holding temperature)
4.8.2 Sequencing reaction
Automated sequencing that used four terminator nucleotides, labelled with four
distinguishable ﬂuorophores, was performed. EXoSAP-IT products were diluted
with 20l of distilled H20. The sequencing reaction was prepared according to the
reagent quantities in Table 4.12, using ABI Biosystems, BigDye Terminator (Applied
Biosystems, USA). The reaction was carried on a Peltier Thermal Cycler (PTC-225,4.8. Sequencing 137
MJ Research, USA) according to the protocol in Table 4.13. Unincorporated dye-
terminators were removed using the DyeEx 2.0 Spin Kit (Qiagen, UK), according to
manufacturer’s instructions.
Table 4.12: Sequencing reaction reagent quantities and annealing temperatures. All
volumes in l. Volumes listed are for a single 20l reaction.
Reagent Volume
Primer 1
BDT mix 10
H20 5
Diluted EXOSAP-IT product 4
Table 4.13: Sequencing reaction thermal cycling programme.
Step Description
1 96C for 5 minutes
2 96C for 30 seconds
3 50C for 45 seconds
4 60C for 4 minutes
5 Repeat steps 2-4 34 more times
6 8C forever (holding temperature)
4.8.3 Sequencing and analysis
Puriﬁed sequencing products were vacuum dried using a Eppendorf 5301 Concentrator
(Eppendorf, UK) for 30 minutes at 45C. Re-suspended residues were transferred
to a 48 capillary ABI 3730 DNA Analyser (Applied Biosystems, USA) for
sequencing. Sequence data were analysed with the 4Peaks software (Mekentosj,
Netherlands).138 Chapter 4. Laboratory methodsChapter 5
Microdissection of Tumour Pathways
in Sporadic Colon Adenomas
5.1 Aims
 Examine the development of sporadic colorectal adenomas. Determine their
clonal structure.
 Infer the relative order and timing of APC and K-ras mutations in the
development of the adenoma.
 Examine any relationship between the type of APC mutation and the type of
K-ras mutation present in early adenomas.
5.2 Chapter Summary
The classical view of tumorigenesis in non-MMR deﬁcient colorectal cancers begins
with clonal expansion following the inactivation of the APC tumour suppressor gene in
a single cell. The next genetic change in the progression towards cancer is an activating
mutation of the K-ras oncogene (FEARON and VOGELSTEIN, 1990; KINZLER and
VOGELSTEIN, 1997). This model of tumour development is widely accepted.
However, there is evidence that K-ras mutations may precede APC inactivation in
some adenomas (reviewed in PRETLOW and PRETLOW (2005)). Additionally, the
two “hits” required to inactivate APC have been shown to be non-random, in that the140 Chapter 5. Microdissection of Tumour Pathways in Sporadic Colon Adenomas
location of the second hit is usually determined by the ﬁrst (LAMLUM et al., 1999).
Similar relationships between types of APC and K-ras mutations may also exist, but
these have not been previously investigated.
In this chapter, the sequence of genetic events driving tumour progression in human
small sporadic adenomas was examined. The aim of this work was to determine the
mutational burden present in each crypt of an adenoma, and then to use these data to
infer the phylogenetic relations between clones in the adenoma, and so characterise the
development ofthe adenoma. Using lasercapture micro-dissectionof individualcrypts,
followed by direct sequencing, the mutation status of APC and K-ras genes in each
crypt was determined. This information was combined to produce clonal maps of each
adenoma, which showed the spread of the mutated clones through the neoplasm.
The frequency of K-ras mutation in these early adenomas was high, with (8=12)
neoplasms containing at least one crypt with a K-ras mutation. Further, many (5=12)
of the adenomas were composed entirely of crypts harbouring both K-ras and APC
mutations, suggesting that K-ras mutations could have preceded APC inactivation in
these adenomas. To test this hypothesis, a simple mathematical model was developed,
which predicted the selective advantage required by an APC = K-ras+=  crypts to
displace APC =  crypts from a small polyp. The model suggested that if K-ras
mutation occurred after APC inactivation, then K-ras activation would have to bestow
a large selective advantage on a clone in order for the clone to dominate the adenoma in
the presumably short time that the adenoma had been growing. Hence there appeared to
be two groups of adenomas, deﬁned by whether K-ras mutation preceded or followed
APC inactivation.
Next, the relationship between APC and K-ras mutations in these adenomas was
examined. Adenomas were classiﬁed according to the estimated “severity” of their
APC mutant genotype. No association between the inferred order of mutations and
the APC mutation type was seen. The data showed a marginal excess of adenomas
with a less severe APC mutation and K-ras mutations, although the excess was not
statistically signiﬁcant, possibly as a result of the small sample size. To investigate
this hypothesis further, a much larger statistical analysis of published material on the
frequency of somatic mutation of K-ras and APC in colorectal cancers was performed.5.3. Introduction 141
In this larger data set, the frequency of K-ras mutations showed a borderline association
with the supposed milder APC phenotype. Further, the distribution of K-ras mutation
types differed signiﬁcantly between groups of adenomas deﬁned by the presence of a
severe or non-severe APC mutation. APC-severe cancers showed a paucity of K-ras
G12D and G13D mutations compared to APC-mild cancers, whereas G12V mutations
were found at approximately the same frequency in each group.
5.3 Introduction
The development of colon cancer is relatively well characterised. By collating
knowledge gained from the study of colorectal neoplasms from patients with hereditary
disposition to colon cancer, a number of papers by Vogelstein have suggested the
order of mutations that lead from healthy tissue to a colon cancer (FEARON and
VOGELSTEIN, 1990; KINZLER and VOGELSTEIN, 1997). Tumour growth is initiated
by inactivation of the APC tumour suppressor gene, a gatekeeper mutation (KINZLER
and VOGELSTEIN, 1997), and the subsequent selectively advantageous mutation tends
to activate the K-ras oncogene. Further progression is through mutations of genes
including p53 and SMAD4 or DCC. This pathway to cancer, shown in Figure 5.1, is
parochially termed the “Vogelgram”, and has become widely accepted as the baseline
model of colorectal carcinogenesis.
APC K-ras p53/Smad4/DCC
Normal Adenoma Large
adenoma
Cancer Metastasis
Other changes
Increasing malignancy
Figure 5.1: The basal model of the order genetic events in sporadic colorectal
tumorigenesis. The ﬁgure depicts the widely accepted sequence of genetic alterations
that transform normal colonic epithelial cells into malignant carcinoma. Figure adapted
from (JONES et al., 2008b).
However, there is increasing evidence that in some adenomas, K-ras mutations
may precede APC mutations in tumorigenesis. APC is a large gene, and thus142 Chapter 5. Microdissection of Tumour Pathways in Sporadic Colon Adenomas
detecting mutations in APC is technically difﬁcult. In comparison, K-ras mutation
is straightforward to detect, as nearly all oncogenic mutations occur at codon 12 or 13.
Dysplastic aberrant crypt foci (ACF) are the putative precursors of colorectal adenomas
(PRETLOW and PRETLOW, 2005). Takayama et al. found K-ras codon 12 mutations
in 63% (17=27) of dysplastic mono-cryptal adenomas from non-FAP patients, whereas
APC and  catenin mutations were never detected in these lesions (TAKAYAMA et al.,
2001). The prevalence of K-ras mutations in hyperplastic lesions is also very high,
although whether these non-dysplastic lesions are precursors of dysplastic neoplasms
remains unclear. In hyperplastic ACFs from sporadic colon cancer patients OTORI
et al. (1998) found that 50/56 hyperplastic ACF showed K-ras codon 12 mutations,
whereas none of these 56 samples had detected APC mutations. Similar ﬁndings where
observed by JEN et al. (1994) K-ras mutations, but not APC mutations, were seen
in all (19=19) non-dysplastic ACFs examined. Another study found K-ras mutations
in 67% (8=12) of non-dysplastic ACFs from non-FAP patients (NUCCI et al., 1997).
SMITH (1994) did not specify the pathology of the ACFs they examined, but they
found K-ras mutations in 25% (13/53) . Further, in normal mucosa, K-ras mutations
were detected in approximately 10% of samples (41/390) in one study (YAMADA et al.,
2005), although a second study found the prevelence to be only 1% (1/100) (SMITH,
1994). By macro-dissection of normal appearing tissue located adjacent to a K-ras =+
tumour, ZHU et al. (1997) found K-ras mutations in 54% of samples (7=13).
Indysplasticlesions(adenomas), thefrequencyofAPCmutationsappearsconsiderably
higher than in ACFs, consistent with the role of APC as the gatekeeper of adenomatous
growth (LAMLUM et al., 2000; POWELL et al., 1992). K-ras mutations are still
frequently found in dysplastic adenomas. Takayama et al. found K-ras codon 12
mutations 65% (20/31) of adenomas and the frequency of APC mutations was 78%
(TAKAYAMA et al., 2001). OTORI et al. (1998) observed lower mutation frequencies
of both genes; 40% of adenomas (4/10) had K-ras mutations, and 40% had APC
mutations, although only a single adenoma had mutations in both genes. JEN et al.
(1994) observed a lower frequency, 25% (3/12), of K-ras mutations in dysplastic
polyps, and a higher frequency, 83%, of APC mutations . Another study reported high
proportion of K-ras mutations in sporadic adenomas (65%), although the frequency of5.3. Introduction 143
K-ras mutations showed a borderline association with adenoma size, and was highest
in the smallest adenomas examined (MCLELLAN et al., 1993).
The studies presented above suggest that the frequency of K-ras mutations is high in
small dysplastic ACFs (63%), but is perhaps slightly reduced in small adenomas (range
25%-65%). In carcinomas, the frequency appears to be reduced further. The results of
a very large meta-analysis found the frequency of K-ras mutations in colorectal cancers
to be 37.7% (n = 2721) (ANDREYEV et al., 1998).
In FAP patients, K-ras mutations in adenomas are observed less frequently than in
sporadic colon cancer patients, whereas the incidence of somatic APC mutations is
much higher. In the 8 dysplastic ACF from FAP patients examined by TAKAYAMA
et al. (2001) K-ras mutations were found in only 13% (1=8) of dysplastic ACF
whereas somatic APC mutations were found in all ACF. NUCCI et al. (1997) observed
the frequency of K-ras mutations in FAP patients to be 17% (3=18). Similar low
frequencies of K-ras mutations in FAP polyps, 7% (5=75) and 4% (2=51), were
observed by FARR et al. (1988) and SMITH (1994) respectively. This suggests that
FAP and non-FAP adenomas develop along different pathways, although the reason
for this is unclear. Hence this work was restricted to the study of sporadic adenomas
only.
Different mutations of the APC gene appear to bestow different selective effects on
a cell (see Introduction 1.6.1). Combinations of APC mutations are selected for, so
that the two hits required to inactivate the tumour-suppressor gene are non-random
and so produce the “optimal” genotype, which presumably confers the greatest growth
advantage (LAMLUM et al., 1999; ROWAN et al., 2000). APC mutations are sufﬁcient
for the growth of adenomas (LAMLUM et al., 2000), however, certain types of APC
mutation may inﬂuence the type of subsequent K-ras mutation, or vice-versa. The
type of APC mutation that founds an adenoma could be thought of as determining
the tumour “micro-environment”, such that certain subsequent mutations are highly
selectively advantageous in this environment, and so become ﬁxed in the population
of adenoma cells. Other mutations may confer no, or little, selective advantage in
the tumour micro-environment, so not reach ﬁxation, or even be lost through random
drift.144 Chapter 5. Microdissection of Tumour Pathways in Sporadic Colon Adenomas
In this chapter, the order and timing of APC and K-ras mutations in the development
of small colorectal adenomas was investigated. Laser-capture micro-dissection was
used to extract individual crypts from 12 small colorectal adenomas. In each crypt,
the mutation cluster region of APC and the frequently mutated region of K-ras were
then sequenced to determine their mutation status. Results were combined to produce
a clonal map of the adenoma. The order and timing of APC and K-ras mutations in the
development of the adenoma were then inferred by examining the clonal composition
of the adenoma.
5.4 Methods
The clonal composition of 12 small adenomas was examined. All adenomas were
selected from patients with no family history of cancer. Permission to perform
molecular analysis of these cancers was granted by the NHS Oxfordshire Research
Ethics Committee B. Detailed description of the laboratory methodology used to
examine the adenomas can be found in Chapter 4. Brieﬂy, a H&E stained slide was
used to identify crypt pathology. Parafﬁn embedded tissue serially cut onto sterile
slides and then micro-dissected on a crypt by crypt basis using laser capture micro-
dissection. Crypts were sampled around the surface of each adenoma, and also from
adjacent normal mucosa if available. DNA was extracted for each crypt by overnight
digestion in Proteinase K. The amount of DNA in each crypt was small, so prior to
direct sequencing, SSCP of the APC MCR was performed on macro-dissected tissue
(needledissection, seeChapter4, Section4.4.1)fromeachadenomatoidentifymutated
regions. Mutated regions were then sequenced directly using a nested PCR reaction.
K-ras mutations almost always occur around codons 12 and 13, or less frequently at
codon 61, so this region was sequenced directly using a nested PCR reaction.
LaboratoryworkwascarriedoutincollaborationwithSimonLeedham, Histopathology
Department, Cancer Research UK London Research Institute.5.5. Micro-dissection results 145
5.5 Micro-dissection results
Results are displayed in Tables 5.1 - 5.3. Each adenoma has the status of APC and
K-ras displayed for each of the crypts that were genotyped.146 Chapter 5. Microdissection of Tumour Pathways in Sporadic Colon Adenomas
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5.5.1 APC mutations
In adenoma 1, a frame-shift mutation at codon 1413 was found in crypts 7-11. Crypts
1-6 were also dysplastic, but the frameshift mutation could not be detected in them.
Presumably, these crypts contained cells with a different APC hit. Thus, this adenoma
may be composed of two independently initiated APC clones.
No APC mutation could be detected in adenoma 5. SSCP screening of the APC MCR
of this polyp was inconclusive, and direct sequencing of MCRs 3, 5 and 7 found no
mutations. Adenoma 5 could still have harboured an undetected APC mutation that
was either missed by the SSCP screen or which lay outside of the MCR. Alternatively,
this adenoma may have been genuinely APC-wild-type, possibly developing due to
-catenin mutation.
Adenoma 8 had a number of crypts that were wild-type for APC (crypts 1, 2, 8, 13
and 14). Crypts 1, 2, 13 and 14 were adjacent normal crypts, whereas crypt 8 appeared
to be an entrapped normal crypt (see Figure 5.3). Similarly, crypt 1 of adenoma 2
appeared histologically normal, and had no detected APC mutation. Crypts 1 and 29-
31 of adenoma 12 also appeared wild-type and no APC mutations were found (see
Figure 5.5).
Evidence of top-down spread of tissue was observed in adenoma 6 (see Figure 5.4).
The dysplastic half of crypt 12 contained a one basepair deletion at nucleotide 4118 in
APC, whereas the non-dysplastic region of the crypt was APC wild-type.
5.5.2 K-ras mutations
The majority of adenomas (67%, 8/12) contained crypts that had a mutated K-ras allele.
In 4/8 of the adenomas, a mutated K-ras gene was observed in every crypt which was
also mutant for APC (adenomas 1, 4, 6 and 7). 3/8 adenomas had K-ras mutations in
a subset of the APC mutant crypts (adenomas 2, 3 and 12). Adenoma 5 had a K-ras
G13D mutation in crypts 2-5, but no APC mutation was identiﬁed in this adenoma. The
remaining 4/12 adenomas had no detectable K-ras mutation (adenomas 8-11).
In adenoma 2, the K-ras mutant crypts were localised to a small region of the adenoma,
which suggested that the K-ras mutant crypt had been acquired relatively late in the5.5. Micro-dissection results 149
Table 5.3: Polyp mutation data (polyp 12).
Polyp ID 12
APC Kras
Crypt 1 wt wt
2 wt wt
3 1370fsX3 wt
4 1370fsX3 G12V
5 1370fsX3 wt
6 1370fsX3 wt
7 1370fsX3 hom G12V
8 1370fsX3 hom G12V
9 1370fsX3 wt
10 1370fsX3 G12V
11 1370fsX3 failed
12 1370fsX3 G12V
13 1370fsX3 G12V
14 1370fsX3 wt
15 1370fsX3 G12V
16 1370fsX3 wt
17 1370fsX3 wt
18 1370fsX3 G12V
19 1370fsX3 G12V
20 1370fsX3 G12V
21 1370fsX3 G12V
22 1370fsX3 G12V
23 1370fsX3 G12V
24 wt hom G12S
25 1370fsX3 G12V
26 1370fsX3 G12V
27 wt wt
28 1370fsX3 wt
29 1370fsX3 G12V
30 wt wt
31 wt wt150 Chapter 5. Microdissection of Tumour Pathways in Sporadic Colon Adenomas
Crypt 6:
Crypt 7:
Figure 5.2: APC sequencing results from adenoma 1. Sequencing electropherogram
from crypts 6 and 7 of adenoma 1. A frameshift mutation, an insertion of single T, is
clearly visible in crypt 7 (indicated by an arrow), but this mutation was not present in
the dsyplastic crypts 1-6, suggesting the polyp had polyclonal origins.
development of the adenoma. In adenoma 3, every crypt had identical APC mutations
(mis-sense mutation at amino acid 1577), but multiple K-ras mutations were observed:
crypts1-3and13-17hadK-rasG12Dtransitions, crypts4-7and9hadG12Atransitions
and crypt 8 and 10-12 were K-ras wild-type. Most crypts in adenoma 12 were
heterozygous for G12V mutations, some were K-ras wild type, and in two crypts
homozygous G12V mutations were observed (see Figure 5.6 and Figure 5.5).
Clonal maps of adenomas 8 and 12 are presented in Figures 5.3 and 5.5 respectively.
In adenoma 12, the extent of multiple different mutant clones can be clearly seen.
Adenoma 8 shows how polyps can contain morphologically normal crypts.
5.6 Interpretation of results
5.6.1 Timing of K-ras inactivation
This high mutation frequency (67%) compares favourably to previously published
data (TAKAYAMA et al., 2001; OTORI et al., 1998; MCLELLAN et al., 1993). K-ras5.6. Interpretation of results 151
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APC 1555fsX4 / K-ras wild-type
Key:
Figure 5.3: H&E and methyl green stains of adenoma 8. The top image is a micrograph
of the methyl green stained laser capture slide of adenoma 8. Individual micro-
dissected crypts can be clearly seen, and the mutation status of APC and K-ras is
indicated by the coloured boxes. The bottom image is the H&E stained section of a
contiguous section. The crypt morphology can be determined using the H&E. Crypts
1,2 13 and 14 were morphologically normal crypts. Crypts 1 and 2 were located to
the left of the adenoma in non-involved mucosa. Crypt 6 appeared to be an entrapped
normal crypt. The morphology of these crypts was conﬁrmed by direct sequencing:
crypts 3-5 and 7-12 carried a truncating APC mutation, a two basepair deletion at
nucleotide 4665. The other crypts appeared wild-type for APC.152 Chapter 5. Microdissection of Tumour Pathways in Sporadic Colon Adenomas
12 normal
12 mutant
Figure 5.4: H&E of adenoma 6, crypt 12. Evidence of top-down spread. An APC
mutation was detected in the dysplastic appearing top half of crypt 12, but not in the
normal appearing basal half, suggesting that the mutated epithelial tissue was invading
this crypt from the top (luminal opening) towards the crypt base.
inactivation undoubtedly occurs after APC inactivation in some adenomas: 8/12 either
had no detected K-ras mutations, or contained a K-ras sub-clone. The remaining 4/12
adenomas (33%) were composed entirely of crypts that contained both APC and K-ras
mutations. These adenomas could have formed in two ways:
1. APC inactivation occurred prior to K-ras mutation. APC inactivation caused the
growth of the adenoma. During adenomatous growth, a crypt in the adenoma
acquired a K-ras mutation. The APC = K-ras =+ crypt had a growth advantage
compared to the APC  crypts. This resulted in a selective sweep of APC = K-
ras =+ crypts, which produced an adenoma composed entirely of APC = K-
ras =+ crypts.
2. K-ras mutation preceded APC inactivation. The K-ras =+ crypt subsequently
acquired further mutations which caused the inactivation of APC and the
initiation of adenomatous growth. Therefore, all crypts in the adenoma were
APC = K-ras =+.5.6. Interpretation of results 153
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Figure 5.5: Clonal map of adenoma 12. Adenoma 12 contained multiple different
mutations. The crypt map shows their spatial arrangement in the adenomatous tissue.
The majority of the adenoma is composed of clones containing both K-ras and APC
mutations. The presence of multiple clones in the adenoma is clearly illustrated by the
presence of two small regions that contain either crypts with only an APC mutation, or
crypts with an unusual homozygous K-ras mutation.154 Chapter 5. Microdissection of Tumour Pathways in Sporadic Colon Adenomas
Crypt 17:
Crypt 12:
Figure 5.6: K-ras sequencing results from adenoma 12. Most crypts were heterozygous
for K-ras G12V mutations (top trace), but two crypts (17 and 20) were unusual
homozygous G12V mutants (bottom trace). The wild-type sequence of the codon is
GGT.
If K-ras mutation occurred after APC inactivation, to reach ﬁxation K-ras =+ crypts
would have to rapidly sweep through the adenoma population in order to reach ﬁxation
in the presumably short period of time that the adenoma had been growing. Using this
idea, a simple mathematical model of clonal competition between crypts in an adenoma
was considered, which was used to estimate the selective advantage required by a K-
ras =+ clone to rapidly reach ﬁxation. If K-ras mutations needed to cause a large
selective advantage in order to reach ﬁxation, it would seem more likely that the K-ras
mutation occurred prior to APC inactivation. This analysis assumes that no tumour
growth occurs prior to inactivation of both alleles of APC. The models are considered
in section 5.6.2 below.
If K-ras mutations do precede APC mutations in some adenomas, they do not appear
to be sufﬁcient to initiate tumour growth. If oncogenic K-ras mutations were sufﬁcient
for adenomatous growth, adenomas composed entirely of K-ras mutant crypts, but with
only some crypts also harbouring an APC mutation, would be expected. No such
adenomas were seen. No APC mutation could be detected in adenoma 5, either as
a result of a detection failure or because the adenoma was indeed APC wild-type.5.6. Interpretation of results 155
Adenoma 5 contained K-ras mutations in 4/13 crypts, suggesting that even in the
possible absence of an APC mutation, an oncogenic K-ras mutation did not initiate
tumorigenesis. Further, if APC-deﬁcient crypts grew out of a patch of K-ras mutant
crypts, occasional K-ras =+APC-wild-type crypts at the margins of adenomas are
expected. Again, no such crypts were seen.
5.6.2 Mathematicalmodelsofclonalcompetitioninanadenoma
To investigate the plausibility that APC inactivation precedes K-ras mutation, simple
mathematical models of clonal competition between crypts in an adenoma were
developed.
Adenomas were assumed to begin growing after inactivation of APC at time t = 0
years. The ﬁrst APC =  crypt also to acquire a K-ras mutation formed at time T. Let
A(t) denote the number of APC mutant crypts, and K(t) the number of K-ras mutant
crypts.
Bottom-up spread only
The simplest model of adenoma growth assumes that tumour growth is solely via
bottom-up spread (PRESTON et al., 2003), so that all clonal expansion is due to
crypt ﬁssion. Top-down spread, which results in one mutant crypt invading another,
is neglected. Let A be the net expansion rate per year of APC = K-ras+=+ crypts
(net expansion rate = ﬁssion rate - extinction rate), and K be the net growth rate of
APC = K-ras =+ crypts. Then the model was deﬁned by:
dA
dt
=AA(t);t  0
dK
dt
=KK(t);t  T
A(0) =1
K(T) =1 (5.1)
which has the solutions:
A(t) = e
At;t  0;K(t) = e
K(t T);t  T: (5.2)
Next it was supposed that the speciﬁcity of K-ras mutant detection in an adenoma was156 Chapter 5. Microdissection of Tumour Pathways in Sporadic Colon Adenomas
such that if K-ras mutations appeared in 100% of crypts examined, then at least 95%
of the crypts in the adenoma contained K-ras mutant cells. Also, it was assumed that
an adenoma had been growing for  = 5 years before biopsy. The growth rate of
APC deﬁcient crypts was assumed to be A = 0:7 per crypt per year (see Chapter 3).
Then growth rate of APC = K-ras =+ crypts (K) required to produce an adenoma
that appeared to be completely composed of crypts with a K-ras mutation, given that
the ﬁrst K-ras mutant crypt appeared at t = T years, was calculated by solving:
K(t)
K(t) + A(t)
 0:95 (5.3)
for K. Hence, the relative increase in growth rate required by a K-ras mutant crypt
is:
 =
K
A

1
A
5A   log( 5
95)
5   T
(5.4)
If a K-ras mutant crypt is formed shortly after the initiation of adenoma growth, the
K-ras mutant crypt must divide around twice as fast as its APC mutant rivals in order to
dominate the adenoma after 5 years (see Figure 5.7). Alternatively, if the K-ras crypts
forms after 2.5 years of adenomatous growth, it requires a 3.7 fold increase in growth
rate, whereas if it forms after four years a 9.2 fold increase is required.
However, it should be noted that if adenomas had been growing for longer than ﬁve
years, then K-ras clones which occurred early in adenomatogeneous, required a smaller
growth advantage to reach ﬁxation. If equation (5.4) is considered in the limit  ! 1,
with T  , then  ! 1, indicating that K-ras mutant clones require almost no growth
advantage to reach eventual ﬁxation within the adenoma.
Top-down spread
The basal model presented above was modiﬁed to include top-down spread. The term
A(t)K(t) described the rate at which K-ras/APC mutant crypts invaded APC mutant
crypts, where  was the rate of top-down spread of K-ras =+APC =  crypts per crypt
per year. The crypt population in the adenoma was assumed to be well mixed so that
the spatial arrangement of crypts in the adenoma could be neglected. This resulted in5.6. Interpretation of results 157
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Figure 5.7: Increase in growth rate of K-ras =+ crypts when only bottom-up spread
is permitted. Time of K-ras mutation against required relative increase in growth rate
of crypts with both K-ras and APC mutations, compared to crypts with only an APC
mutation, in order for the K-ras mutant crypts to dominate the adenoma after ﬁve years
of growth. Only bottom-up spread (crypt ﬁssion) is permitted. If oncogenic K-ras
mutation occurs late, K-ras crypts require a much higher growth rate than APC crypts
to dominate the adenoma.
the equations:
dA
dt
= AA(t);T > t  0;
dA
dt
= AA(t)   A(t)K(t);t  T;
dK
dt
= KK(t) + A(t)K(t);t  T;
A(0) = 1;
K(T) = 1: (5.5)
These equations have no analytic solution, but were easily solved numerically using a
Runge-Kutta type integration scheme in Mathematica (WOLFRAM RESEARCH, INC.,
2005). To describe the behaviour of these equations, it was assumed that A = 0:7
as described above, and that an adenoma had been growing for 5 years before biopsy.
Then given that the ﬁrst K-ras deﬁcient crypt formed after T years, for each set of158 Chapter 5. Microdissection of Tumour Pathways in Sporadic Colon Adenomas
parameters fK;g the equations 5.1 were numerically integrated, and the set of values
of K and  which resulted in an adenoma composed of at least 95% K-ras mutant
crypts at biopsy (see equation 5.3) was recorded.
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Figure 5.8: Increase in growth rate of K-ras =+ crypts when top down and bottom-
up spread is permitted. Relative increase in growth rate of K-ras =+APC =  mutant
crypts in an adenoma initiated by APC inactivation. x-axis: relative increase in rate
of crypt ﬁssion of K-ras =+APC = , per crypt. y-axis: rate of top down spread of K-
ras =+APC =  crypts, per crypt per year. Line colour indicates time of formation of
K-ras =+ clone (T). Blue line T = 1 year, green line T = 2 years, orange line T = 3
years, red line T = 4 years.
Figure 5.8 shows the minimum values of the relative increase in ﬁssion rate () and
the rate of top-down spread () required for K-ras =+ crypts to reach ﬁxation about 5
years, given that the mutant clone formed T years after the initiation of adenomatous
growth. If the K-ras+=  clone formed after T = 3 years, invading crypts require a near
ﬁve-fold increase in ﬁssion rate or a high rate of top down spread.
5.6.3 Different pathways of tumorigenesis
The order and types of mutations found in an adenoma may be related to the initial
genetic changes in the adenoma. The ﬁrst mutation that occurs in a crypt must be
a stochastic event. Phenotypic effects resulting from the initial mutation, such as5.6. Interpretation of results 159
alterationofthemicro-environmentofthecrypt, orresultingintrinsicchangesinmutant
cells, may alter the selective advantage bestowed by subsequent mutations, and so
predispose to speciﬁc genetic alterations. The data were examined to see whether the
putative order of mutations was related to the type of APC mutation present in the
adenoma, since the selective advantage bestowed by an APC mutation is likely to be
determined by the speciﬁc mutation type (see Introduction 1.6.1).
The hypothesis tested was that the proposed milder types of APC mutations would be
more likely to require a K-ras mutation to initiate adenomatous growth, whereas severe
types of APC mutation would tend to be sufﬁcient to initiate tumour growth.
APC phenotype classiﬁcation
To classify the phenotypic effect of APC mutation, the selective advantage of each APC
mutation was estimated. Truncating APC mutations around codon 1309 (codons 1285-
1379), that result in a single remaining 20 amino acid binding repeat, produce the most
severe phenotypes in mice and humans, so presumably confer an optimal selective
advantage, whereas other truncations appear to provide less of a selective advantage
(see Introduction 1.6.1). Further, the location of the second hit is usually determined
bythelocationoftheﬁrsthit(LAMLUM etal.,1999). Mis-sensemutationsaround1309
usually result in LOH as the second hit, whereas mis-sense mutations away from codon
1309 typically cause the second hit to be a truncation elsewhere in the MCR.
Accordingly, the selective advantage of an APC mutation type, or severity of the
genotype, was classiﬁed as follows:
 Severe if the adenoma harboured a truncating mutation in APC between codons
1285-1379.
 Mild if the adenomas did not have a truncating mutation in APC between codons
1285-1379.
Available samples (small polyp size) prevented identiﬁcation of biallelic APC
mutations. Accordingly, this classiﬁcation is a necessary simpliﬁcation.160 Chapter 5. Microdissection of Tumour Pathways in Sporadic Colon Adenomas
Timing of K-ras mutation
The order of APC and K-ras mutations in an adenoma was inferred by considering the
clonal composition of the adenoma. Adenomas were divided into two groups:
1. Those with an initial APC mutation. This group includes all adenomas with no
K-ras mutated crypts, and those adenomas with only a proportion of the crypts
containing K-ras mutations.
2. Those with an “initial” K-ras mutation. This group is composed of the adenomas
with K-ras mutations in every crypt.
No association between type of APC mutation and timing of K-ras
mutation
The timing of K-ras mutation showed no clear association with APC mutation type (see
Table 5.6.3).
APC mutation type
K-ras acquitision time mild severe
pre-APC 2 2
post-APC 4 3
Table 5.4: Timing of K-ras mutation compared to APC mutation type. The data shows
no association (p = 1 Fisher’s exact test).
5.6.4 AssociationbetweenAPCmutationtypeandK-rasmutations
The data were then investigated to see whether there was an association between the
typeofAPCmutationandthepresenceofaK-rasmutation. ThetypesofAPCmutation
present in an adenoma might be related to whether a K-ras mutation is acquired at all.
For example, if the APC mutation present in the adenoma bestowed a large selective
advantage, subsequent acquisition of an activating K-ras mutation may provide limited
extra selective advantage, and so the K-ras mutant clone may be unlikely to reach5.6. Interpretation of results 161
ﬁxation in the adenoma population. Therefore, in adenomas with severe type APC
mutations a relative deﬁciency of K-ras mutations would be expected. Further, certain
combinations of APC and K-ras mutations may produce optimal selective advantages,
and so certain pairs of mutations will often tend to become ﬁxed in the adenoma. Other
combinations may produce less, or no, selective advantage and so be prone to loss
through random drift.
The types of APC mutation were classiﬁed as above (Section 5.6.3) and the frequency
of K-ras mutation with each type of APC mutation was considered. The data showed a
slight excess of K-ras mutations with APC-mild phenotypes (see Table 5.6.4), although
the difference was not signiﬁcant (p = 1 Fisher’s Exact Test, risk ratio 1.39).
APC mutation type
mild severe
K-ras wt 1 2
K-ras mutant 5 3
Table 5.5: Frequency of K-ras mutations by APC mutation type. The data shows no
signiﬁcant association (p = 0:55, Fisher’s Exact Test), but there is a slight excess of
adenomas with both an APC-mild type mutation and a K-ras mutation.
The lack of signiﬁcant association could be the result of the small sample size. To
increase the sample size, an analysis of published somatic APC and K-ras mutations
was performed.
5.6.5 Population data
To examine the association between the frequency and type of K-ras and APC
mutations data in a larger data set, data from COSMIC, the catalogue of somatic
mutations in cancer, was used (BAMFORD et al., 2004; FORBES et al., 2006). COSMIC
is a curated database that catalogues published mutations in genes that show frequent
somatic mutations in human cancers. COSMIC release 35, published 16 Jan 2008, was
used. Data are classiﬁed primarily according to gene. Data for each is in a separate162 Chapter 5. Microdissection of Tumour Pathways in Sporadic Colon Adenomas
ﬁle that lists all somatic mutations recorded for that gene. Information recorded in
the database includes: COSMIC Sample ID (unique sample identiﬁer), mutated amino
acid using standard nomenclature (DEN DUNNEN and ANTONARAKIS, 2001), tissue
type, tissue source (for example fresh frozen or cell-line), histology, publication details,
and mutation zygosity where available. Files are in comma delimited format (csv) or
Microsoft Excel format (xls).
Data analysis
Data analysis was performed using R (R DEVELOPMENT CORE TEAM, 2007). Lists
of somatic mutations for APC and K-ras were downloaded in csv format and imported
into R. Samples that had published somatic genotypes for both K-ras and APC were
identiﬁed by joining the two tables using the unique identiﬁer “COSMIC Sample ID”.
This left 1722 unique samples. Next, samples where the primary tissue type was
not “large intestine” were discarded, leaving 519 samples. Further, cell-line samples
were removed, as cell lines may have acquired additional mutations through repeated
passaging, and so not be representative of the mutation spectrum in colorectal cancers.
This left 479 samples.
Many samples that had been tested for APC did not have a detected mutation (75%,
347/470). The frequency of APC mutations in colorectal cancers is thought to be
around 80% (MIYOSHI et al., 1992). This apparent disparity between the reported
APC mutation frequency and the COSMIC database may be because of the technical
difﬁculty in identifying mutations in APC. APC is a large gene, composed of 2843
amino-acids, and many studies genotype only a small region of the gene, so that many
mutations may go undetected. Hence samples where an APC mutation was not found
were excluded from the analysis, leaving 132 samples. Next, samples which had a
detected APC mutation, but where the mutation was not precisely known (probably
due to a technique such as SSCP being used to identify mutations) were excluded. This
left a total of 114 samples with adequately characterised APC mutations.
Next, samples with a non-truncating APC mutation were excluded. Such samples
were relatively rare (10/114). Although mis-sense mutations in APC may have a
prognostic effect (FRAYLING et al., 1998), their pathogeniticity compared to truncating5.6. Interpretation of results 163
mutations is unclear. After exclusion of mis-sense mutations 104 samples remained. A
single cancer had two K-ras mutations listed. This was also excluded, leaving 103
samples.
Next APC mutations were classiﬁed according to their genotype. Samples which had
a truncation mutation between amino acids 1285 and 1379, which resulted in retention
of a single 20 amino-acid binding repeat, were labelled as “APC-severe”; otherwise the
sample was described as “APC-mild”. A few samples (4/104) had more than one listed
somatic mutation in APC. It was assumed that an APC-severe genotype was dominant,
so that if either or both of the mutations were a truncation between amino acids 1285
and 1379, the cancer was classiﬁed as APC-severe, otherwise it was classiﬁed as APC-
mild.
The 103 cancers hadbeen curated from thirteen papers(references: (YUAN et al., 2001;
DEUTER et al., 1996; KANAOKA et al., 1996; JEN et al., 1994; MIYAKI et al., 2003,
2002; LILLEBERG et al., 2004; DOMINGO et al., 2004; KIM et al., 2004a; AOKI et al.,
1994; MIYAKI et al., 1997; JEON et al., 2008; DE ABAJO et al., 2007)). These papers
were reviewed to conﬁrm that all cancers were sporadic. If cancers from patients with
germline APC mutations were included in the analysis, this would have systematically
under-represented cancers with severe-type somatic APC mutations. Cancers with a
germline mutation around codon 1309 tend to have a second hit through allelic loss
(LAMLUM et al., 1999). COSMIC only lists somatic mutations, and cancers with
identiﬁed somatic LOH events would have been excluded by the ﬁltering described
above, whereas FAP patients with a germline mutation elsewhere in APC tend to have
a truncating mutation in the MCR as their second hit, so would have been included after
the data were ﬁltered.
The following analyses were performed:
1. The association between the frequency of K-ras mutations with APC-severe and
APC-mild phenotypes (Fisher’s Exact Test).
2. The association between the type of K-ras mutations with APC-severe and APC-
mild phenotypes (Fisher’s Exact Test).164 Chapter 5. Microdissection of Tumour Pathways in Sporadic Colon Adenomas
Results
Table 5.6 shows the frequency of K-ras mutations with APC-severe and APC-mild
phenotypes. K-ras mutations show a possible association with an APC-mild phenotype
(p = 0:055, Fisher’s Exact Test, RR of K-ras mutation with an APC-severe phenotype
= 0:52).
Table 5.6: Frequency of K-ras mutations with APC-severe and APC-mild phenotypes.
APC-mild APC-severe
K-ras wt 36 32
K-ras mutant 26 9
Table 5.7 shows the frequency of K-ras mutation types with APC-severe and APC-mild
phenotypes. K-ras G12D and G13D mutations are rarely seen with the APC-severe
genotype (risk ratios 0.11 and 0.18 respectively, p-values (compared to the frequency of
APC-mild and APC-severe mutations in cancers with no K-ras mutation) are p < 0:006
and p < 0:07 respectively). K-ras G12V occur with approximately the same frequency
with APC-severe and APC-mild mutations (risk ratio 0.84, p = 1).
5.7 Discussion
Small adenomas, the precursors of colorectal cancers, have been growing for a
presumably short time and therefore their clonal composition represents a snapshot of
the initial events of colorectal carcinogenesis. The frequency of K-ras mutations in the
adenomas examined in this chapter was high (66%) and compared favourably to other
studies of early dysplastic lesions (TAKAYAMA et al., 2001). APC mutations were
found in all but one of the adenomas examined (92%, 11/12), which was consistent
with APC inactivation as the gatekeeper of adenomatous growth (LAMLUM et al.,
2000; POWELL et al., 1992). No evidence was observed that K-ras mutations were
sufﬁcient to initiate adenomatous growth, since no adenomas that were homogeneous
for K-ras mutations, and heterogeneous for APC mutations, were seen. Contrary to the5.7. Discussion 165
Table 5.7: Frequency of K-ras mutation types with APC-severe and APC-mild
phenotypes.
APC-mild APC-severe
K-ras wt 35 32
p.G12A 1 0
p.G12D 13 1
p.G12R 1 0
p.G12S 0 4
p.G12V 4 3
p.G13D 7 1
p.Q61H 1 0
ﬁndings of ZHU et al. (1997), no K-ras mutations were observed in normal appearing
cryptsthatweresituatedadjacenttoK-ras =+ adenomas. Apossibleexplanationforthe
discrepancy is that, Zhu et al. manually macro-dissected tissue adjacent to adenomas,
and then used a particularly sensitive assay to screen for K-ras mutations. Hence their
detection of K-ras mutations in normal appearing epithelium could be because of small
amounts of contaminating tumour tissue. The laser capture techniques used in this
chapter minimise the risk of contaminating tissue.
K-ras mutations were likely to have occurred prior or close to the time of APC
inactivation in some adenomas, as otherwise a late developing K-ras =+ clone would
have required a very large selective advantage in order to reach clonal dominance in
the presumably short time that the adenoma had been growing. Further, no association
was found between the type of APC mutation and the inferred order of APC and K-
ras mutations. Hence, it appears that if K-ras mutations do occasionally precede APC
mutations in adenomatous growth, the order of mutations is likely to be the result of
a random event, rather than the order of mutations representing a distinct pathway of
tumorigenesis.
APC is a tumour suppressor gene, and hence requires two allelic hits for inactivation
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a single hit for activation. Assuming that individual K-ras and APC hits occur
with equal likelihood, which may be a gross over-simpliﬁcation (since tumorigenic
APC mutations can occur in a large region whereas oncogenic K-ras mutations are
generally restricted to two codons), then APC inactivation should occur many orders
of magnitude less frequently than oncogenic K-ras mutation. However, since K-ras
mutation is insufﬁcient to initiate adenoma growth, some K-ras mutations may go
undetected, whereas presumably most cells that acquire two APC hits result in a
potentially detectable adenoma (POWELL et al., 1992; LAMLUM et al., 2000). The
high frequency of K-ras mutations observed in early adenomas may be the result of a
relatively high rate of somatic K-ras mutations, that behave as “passenger” mutations,
until the subsequent inactivation of APC. Alternatively, somatic K-ras mutation may
initiate clonal expansion without causing overt morphological changes to the crypt - a
ﬁeld cancerization effect.
A relatively high rate of somatic K-ras mutation is further supported by the ﬁnding
that 2/12 of the adenomas examined in this chapter contained multiple different K-
ras clones. This relatively high frequency (17%) of mutiple K-ras clones is much
greater than the frequency observed in colorectal cancers (0.029%)1. Previous studies,
however, may have failed to detect minority K-ras clones, as genotyping would have
been performed on macro-dissected samples that aggregated the DNA from many
hundreds of crypts. Since the detected frequency of multiple K-ras clones in cancers is
low, it is likely that if the two adenomas with multiple K-ras clones had continued to
develop, one of the two K-ras clones would have out-grown the other and produced
a K-ras monoclonal adenoma. Similarly, to reconcile the high frequency of K-ras
mutations observed in early adenomas (25-66%, see Section 5.3) compared to the lower
frequency observed in cancers (37.7%) (ANDREYEV et al., 1998), some K-ras mutant
clonesinearlyadenomasmustsubsequentlybelostduringfurthertumourdevelopment,
either as a result of genetic drift or out-growth of a more advantegous clone in the
adenoma.
Whether a particular type of K-ras mutation will reach ﬁxation in an adenoma may
depend both on the type of the K-ras mutation and the molecular characteristics
1Analysis of K-ras mutations listed on COSMIC (WELLCOME TRUST SANGER INSTITUTE, ????).5.8. Conclusion 167
of the adenoma, namely the type of founding APC mutation. The analysis of
published data of the frequency of APC and K-ras mutation types in sporadic colon
cancers performed in this chapter revealed a borderline paucity of K-ras mutations
that were found with optimal type APC mutations (termed APC-severe), compared
to the frequency of K-ras mutations found in cancers with sub-optimal APC mutations
(termed APC-mild). Assuming that K-ras mutations occur at the same frequency in
both groups, this data could be explained if K-ras mutations confer a greater selective
advantage when coupled with a sub-optimal APC mutation. When coupled with a
milder APC mutation, a K-ras mutant clone would be more likely to reach ﬁxation,
whereas when coupled with a severe APC mutation, the K-ras mutant clone may be
more frequently lost through genetic drift. Further, K-ras G12D and G13D were
observed signiﬁcantly less often with APC-severe mutations, whereas K-ras G12V
mutations were found at the same frequency with either class of APC mutation. This
possibly suggests the combination of K-ras G12D or G13D mutations with APC-severe
mutations does not produce a signiﬁcant selective advantage, possibly because APC-
severe type cells have a sufﬁcient increase in growth rate as to render subsequent K-ras
G12D or G13D mutations inconsequential. In contrast, K-ras G12V mutations were
observed at the same frequency irrespective of type of APC mutation, so it appears
that this mutations may always provide a signiﬁcant selective advantage. Interestingly,
K-ras G12V mutations are the only K-ras mutation type associated with a worse
prognosis (ANDREYEV et al., 2001), so presumably K-ras G12V mutations cause a
more aggressive phenotype.
5.8 Conclusion
Laser capture micro-dissection, coupled with optimised direct sequencing techniques,
can be used to observe the clonal structure of small adenomas. This clonal structure is
indicative of the ﬁrst clonal expansions that led to the formation of the adenoma.
K-ras mutations are frequently found in early adenomas, and in some cases activating
K-ras mutations may occur prior to APC inactivation, although the order of mutations
appears to be a random event. K-ras mutations alone appear to be insufﬁcient to initiate
adenomatous growth. K-ras mutations appear to be more frequently found in adenomas168 Chapter 5. Microdissection of Tumour Pathways in Sporadic Colon Adenomas
and cancers with sub-optimal APC mutations, although the association is borderline
and should be investigated further. Analysis of a public data set suggests that K-ras
mutation types may show a non-random distribution between APC mutation types,
with G12D and G13D mutations showing a strong association with less severe APC
mutations.
5.9 Further work
5.9.1 Mouse models
Interactions between APC and K-ras mutations should be examined in a suitable mouse
model. The behaviour of the murine Apc gene is very similar to the human homologue,
APC. Consequently, the mouse is used as a model organism for investigating colorectal
cancer development. The tumour burden in mice with the hypothesised “just-right”
combinations of Apc and K-ras mutations should be compared to the tumour burden
in mice with non-optimum combinations of mutations. Just-right combinations of Apc
and K-ras mutations should produce the most severe phenotypes.
Of particular interest are the K-ras G12D and G12V mutations; these are the most
frequently occurring K-ras mutations in humans cancers (ANDREYEV et al., 1998).
In this chapter, it was shown that K-ras G12D are rarely found with APC-severe type
mutations, whereas K-ras G12V mutations are found at the same frequency with both
APC-severe and APC-mild mutations. This suggests that an acquisition of a K-ras
G12D mutation only provides a signiﬁcant selective advantage in the presence of
an APC-mild mutation, whereas K-ras G12V mutations always bestow a selective
advantage. To test this four strains of mice should be created: Apc-mild/K-ras
G12D, Apc-mild/K-ras G12V, Apc-severe/K-ras G12D and Apc-severe/K-ras G12V,
and comparing the phenotypes of these mice to two groups of control mice that have
either Apc-mild and Apc-severe mutations.
Severity of the cancerous phenotype in the mice could be measured by tumour burden.
Molecular milestone events, such as p53 or p21 mutation, or histological features such
as invasion of the muscular layer, could also be assessed.
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mouse models:
1. Apc-severe/K-rasG12VmiceshouldproduceamoreseverephenotypethanApc-
severe/K-ras G12D mice.
2. ThephenotypeofApc-severe/K-rasG12Dmicewillbecomparabletothecontrol
Apc-severe mice.
3. Both Apc-mild/K-ras G12D and Apc-mild/K-ras G12V mice will show a more
severe phenotype than the control APC-mild mice.
Additionally, phenotypes of APC-mild/K-ras G12D and APC-mild/K-ras G12V mice
should be compared to Apc-severe mice. This comparison may show whether the
combination of non-optimum Apc mutation and an additional K-ras mutation produces
a more severe phenotype than an Apc-severe mutation alone.
Mouse types
The Min-mouse carries a germline nonsense mutation in Apc at amino acid 850
(MOSER et al., 1990; SU et al., 1992). In the framework presented above, this mouse
will tend to produce tumours with the equivalent of an APC-mild phenotype. Recently,
the Tomlinson lab have developed a new APC mutant mouse which has a germline mis-
sense mutation in Apc at codon 1322. Correspondingly, this mouse has the equivalent
of an APC-severe phenotype.
K-ras G12D mutations are lethal in the mouse embryo (JOHNSON et al., 1997; KOERA
et al., 1997). Further, somatic activation of oncogenic K-ras, through spontaneous
recombination in transgenic mice, causes widespread neoplastic and developmental
defects (TUVESON et al., 2004), particularly in the lungs (JOHNSON et al., 2001).
Hence, to study the effect of K-ras mutations in the development of colorectal
neoplasms, the confounding effects of oncogenic K-ras activation in other tissues must
be accounted for. To achieve this, transgenic mice with inducible oncogenic K-ras
should be used, which will allow for targeted expression of mutant K-ras in the bowel
of adult mice. Existing transgenic mice with conditional oncogenic K-ras mutations
are reviewed in (JANSSEN et al., 2005), and both conditional K-ras G12D and G12V
transgenic mice are available.170 Chapter 5. Microdissection of Tumour Pathways in Sporadic Colon Adenomas
5.9.2 Larger colorectal cancer cohort
Insufﬁcient data are currently available to reliably detect a weak association between
the frequency of K-ras mutations and the APC-mutation type. A study with much
larger data sets is required to reliably detect whether K-ras mutations are non-randomly
associated with APC-mutations.
The sample size required in the APC-mild and APC-severe groups to conﬁdently detect
a difference between the frequency of K-ras mutations in each group was calculated.
The required power of the study was set at 90%, and required conﬁdence levels of 95%,
99% and 99.9% were considered. If there is no association between the frequency of
K-ras mutation and APC-mutation type, the frequency of K-ras mutations was assumed
to be 0.4, as observed in a large meta-analysis of the frequency of K-ras mutations in
colorectal cancers (ANDREYEV et al., 1998). Then, sample size was calculated for
various levels of the relative risk of ﬁnding a K-ras mutation mutation with an APC-
mild mutation, rather than an APC-severe mutation.
The sample size is given by:
n 

u
p
0(1   0) + 1(1   1) + v
p
2b (1   b )
2
(1   0)2 (5.6)
where b  = 1
2(0 + 1), and 0 and 1 are the proportions of cancers with K-
ras mutations in the APC-severe and APC-mild groups respectively. u and v are
percentage points of the normal distribution that correspond to 100% power and
100% conﬁdence, respectively (KIRKWOOD and STERNE, 2003).
Calculated minimum required sample size is shown in Figure 5.9.2. If the relative
risk of ﬁnding APC-mild and K-ras mutations, compared to APC-severe and K-ras
mutations, is less than 1.57, samples sizes greater than 200 cancers are required to
detect a signiﬁcance difference between the groups with 95% conﬁdence. Hence,
the data presented here were insufﬁcient to detect conﬁdently a mild to moderate
association between the frequency of K-ras mutation amongst the APC-genotype
groups.5.9. Further work 171
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Figure 5.9: Required sample size for detecting the association between K-ras mutations
and an APC-mild genotype. The relative risk is the ratio of the probabilities of
observing K-ras =+APC-mild cancers to K-ras =+APC-severe cancers.
5.9.3 Clonal analysis of neoplasms
This work has optimised DNA yield and genotyping techniques for small volumes
of parafﬁn embedded tissue. Routinely, a minimum of 6 PCR reactions could be
performed on the DNA from a single crypt. These techniques could be applied
to further characterise the development of colorectal adenomas, for example by
combiningthesetechniqueswithmethylationanalysis(YATABE etal.,2001; KIM etal.,
2004c; KIM and SHIBATA, 2004; NICOLAS et al., 2007) to infer expansion rates of
sub-clones and better characterise the phylogenetic relations between sub-clones. The
techniques could be applied to study neoplastic growth in other tissues, for example
elsewhere in the gastrointestinal tract, or in the lungs.
5.9.4 Mathematical modelling of clonal competition
Mathematical modelling of the formation of APC and K-ras mutant clones, and
subsequent competition between clones, would provide useful further insight into
the clonal dynamics of early adenomas. In particular the expected genotypes of172 Chapter 5. Microdissection of Tumour Pathways in Sporadic Colon Adenomas
cancers, that result from selective couplings of particular mutations, could be predicted.
Recently, Beerenwinkel et al. developed a simple Wright-Fisher type model of clonal
expansion, that described sub-clone dynamics during cancer growth (BEERENWINKEL
et al., 2007). This model could be used, but modiﬁed slightly to include mutations
prior to adenomatous growth, and also by allowing the relative increase in selective
advantage bestowed by a mutation be determined by the mutation type. The effect
of “optimal” combinations of mutations could also be investigated in this model
framework.Chapter 6
Low Level Microsatellite Instability
This work has been published in the Journal of Pathology (GRAHAM et al.,
2008).
6.1 Aims
 Examine the frequency of microsatellite slippage in non-MSI-H cancers.
 Determine whether low-level microsatellite slippage can be explained by a low
rate of normal somatic slippage, or if an increased slippage rate is required.
6.2 Chapter Summary
Microsatellites (MSs) are short, repetitive, sequences of DNA that occur throughout the
genome. An MS locus consists of a short motif, such as CA, that is repeated a number
of times. Microsatellite instability (MSI) is a common and well characterised form of
genetic instability in colorectal cancers (reviewed by GRADY (2004)). Many cancers
have one or more MS loci that show changes in the number of motif repeats when
compared to the germline (IONOV et al., 1993). Cancers which have many loci that
show a high degree of variability in motif repeats tend to have germline mutations in
the mismatch repair (MMR) genes (DE LA CHAPELLE, 2004; HOEIJMAKERS, 2001;
KINZLER and VOGELSTEIN, 1996), or to have methylation of the MLH1 promoter,
which is associated with protein loss (KANE et al., 1997; VEIGL et al., 1998). These
(epi)genetic changes impair the DNA repair machinery of the cell, causing an increase174 Chapter 6. Low Level Microsatellite Instability
in the rate of MS slippage, so slippages accumulate at many loci. Consequently, MMR-
deﬁcient cancers are termed microsatellite instability - high cancers (MSI-H). It has
been suggested that some cancers with a lower level of MS slippage (slippage at only
a few loci), and without MMR deﬁciency, form another distinct pathological group
(BOLAND et al., 1998). These cancers are labelled low-level MS unstable (MSI-L).
Analogous to MMR-deﬁciency in MSI-H cancers, putative MSI-L cancers are thought
to have an underlying defect, possibly transient, that increases their MS slippage rate.
As yet, no such defect has been reliably identiﬁed, and further, no associations of MSI-
L with any clinico-pathological variables have been ﬁrmly established (TOMLINSON
et al., 2002).
DuetotherelativelyhighrateofsomaticMSslippageinnormaltissue(BHATTACHARYYA
et al., 1994; HANFORD et al., 1998; KRUGLYAK et al., 1998; LAI and SUN, 2003) and
the large number of cell divisions that occur during carcinogenesis, some MS slippage
is expected in a cancer. This has led some authors to question whether the putative
MSI-L group of cancers do indeed form a distinct pathological group (LAIHO et al.,
2002; TOMLINSON et al., 2002), and instead suggest that MS slippage in these cancers
is the result of normal somatic slippage during carcinogenesis.
In this chapter, data on microsatellite slippage in 47 colorectal cancers were analysed.
CancersweregenotypedatN = 9MSlocibySarahHalford, MolecularandPopulation
Genetics Laboratory, Cancer Research UK London Research Institute (HALFORD,
2005). Cancers were macro-dissected into four distinct regions that were genotyped
separately. MSI-H status was assessed by the presence of slippage at the BAT-26
locus (STONE et al., 2000). A mathematical model was developed, which predicted
the amount of MS slippage expected in cancer due to normal somatic slippage. The
predictionsofthemodelwerecomparedtothedegreeofslippageobservedinthecancer
cohort, to assess the evidence for an increased slippage rate during the growth of each
cancer. If the model predicted that the slippage observed in a particular cancer could
be explained by background slippage alone, then it was concluded that the cancer had
not acquired a MSI-L phenotype. If the model predicted that the degree of slippage
expected from normal somatic slippage was inadequate to explain the slippage in a
cancer, then it was assumed that MS slippage rate of the cancer was increased during6.2. Chapter Summary 175
tumorigenesis. Thus the model facilitated the evaluation of the null hypothesis that all
MS slippage observed in a putative MSI-L cancer resulted from only a normal rate of
somatic mutation.
5/47 cancers were conﬁrmed as MSI-H by the presence of slippage at the BAT-26 locus.
These cancers exhibited a degree of slippage that was more severe than predicted by the
mathematical model. This comparison provided validation that the model was sensitive
to an increase in the MS slippage rate during tumorigenesis. Of the remaining 42
cancers, 10/42 showed a level of slippage in at least one region that was too severe to
be explained by the mathematical model, when the slippage rate was set to  = 10 5
per locus per division. If the slippage rate was increased slightly to  = 5  10 5
per locus per division then none of the non-MSI-H cancers showed a degree of MS
instability that was too severe to be explained by the model. This suggested that most
low-level microsatellite slippage could be explained by a low rate of normal somatic
slippage, and if MSI-L had occurred in these cancers, it was a relatively infrequent
event.
Next it was assumed that the model, with a slippage rate of  = 10 5 per locus
per division, correctly identiﬁed whether a cancer had acquired an MSI-L phenotype.
The sensitivity and speciﬁcity of counting the number of “unstable” loci to identify
MSI-L cancers was then considered. Requiring a single unstable locus for MSI-L
classiﬁcation gave poor speciﬁcity, whereas requiring more than one unstable locus
gave poor sensitivity. Considering the degree of instability present at each locus, rather
than just the number of unstable loci, appeared to be a more reliable indicator of MSI-L
status.
Associations with predicted MSI-L status and patient age at biopsy, site of cancer, and
cancer stage revealed no signiﬁcant associations, although this may have been due to
the relatively small size of the study.
Heterogeneity in the degree of MSI observed in different regions of a cancer was
assessed. Only one cancer had a degree of MSI indicative of MSI-L in all four macro-
dissected regions. In other cancers, MSI that was indicative of MSI-L was restricted
to localised regions. Hence if an underlying genetic change did cause MSI-L in these176 Chapter 6. Low Level Microsatellite Instability
cancers, it tended to occur late in tumour development.
The model of normal somatic slippage in colorectal cancers could explain most of the
low-level microsatellite slippage observed in the cohort of cancers. Hence, there was
little evidence for a discrete group of MSI-L cancers. If an underlying genetic change
did cause MSI-L, it appeared to be a relatively uncommon event that occurred late
during tumorigenesis.
6.3 Introduction
The importance of an increased mutation rate is tumorigenesis is contested.
Tumorigenesis is a multi-stage process, such that the transformation of a normal cell to
an invasive carcinoma requires multiple mutations (FEARON and VOGELSTEIN, 1990;
HANAHAN and WEINBERG, 2000; JONES et al., 2008b). Since the rate of somatic
mutations is relatively low, of the order of 10 10 per base per division, some authors
have argued that an increase in the somatic mutation rate during tumour formation is
necessary for the acquisition of multiple mutations in reasonable time (RAJAGOPALAN
et al., 2003; KOMAROVA et al., 2002; NOWAK et al., 2002). Other authors have
argued that successive waves of clonal expansion, which results in many cells which
are susceptible to further oncogenic mutations, provides an alternative mechanism
for a cancer cell lineage to acquire multiple mutations (TOMLINSON et al., 1996;
MOOLGAVKAR and LUEBECK, 2003; BEERENWINKEL et al., 2007).
A particular type of genetic instability, called microsatellite instability, has been
extensively studied in colorectal cancers (see reviews by DE LA CHAPELLE (2003)
and GRADY (2004)). Microsatellite (MS) loci are a repetitive sequences of DNA found
throughout the genome. A microsatellite locus consists of a short motif of bases, such
as CA, which is repeated a number of times. The length of an MS locus is deﬁned as the
numberofmotifrepeatsatthelocus. Forexample, thelocusCACACACACACACACA
has a length of 8. Microsatellite loci are susceptible to polymerase slippage, which
can cause a change in the number of motif repeats (see Introduction Section 1.7.2)
and hence MS slippages are observed relatively frequently compared to other mutation
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Approximately 15% of colorectal cancers show extensive microsatellite slippage at
most MS loci examined (DE LA CHAPELLE, 2003). Accordingly, these cancers
are labelled as having a high level of microsatellite instability, and are termed
MSI-High cancers (MSI-H). MSI-H cancer cells have defective mis-match repair
machinery; either mutations of the MMR genes (HOEIJMAKERS, 2001; KINZLER and
VOGELSTEIN, 1996; DE LA CHAPELLE, 2004) or methylation of the MLH1 promoter
which is associated with protein loss (KANE et al., 1997; VEIGL et al., 1998) (see
Introduction section 1.7.2), which results in an impaired ability to correct MS slippage
during DNA replication, and so MS slippages accumulate during the many rounds
of cell division in tumour growth. Since microsatellites are located throughout the
genome, the increased frequency of MS slippage increases the likelihood of a mutation
in a tumour suppressor or oncogene, and so drives tumorigenesis.
Some cancers show a lower level of microsatellite slippage, and have been termed MSI-
Low cancers (MSI-L) (BOLAND et al., 1998). These cancers tend to have MS slippage
at only a few of the loci that were genotyped, and the degree of slippage observed at
each locus is signiﬁcantly less than in MSI-H cancers (see Figure 6.3). MSI-H cancers
tend to have multiple extra peaks compared to the germline, whereas MSI-L often
show only a change of a single motif repeat. This MSI-L group of cancers is less
well deﬁned than MSI-H cancers. Typically, putative MSI-L cancers are identiﬁed by
countingthenumberoflocithatshowslippage(reviewedin TOMLINSON etal.(2002)).
Typically, MS-stable cancers (MSS) are classiﬁed by having no loci that show slippage,
MSI-L cancers classiﬁed by having between 1-3 “unstable” loci, or less than 30% of
the loci examined showing instability, whereas cancers that have more loci showing
slippage are labelled MSI-H. MSI-H status can also be reliably identiﬁed by slippage
at particular indicator loci. For example, the BAT-26 MS locus, located in intron 5
of the mismatch repair gene MSH2, has been shown to be both sensitive and speciﬁc
for identifying MSI-H cancers (STONE et al., 2000). No such indicator loci have been
identiﬁed for MSI-L cancers (LAIHO et al., 2002; BOLAND et al., 1998).
Previous research has examined the associations between putative MSI-L cancers and
various clinical and pathological factors. To date, no signiﬁcant associations have been
found. One group reported an association between MSI-L and K-ras mutations (JASS178 Chapter 6. Low Level Microsatellite Instability
hereditary cancer clinic between July 2002 and
September 2004, were studied. In these families
MSI analysis was performed in the tumor of the
youngest patient available. When MSI analysis was
performed in more than one tumor within a family,
only the tumor of the youngest family member was
included in the analysis of the family history. The
family history was studied for fulfillment of Am-
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9 and modified Bethesda guidelines
2001.
10 Inheritance patterns were divided in (1)
autosomal dominant (AD), defined as first-degree
relatives with CRC in two or more generations, (2)
AD with reduced penetrance defined as two or more
nonfirst-degree relatives with CRC and (3) autoso-
mal recessive (AR) which is defined as two or more
first-degree relatives with CRC in one generation.
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of the Medical Ethics Committee of the Radboud
University Nijmegen Medical Centre.
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Figure6.1: GenescantracesfromMSI-H,MSI-LandMSScancers. (A)Genescantrace
of normal DNA. Small amounts of slippage are observed after PCR even in normal
(wild-type) DNA, due to slippage during the DNA ampliﬁcation process. (B) Typical
trace from a putative MSI-L cancer. A single extra allele that differs by a single motif
repeat is observed. (C) Trace from an MSI-H cancer shows severe instability: there
are many extra alleles, some of which show large deviations in length compared to the
germline. Image reproduced with permission from KETS et al. (2006).
etal.,1999), butnumerousotherstudieshavenotfoundtheassociation(seeforexample
HALFORD et al. (2005); LAIHO et al. (2002) or review in TOMLINSON et al. (2002)).
Further, the same group reported an association between MSI-L and methylation of
O-6-methylguanine DNA methyltransferase (MGMT) (WHITEHALL et al., 2001), but
again a subsequent study did not observe such an association (HALFORD et al., 2005).
A relatively large study of patients with sporadic stage C colorectal cancers (n = 255
patients) found a borderline association between MSI-L and reduced cancer speciﬁc
survival (WRIGHT et al., 2005), although no stage-speciﬁc associations have been
noted in other studies (see review in TOMLINSON et al. (2002)). Recently, a study
of (n = 98) colorectal cancers found an association between MSI-L and a reduced
immune response (reduced numbers of lymphocytes in the cancer) (KETS et al., 2006).
The lack of a reliable deﬁnition for MSI-L has made looking for such associations
difﬁcult.6.3. Introduction 179
Somatic MS slippage occurs at a relatively high rate in apparently normal cells.
Estimates from cancer cells lines suggest a rate of around 10 7   10 5 per locus per
cell per division in MMR-proﬁcient cancer cell lines (BHATTACHARYYA et al., 1994;
HANFORD et al., 1998), and analysis of slippage rates between human generations
range between about 10 8 and 10 3 (LAI and SUN, 2003; KRUGLYAK et al., 1998),
with the mean slippage rate for a dinucleotide repeat about 2  10 4 (LAI and SUN,
2003). Cancer growth involves many rounds of cell division, due in part to the
number of amplifying divisions required to produce the large number of cells in a
cancer (around 109 in a cancer of around 1cm3), and also because of repeated selective
sweeps as cancer cells acquire new selectively advantageous mutations. Hence, the
combination of a large number of divisions coupled with a relatively high slippage rate
means that some MS slippage is expected in a cancer. Consequently, some authors
have questioned whether MSI-L cancers do in fact form a pathological group that
is distinct from cancers that show no MS slippage (LAIHO et al., 2002), and have
suggested that the MS slippage observed in MSI-L is due to infrequent random events
during tumorigenesis, rather than representing qualitatively different genetic pathways
(HALFORD et al., 2002).
A previous statistical analysis of MSI frequencies have not found evidence for a distinct
MSI-L classiﬁcation, and suggested that the data is best explained by just MSS and
MSI-H classes. Gonzalez-Garcia and colleagues compared how well data from n =
415 patients genotyped at N = 6 loci was explained by a model with either just MSS
cancers, MSI-H and MSS cancers, or MSI-L, MSI-H and MSS cancers (GONZ´ ALEZ-
GARC´ IA et al., 2000). In each model, the number of mutated loci expected in a cancer
was modelled as binomial distribution, dependent on the mutation rate r. r depended
on whether the tumour was MSS and MSI-L and MSI-H. The best ﬁt of the model was
given by the two population model where there were just MSI-H and MSS cancers.
HALFORD et al. (2002) noted that their cohort of cancers showed an excess of MSS
cancers (no ‘unstable’ loci) and a slight excess of cancers with between 10-25% of
instability. In their study that genotyped n = 90 cancers at N = 377 MS loci, LAIHO
et al. (2002) noted that the proportion of markers unstable in a cancer appeared to
increase with patient age. Thus, they conclude that the slight excess of MS slippage180 Chapter 6. Low Level Microsatellite Instability
observed in some cancers could just reﬂect an increase in the number of cells divisions
during tumorigenesis.
In this chapter, a mathematical model of MS slippage during carcinogenesis was
developed. The aim of the model was to predic the degree of MS slippage that was
expected in a cancer from a low rate of normal somatic slippage. The model was
then used to assess the degree of MSI observed in a cohort of non-MSI-H colorectal
cancers, and decide whether the low-level of microsatellite slippage observed in some
of these cancers could be reasonably attributed to normal somatic slippage, or whether
an increased MS slippage rate was required. In contrast to the previous techniques
described above, the approach taken here describes both the degree of instability
present at each locus, as well as the considering the number of unstable loci. This
permits a more precise characterisation of the degree of apparent genetic instability
present in a cancer.
6.4 Methods
6.4.1 Laboratory methods
MS slippage was examined in 47 parafﬁn embedded sporadic colorectal cancers.
Permission to perform molecular analysis of these cancers was granted by the NHS
Oxfordshire Research Ethics Committee B. Each cancer was genotyped using a panel
of N = 9 MS loci as listed in Table 6.1. The panel consisted of seven dinucleotide
repeats and two tetranucleotide repeats. All markers were located either in intronic
regions of genes, or outside of genes. Hence, slippages at these loci presumably had
little, if any, selective effect on a cell. All loci had been previously identiﬁed as prone
to slippage in non-MSI-H cancers (HALFORD et al., 2002, 2003).
Macro-dissection
Genotyping experiments were performed by Sarah Halford (HALFORD, 2005). Brieﬂy,
each cancer was macro-dissected into four distinct regions using a sterile needle.
Regions were selected to be easily macro-dissected, so as to minimise contamination
between areas. DNA was extracted according to the macro-dissection protocol6.4. Methods 181
Table 6.1: Details of genotyped microsatellite loci.
Locus name Location Repeat type
D10S197 Intron of GAD2 Dinucleotide
D13S175 Not in gene Dinucleotide
D15S144 Not in gene Tetranucleotide
D15S659 Not in gene Tetranucleotide
D17S250 Not in gene Dinucleotide
D18S58 Not in gene Dinucleotide
D2S123 Not in gene Dinucleotide
D5S346 Intron of REEP5 Dinucleotide
D8S87 Not in gene Dinucleotide
described in Section 4.4.1.
Genotyping
PCR was performed using standard reaction conditions. PCR products were analysed
with the ABI377 prism sequencer (Perkin-Elmer), and results were interpreted using
Genotyper software (Perkin-Elmer). If MS slippage was identiﬁed at a particular locus,
the genotyping was repeated to conﬁrm that the slippage was not the result of slippage
during PCR ampliﬁcation. The results of the genotyping are shown in full in the
Appendix, Section 8.4.
MSI-H status
MSI-H status of each cancer was determined by presence or absence of slippage at the
BAT-26 locus (STONE et al., 2000).
6.4.2 Descriptive statistic
A collection of allelic lengths could be present in each PCR product. To describe the
alleles, the average minimum mean-squared distance from the germline (denoted by182 Chapter 6. Low Level Microsatellite Instability
A), was calculated. The molecular methods used to genotype the cancers are unable
to determine which of the germline alleles each allele in the sample was derived from.
Hence the statistic A was designed to assume maximum parsimony, such that, an allele
of length l was derived from the germline allele that was the most similar in size.
Analysis of the PCR product in the Genotyper software indicated the relative
concentration of each allele in the PCR product. However, these measurements tend to
be unreliable as an indicator of the true proportions of each allele in the sampled cancer
cells, due to possible contaminating normal tissue and slippage that occurs during PCR
(SIEBEN et al., 2000). Hence the statistic A considered only whether an allele of a
particular size was present or absent in the PCR product.
For each region of each cancer, the lengths of the alleles present in the sample, at the
locus i, were denoted by li1, li2, :::, lin. The germline lengths were at locus i were
denoted by gi1 and gi2 respectively. Then the average minimum mean-squared distance
from the germline at locus i (ai) was deﬁned as:
ai =
 
1
n
n X
j=1
min
 
(lij   gi1)
2;(lij   gi2)
2
! 1
2
(6.1)
The data from all N loci were summarised as:
A =
1
N
N X
j=i
ai (6.2)
6.4.3 Microsatellite slippage model
The mathematical model of MS slippage during cancer growth was based on that of
TSAO et al. (2000) and is summarised in Figure 6.2. The model described slippage at
a MS locus before and during cancer growth. It was assumed that a cancer grew from
a single rogue cell. The lineage of this cell was simulated from birth until a cancer of
approximately 109 cells, which corresponds to a cancer of about 1cm3 in volume, was
formed. It was assumed that cancers grew exponentially after TG divisions, where TG
was chosen according to the patients age at biopsy so that cancers had been growing for
about ten years before being removed from the body. Cells were assumed to divide at a
rate of C = 182 divisions per year, which corresponded to a cell division approximately
every two days. The rate of cell division was assumed to remain constant during cancer
growth.6.4. Methods 183
Cancer growth 
after TG divisions
MS slippage rate of µ 
per locus per cell 
division.
A cancer of 
109 cells is 
produced
Sample 1000 cells 
and genotype -1, 0, 2
Allele lengths 
normalised 
relative to 
germline 
Figure 6.2: Summary of mathematical model of microsatellite slippage during
tumorigenesis. The lineage of a cell is simulated from birth until a cancer of
approximately 109 cells is produced. Cancer growth begins after TG divisions, where
TG was chosen so that a cancer had been growing for 10 years at biopsy. Microsatellite
slippage of 1 motif repeat occurs at a constant rate  at each cell division; cells divide
182 times per year. After the cancer growth had been simulated, a sample of S = 1000
cells was taken from the cancer, and the MS alleles present in the sample analysed.
Allele lengths were normalised relative to the germline. An allele was considered
detectable in the sample if it constituted more than X% of the sample, where X was
the PCR detection threshold.
Cancer growth rates
Rather than growing exponentially, cancers may expand much more slowly (linearly),
especially if there is a high rate of cell death within the cancer. This alternative slower
growth would mean that there were more cell divisions separating the cells in the cancer
from their most recent common ancestor, and hence more variation would be expected
at each MS locus. Hence the construction of the model was designed to produce a
conservative estimate of the degree of MSI expected in a cancer.
Microsatellite slippage
Pre-cancer cells were assumed to be diploid, so contained two allelic copies of a MS
locus. The initial normalised germline lengths of the locus were denoted as g1 and g2
respectively where, without loss of generality, g1 = 0 and g2  g1.
A basal model of stepwise microsatellite slippage was assumed. Each time a cell
divided, slippage of 1 motif repeats could occur at each allele of the MS locus184 Chapter 6. Low Level Microsatellite Instability
with probability . The rate of slippage remained constant throughout the simulation,
and was assumed to be the same for all MS loci. Somatic MS slippage is relatively
poorly characterised so this simple stepwise model was chosen as an adequate ﬁrst
approximationtothepresumablycomplexpatternsofMSslippageincolorectalcancers
(LAI and SUN, 2003). This simple model was also conservative with respect to the
degree of slippage expected under the null hypothesis, since slippages of a more than
one motif repeat were not permitted.
Published estimates of MS slippage rates in cancer cells were very broad (HANFORD
et al., 1998; BHATTACHARYYA et al., 1994), and rates appeared to depend upon the
number of motif repeats present at a particular locus (LAI and SUN, 2003). Hence,
the model was examined with two relatively low slippage rates:  = 5  10 5 and
 = 10 5 per cell per division. These relatively low rates compared favourably with
the rates used in other published models (TSAO et al., 2000). The rates were chosen
not be a deﬁnitive estimate of the MS slippage rate at each locus, but rather to allow the
effect of low background rate of somatic slippage to be examined.
Cell ploidy
To examine the effect of cell ploidy, it was assumed that cancer cells were either
diploid or tetraploid. In the tetraploid case, it was assumed that cancer cells became
tetraploid due to abnormal chromosome duplication at the initiation of cancer growth,
that resulted in two copies of each of the two original alleles. Following this initial
aberrant event, it was assumed that no further abnormal chromosome duplication
occurred. Slippage at each of the resulting four alleles then occurred according to
the stepwise mutation model described above.
PCR Detection threshold
Once cancer growth had been simulated, a number of cells (S = 1000) were randomly
sampled from the cancer. Due to the inherent variability of the PCR process, an allele
present in a sample would only be reliably identiﬁed if it constituted a signiﬁcant
proportion of the total alleles in the sample (SIEBEN et al., 2000). To account for this,
in the model the PCR detection threshold was set at X%, so that an allele of length k6.4. Methods 185
was only considered present in the sample if at least X% of the total number of alleles
in the sample had length k. The model was simulated for two plausible dectection
thresholds of X = 10% and X = 20%.
6.4.4 Model construction and simulation
A coalescent type construction was used for the model, similar to that of TSAO et al.
(2000). Using this framework, only the ancestry of the S = 1000 cells that were
sampled from the cancer needed to be simulated, rather than the ancestry of the entire
109 cells in the cancer.
The simulation had three parts:
1. Offspring counts. The number of cells having 0, 1 or 2 offspring in each
generation were computed. In generation i, the number of cells having 0, 1 or 2
offspring were labelled ni0, ni1 and ni2 respectively, and were computed for each
generation of cells from the zygote until the cancer of 109 cells was formed after
age  C divisions (see Table 6.2). Cancer growth began after TG, where TG was
chosen such that a cancer grew for a period of ten years, thus TG = (age 10)C.
Prior to TG divisions, each cell had a single offspring cell that formed part of the
lineage of the tumour, hence ni0 = ni2 = 0 and ni1 = 1 for i = 1;:::;TG. After
TG divisions, the cancer was assumed to grow exponentially such that a cancer
of 109 cells was formed after ten years. Note that the number of cells in the ith
generation is then ni1 + 2ni2.
2. Construction of ancestral tree of sampled cells. The offspring counts computed in
part 1 were used to construct the ancestral tree that deﬁnes the relations between
cells in the sample. A sample of S = 1000 cells was “sampled” at random from
the cancer. Suppose that the sample was taken from the offspring of generation
i. The offspring counts from generation i deﬁned the probability of each of the
cells in the sample sharing a parent cell in generation i   1. Thus, for i =
age182;:::;1, the ancestral relations between each cell in the sample could be
constructed.
3. Simulation of microsatellite slippage. The initial cell, at generation i = 0186 Chapter 6. Low Level Microsatellite Instability
was initialised with the germline microsatellite lengths gi0 and gi1. Starting at
generation i = 1 and moving the down the ancestral tree constructed in step 2, the
microsatellite lengths of each daughter cell in the tree were simulated according
to the microsatellite slippage model described above (Section 6.4.3).
Table 6.2: Example of computation of number of offspring cells in each generation.
Numbers of cells
Generation 0 offspring 1 offspring 2 offspring Total cells in next generation
0 0 1 0 1
1 0 1 0 1
2 0 1 0 1
3 0 1 0 1
4 0 1 0 1
5 0 1 0 1
6 0 1 0 1
7 0 1 0 1
8 0 1 0 1
. . . . .
. . . . .
. . . . .
TG 0 0 1 2
TG + 1 0 1 1 3
TG + 2 0 1 2 5
. . . . .
. . . . .
. . . . .
Age/182 0 100000000 450000000 10000000006.5. Results 187
Simulation of model
The model was written in C. Simulations were performed on the UCL Central
Computing Services C3 Linux cluster. The simulation results were compared to the
laboratory data using R (R DEVELOPMENT CORE TEAM, 2007).
6.4.5 Comparison of model to data
To compare the expected versus observed MS slippage the statistic A was used. For
each patient, the model was simulated for each of the N MS loci. These N simulations
were described as a single instance of the model. An approximation to the underlying
distribution of A (labelled b A) that was expected under the model was produced by
repeated simulation of the model, 105 instances for each cancer, and recording each
value of A. The distribution b A depended upon the germline allele lengths of each MS
locus and the age of the patient at biopsy, and so had to be simulated for each cancer in
turn.
To calculate a p-value, the probability that MS slippage at least as extreme as the
slippage observed in each region of the cancer would occur under the ‘null hypothesis’
model, the proportion of simulation repeats that produced a value of A at least as
extreme as observed in the cancer region was calculated. This p-value was deﬁned
as:
p = P(Asim  Aobs) (6.3)
where Asim was the simulated value of A and the Aobs was the value of A observed
in the cancer. For each sample, the null hypothesis was rejected if p < 0:05 and the
cancer was labelled putative MSI-L.
6.5 Results
The microsatellite slippage observed in a cohort colorectal cancers was assessed using
a model of normal somatic microsatellite slippage during tumorigenesis. Comparison
of the degree of slippage predicted by the model, to the degree of slippage observed in
each cancer, allowed the testing of the ‘null hypothesis’ that the MS slippage observed
in the cancer was due only to a low rate of background slippage.188 Chapter 6. Low Level Microsatellite Instability
6.5.1 Model behaviour
Effect of detection threshold
Increasing the PCR detection threshold from 10% to 20% did not signiﬁcantly alter the
distribution of A values (see Figure 6.3).
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Figure 6.3: Effect of altering cell ploidy or PCR detection threshold. Simulations were
computed with N = 9 loci, germline lengths g0 = 0, g1 = 1,  = 5  10 5, with a
PCR detection threshold X = 10% and diploid cancer cells unless otherwise stated.
.
Effect of cancer cell ploidy
Assuming cancer cells were tetraploid or diploid, due to an erroneous cell division
at the initiation of cancer growth did not signiﬁcantly alter the p-values (see Figure
6.3).
Number of loci successfully genotyped
The variance of A (A) increased as the number of successfully genotyped loci (N)
decreased (see Figure 6.4). As N increased, the variance of A monotonically decreases.6.5. Results 189
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Figure 6.4: Variance of A as a function of N, the number of successfully genotyped
loci. The variance of A decreases as the number of successfully genotyped loci
increases. Simulations were computed with germline lengths g0 = 0, g1 = 1, a PCR
detection threshold X = 10%,  = 10 5 and diploid cancer cells.
Slippage rate
Increasing the slippage rate () increased the mean value of A (see Figure 6.5.1), so
that more MS slippage was expected in a cancer due to normal somatic slippage.
6.5.2 Validation of model on MSI-H cancers
The model was compared to the slippage observed in the ﬁve MSI-H cancers (See
Table 6.5, cancers H1-H5). This comparison served as a ‘test-case’, to see if the model
of normal somatic slippage would be unable to explain the slippage observed in cancers
with an elevated slippage rate.
Five MSI-H cancers in the cohort of 47 cancers were identiﬁed by the presence of190 Chapter 6. Low Level Microsatellite Instability
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Figure 6.5: Distribution of A for  = 10 5 (red line) and  = 5  10 5 (blue line).
Simulations results are for N = 9 loci, each with germline lengths g0 = 0, g1 = 1,
PCR detection threshold X = 10% and diploid cancer cells.
slippage at the BAT-26 locus (STONE et al., 2000). All ﬁve MSI-H cancers had
signiﬁcant MS slippage at most of the loci examined. The slippage rate was set at
 = 10 5 per locus per cell division, and it was assumed that cancer cells were diploid
and that the PCR detection threshold was 10%. Then, in all regions of the ﬁve cancers
the degree of MSI exhibited was very unlikely to occur under the null hypothesis. P-
values are shown in Table 6.5, and the largest p-value observed was p < 10 5. Similar
results were obtained if the slippage rate was increased to  = 5  10 5 (largest p-
value: p = 0:026). As noted above, cancer cell ploidy and the PCR detection threshold
did not signiﬁcantly alter the p-values. Therefore it was conﬁrmed that the MS slippage
in the ﬁve MSI-H cancers was very likely to have resulted from an elevated slippage
rate.6.5. Results 191
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6.5.3 MS slippage in non-MSI-H cancers
Next the model was compared to the slippage observed in the 42 remaining non-MSI-H
cancers. Initially a slippage rate of  = 10 5 per locus per cell division was assumed.
Cancer cells were assumed to be diploid and the PCR detection threshold was set at
10%. Using these assumptions, 10 out of the 42 non-MSI-H cancers (24%) contained
at least one region where the degree of MSI was too severe to be explained by the null
hypothesis (p < 0:05 in these cancers) suggesting that these 10 cancers had acquired
an increased slippage rate during tumorigenesis and were indeed MSI-L (see Tables
6.3-6.5). Borderline levels of MSI (p < 0:1) were observed in regions of two cancers
(cancers 36 and 38), but both these cancers contained another region where the amount
of slippage was indicative of MSI-L.
The degree of MSI in these ten putative MSI-L cancers was then examined (see Tables
6.3-6.3). 4 of these 10 cancers (cancers: 9-11 and 38) had a putative MSI-L region
that had only one unstable locus, which always had multiple extra alleles that showed
a maximum deviation from the germline of at least ﬁve motif repeats. 5 cancers had
MSI-L regions with two unstable loci (cancers: 4, 18, 20, 29, 36) and only one cancer
had a MSI-L region with three unstable loci (cancer 35); these cancers had multiple
extra sizes of alleles at at least two loci, or had at least two unstable loci, one of which
that had an allele that differed by at least three motif repeats from the germline. In
comparison, non-MSI-L cancers always had less than three regions showing slippage,
which was less severe than in putative MSI-L cancers. Typically a value of A > 0:25
was sufﬁcient to produce a p-value less than 0.05. Cancer 36 had values of A = 0:37,
0.37 and 0.34 in regions 2-4, respectively, but these values did not produce a signiﬁcant
p-value. This is because only ﬁve loci were successfully genotyped in cancer 36, and
the variance of A is greater when fewer loci are examined (see Figure 6.4).
6.5.4 Most microsatellite slippage in non-MSI-H cancers can be
explained by background slippage
Next, the data were compared to the model with a slightly higher slippage rate of  =
5  10 5 per locus per cell per division. It was again assumed that cancer cells were
diploid and that PCR detection threshold was 10%. With this slightly higher slippage6.5. Results 195
rate, the slippage observed in all the non-MSI-H cancers could be adequately explained
by the null hypothesis. The smallest p-value observed in the non-MSI-H cancers was
p = 0:094.
6.5.5 Associations with clinico-pathological variables
Dukes stage (Fisher’s Exact test, p = 0:7115), location in colorectum (Fisher’s Exact
test, p = 1), patient sex (Fisher’s Exact test, p = 0:4682) and age at biopsy (Mann-
Whitney test p = 0:8015) was compared between the putative MSS and MSI-L cancers,
identiﬁed with  = 10 5. No signiﬁcant associations were found.
6.5.6 Timing of MSI-L
Of the 10 cancers identiﬁed as putative MSI-L, only one (cancer 29) appeared to have
MSI-L in all four regions. Cancer 29 had two unstable loci that showed signiﬁcant
slippage in all four regions of the cancer and had a maximum change of at least 3
repeats from the germline. Of the remaining 9 putative MSI-L cancers, 5 cancers had
MSI-L in only one region, 1 cancer had MSI-L in two regions, and a further 2 cancers
had MSI-L in three regions. Therefore, if these 9 cancers were truly MSI-L, then the
increase in slippage rate was likely to have occurred late in the development of the
cancer. If MSI-L had occurred early, then all the regions of a cancer would show
similarly high degrees of MSI.
6.5.7 Number of unstable loci as a predictor of MSI-L status
It was considered how reliable the number of unstable loci was as a predictor of MSI-L
status. The model with  = 10 5 was assumed to correctly identify regions of a cancer
that were MSI-L. Then the sensitivity and speciﬁcity of identifying these regions by
their having at least 1, 2 or 3 loci that showed slippage was calculated (see Table 6.6).
Classifying a cancer as MSI-L by the presence of slippage at a single locus had poor
speciﬁcity, whereas requiring slippage at multiple loci for MSI-L classiﬁcation had
poor sensitivity.196 Chapter 6. Low Level Microsatellite Instability
Table 6.6: Sensitivity and speciﬁcity of using the number of unstable loci for MSI-L
classiﬁcation. The model with slippage rate  = 10 5 was assumed to identify reliably
regions of each cancer that were MSI-L. The sensitivity and speciﬁcity of counting the
number of unstable loci in each region was then computed.
Minimum number of
unstable loci required for
MSI-L classiﬁcation Sensitivity Speciﬁcity
1 1 (18/18) 0.69 (102/150)
2 0.72 (13/18) 0.97 (145/150)
3 0.06 (1/18) 1 (150/150)
6.6 Discussion
Using a mathematical model of microsatellite slippage during tumour growth, the
degree of microsatellite slippage expected in a cancer without an elevated slippage
rate was predicted. Assuming that the normal somatic slippage rate is relatively low
(slippage rate of  = 10 5 per locus per cell per division) then most slippage observed
in a group of non-MSI-H cancers could be reasonably explained by normal somatic
slippage. A minority of the non-MSI-H cancers that were genotyped (24%) contained
a region that had slippage that was more severe than predicted by the model, and so
were labelled as MSI-L. If the proportion of the regions that showed ‘severe’ slippage
was considered, then the frequency of putative MSI-L regions was only 18/168 (11%).
Hence, if the model did correctly identify MSI-L cancers, then the model suggested
that MSI-L cancers were relatively rare.
OnlyasinglecancerwasobservedtohaveadegreeofMSIthatwasindicativeofMSI-L
in all four regions that were genotyped. This suggests that the acquisition of an MSI-L
phenotype is not an early event in tumorigenesis, since it is likely that an increase in
the slippage rate early in tumorigenesis would cause detectable slippage in most of the
cells in the cancer.
If the normal MS slippage rate was assumed to be slightly higher,  = 5  10 56.6. Discussion 197
per locus per cell per division, all of the slippage observed in the non-MSI-H cancers
could be adequately explained by background slippage. With this elevated mutation
rate, slippage in MSI-H cancers could still not be explained by the model. Although
precise estimates of somatic slippage rates were unavailable, estimates of MS slippage
rates between human generations, and slippage rates in MMR-proﬁcient cancer cells,
ranged from 10 8-10 3 per locus per division (LAI and SUN, 2003; HANFORD et al.,
1998; KRUGLYAK et al., 1998), and were typically toward the upper end of this scale
(KRUGLYAK et al., 1998; LAI and SUN, 2003), so an average background rate of  =
5  10 5 is reasonable. Moreover the N = 9 MS loci examined in this study were
selected as they were sensitive for detection of putative MSI-L cancers (HALFORD
et al., 2002, 2003), so they were likely to have a relatively high slippage rate.
Although it was not possible to be sure of the precise background somatic MS slippage
rate at each locus, the model illustrated that, given a low somatic slippage rate, it
was reasonable to expect a non-negligible degree of slippage in a cancer. It should
be noted that it is unlikely that the model could accurately predict the true degree of
MSI that would occur in any particular cancer. This does not detract from the analysis
presented here. The model was designed only to provide a prediction of the basal level
of microsatellite slippage that could be expected in any cancer, so that the prediction
could be used to critically assess the degree of MSI observed in a cohort of non-MSI-H
cancers. The model clearly illustrated that occasional ‘MSI’ is expected from normal
somatic slippage alone, and so low-level microsatellite slippage is not necessarily the
result of some underlying change that causes an increase in the slippage rate.
Furthermore, the construction of the model was designed to minimise the degree of
MS slipapge expected by chance, and so the predictions of the model are conservative
with respect to the existence of MSI-L. For example, in the model, cancers were
assumed to grow for 10 years, whereas recently published data suggests that cancers
may actually grow for more than 17 years (JONES et al., 2008b). Also, it was supposed
that cancers grew at a slow exponential rate, whereas growth may be much slower,
perhaps linear, so that there would be more rounds of cell division in which slippages
can accumulate. Further, it was assumed that cancer cells divide about once every two
days. There are many estimates of cancer cell division rates, but notably, similar work198 Chapter 6. Low Level Microsatellite Instability
has assumed a rate of one cell division per day (TSAO et al., 2000; YATABE et al.,
2001; BEERENWINKEL et al., 2007). This higher rate of division would mean that
more slippage would be expected in a cancer due to normal somatic slippage, since
more rounds of cell division and death would occur in the ten years that a tumour had
been growing. Therefore, it is concluded that an elevated slippage rate is not required
to explain most MS slippage observed in non-MMR-deﬁcient cancers.
Analysis of the number of ‘unstable’ loci as an indicator of MSI-L status was shown to
be unreliable. The model suggests that cancers which have at least one locus that shows
signiﬁcant slippage (a change of at least 4 motif repeats from the germline and multiple
extra alleles), or multiple ‘unstable’ loci, at least one of which is highly unstable, are
the most likely to have acquired a mutator phenotype. An approximately equivalent
indicator is a value of A > 0:25 when sufﬁcient loci (N  9) are examined.
Does MSI-L exists even in a minority of non-MSI-H cancers? During PCR, MS
loci can slip (SIEBEN et al., 2000), so MSI will be occasionally observed in cancers
that are actually MSS. MSI-L could be the result of external mutagenic factors, so
that occasional MS slippages result from unpredictable events in that occur during
the development the cancer, rather than an intrinsic genetic or epigenetic defect. A
low slippage rate, coupled with the many rounds of division that occur during the
growth of a cancer, means that some slippage is expected in a cancer even without an
elevated slippage rate. Clear evidence for a distinct MSI-L group of cancers would
be provided by the discovery of a strong association of MSI-L with a clinical or
pathological variable. Previous work has looked for such an association, by examining
the co-occurrence of putative MSI-L an variables such as K-ras mutations, loss of
heterozygosity events at APC, or methylation of O6-methylguanine methyltransferase,
as noted in the Introduction to this Chapter. The ﬁndings have been inconsistent,
with most studies ﬁnding no signiﬁcant association between MSI-L and any clinico-
pathological or molecular variable. Potentially, the reason for the inconsistency could
be the difﬁculty in identifying MSI-L cancers. The associations could be re-examined
using the deﬁnition of MSI-L provided in this chapter.6.7. Conclusions 199
6.7 Conclusions
There is little evidence for a distinct group of MSI-L cancers. A low background
somatic slippage rate can explain most apparent low-level microsatellite instability
observed in non-MSI-H colorectal cancers. A few non-MSI-H cancers exhibit a degree
of slippage more severe than expected from a low rate of somatic slippage, although
the degree of MSI observed in these cancers can be explained by a slightly higher
somatic slippage rate. If MSI-L did occur in some cancers, it was not an early event in
their development, since the degree of MSI in a cancer varied between spatially distinct
regions. Counting the number of unstable loci in a cancer is a poor predictor of MSI-L
status.
6.8 Future Work
6.8.1 Association with clinicopathological variables
Previously published work has suggested an association between MSI-L and various
genetic, clinical or pathological features of a cancer, such as K-ras mutations (JASS
et al., 1999), MGMT hypermethylation (WHITEHALL et al., 2001), cancer staging
(WRIGHT et al., 2005) and the level of immune response (KETS et al., 2006). Evidence
for the associations is contested though, and as many other studies found no such
associations (for example, see review by TOMLINSON et al. (2002)). The reason for
the inconsistency could be the difﬁculty in reliably identifying MSI-L cancers. Using
the deﬁnition of MSI-L suggested in this chapter, evidence for these associations could
be re-examined. If associations are relatively weak, a large sample size of cancer will
be required to conﬁdently detect an association.
6.8.2 Molecular analysis
Recent developments in sequencing technology permit whole genome sequencing of
small tissue samples (ILLUMINA, 2006). The frequency distribution of the number of
motif repeats per MS locus (constructed from published copies of the human genome)
have been used to estimate the MS slippage rate between human generations (see for
example LAI and SUN (2003); KRUGLYAK et al. (1998)). The frequency distribution200 Chapter 6. Low Level Microsatellite Instability
is assumed to represent an ‘equilibrium distribution’ such that the frequency of a locus
consisting of X motif repeats is maintained by balance between contraction of longer
loci and expansion of shorter loci. The slippage rate is estimated by ﬁtting a stochastic
model of MS expansion and contraction to this equilibrium distribution. Assuming that
the distribution of microsatellite lengths in cancers is approximately in equilibrium, this
method could be applied to study somatic slippage rates during cancer growth. First,
a mathematical analysis would be required to show that the distribution of MS lengths
in a cancer was in quasi-equilibrium. Whole genome PCR, with deep re-sequencing,
could be used to measure the frequency distribution of the number of motif repeats
per MS locus in MSI-H, MSS and putative MSI-L cancers, and similar mathematical
techniques could be used to infer the microsatellite slippage rate in each cancer type.
This analysis would provide a powerful assay to detect MSI-L cancers, and would also
result in an estimate of the somatic MS slippage rate. These data could also be used
to identify a panel of non-polymorphic microsatellites, which show slippage below the
level expected from somatic slippage. MSI-L cancers may then be sensitivity identiﬁed
if they showed slippage at the MS in this panel.
6.8.3 Model complexity
The model of MS slippage during tumorigienesis presented in this chapter is
intentionally simple. The intention of the work presented in this chapter was to use a
simple model of normal somatic MS slippage during tumorigenesis to predict the basal
level of microsatellite slippage that could be reasonably expected in a cancer without
an elevated slippage rate. However, it is unlikely that this parsimonious description is
an accurate representation of the complex factors that inﬂuence MS slippage during
tumorigenesis. A more accurate model should assess the following assumptions and
introduce more complex models as appropriate: per locus slippage rates, slippage rates
that depend on the number of motif repeats at the locus, different cancer growth rates
and heterogeneous cell division rates.
6.8.4 CIMP-low
Some authors have suggested that a sub-group of cancers can be identiﬁed by their
having a low level CpG Island Methylator Phenotype (CIMP-Low) (OGINO et al.,6.8. Future Work 201
2006; JASS, 2007; KAWASAKI et al., 2008). It is suggested that in these cancers,
CpG island methylation occurs at a slightly higher rate than the background somatic
methylation rate. Methylation of a tumour suppressor gene, or its promoter, which
suppresses protein transcription can lead to neoplastic development. Hence, the
acquisition of CIMP-low predisposes to cancer development in an analogous way to
the acquisition of the MSI-L phenotype.
The existence of a CIMP-low phenotype remains controversial, since the number of
methylated loci required for CIMP-low classiﬁcation is chosen arbitrarily. The method
adopted in this Chapter could be adapted to assess the evidence for a CIMP-low
phenotype. The model developed in this chapter could be adapted to predict the level of
methylation expected in a cancer given a low somatic methylation rate. The predictions
of the model could then be compared to the level of methylation observed in a cohort
of putative CIMP-low cancers.202 Chapter 6. Low Level Microsatellite InstabilityChapter 7
Conclusions
The aim of this thesis was to investigate the propagation of mutations during
tumorigenesis, particularly in the human colon. First, the expansion of amutant clone
in a stem cell niche was examined. The Drosophila testis, a very well characterised
niche, was used as a model system to investigate stem cell survival. Next, the
propagation of mutations through the colon was examined. The rate of crypt ﬁssion,
the primary mechanism for expansion of mutant clones in the colon, was estimated.
The order and timing of APC and K-ras mutations in the initial development of
colorectal adenomas was then investigated. Laser-capture micro-dissection, coupled
with optimised sequencing techniques, was used to produce clonal maps to study
the expansion of the mutant clones. Finally, mutations in colorectal cancers were
investigated. It had been suggested that some cancers could be classiﬁed according
to their having a low-level mutator phenotype, which caused an elevated rate of
microsatellite slippage. This hypothesis was investigated by developing a mathematical
model that predicted the level of microsatellite slippage expected in a cancer from
normal somatic slippage, and comparing this prediction to the slippage observed in a
cohort of colorectal cancers.
The earliest tumorigenic mutations are thought to occur in stem cells, since only stem
cells have lineages long enough to be likely to acquire sufﬁcient mutations to initiate
tumour growth (PIERCE and SPEERS, 1988; CAIRNS, 2002). To study the initial events
in tumorigenesis, in this thesis the clonal expansion of mutant stem cells in a niche was
examined. Using the well characterised Drosophila testis stem cell niche as a model204 Chapter 7. Conclusions
system, a mathematical model of the stem cell compartment was developed and used
to identify the stem cell phenotypes that were selectively advantageous. The rate of
invasion of stem cells with particular genetic mutations was predicted. This work has
generated testable predictions which may stimulate future research into the dynamics
of stem cells in the Drosophila testis.
Furthermore, the model illustrated how speciﬁc bio-mechanical properties of a stem
cell can alter the likelihood that the progeny of the stem cell will remain in a niche. This
study of the Drosophila niche should be viewed as an illustration of how an tumorigenic
mutation may become ﬁxed in a niche, through subtly altering the phenotype of a
cell. After ﬁxation of the mutant cell, the cells in the niche are predisposed to
tumorigenesis, even if the original mutation in isolation was insufﬁcient to initiate
tumour growth. Studying pre-tumour progression in the human colon is prohibitively
difﬁcult. Sequencing technology restricts the ability to genotype cells from a single
crypt, since the volume of DNA available is small. Recently however, advances
in sequencing technology have allowed whole genome sequencing of colorectal
neoplasms (JONES et al., 2008b). Adenomas were found to contain between 6
and 23 mutations. This relatively high mutation burden in colorectal adenomas
perhaps suggests that some tumorigenic mutations occur prior to APC inactivation,
and therefore may inﬂuence subsequent tumour progression. Understanding the
mechanisms responsible for the accumulation of mutations in small adenomas, either
through neutral drift that can lead to the ﬁxation of a mutation, or mutation driven
clonal expansion, is likely to become increasingly important as sequencing technology
improves.
The next section of this thesis examined the spread of mutations through the colonic
epithelium. A mutant stem cell arising in a crypt can displace the wild-type stem cells
from the niche through niche succession (YATABE et al., 2001), a process analogous
to mutant stem cell invasion in the Drosophila testes. Subsequent expansion of a
mutant clone is through crypt ﬁssion (GREAVES et al., 2006). In this thesis, the rate of
crypt ﬁssion was inferred from data on the spread of COX-deﬁcient cells in the colon.
Fission was found to be an infrequent event, occuring in each crypt about once every 23
years. This was the ﬁrst estimate of the ﬁssion rate that was inferred directly from data205
from human colons, rather than by comparison with murine crypts. The estimate was
signiﬁcantly longer than the previous availiable estimate. A mathematical model of the
partitioning of stem cells between daughter crypts during ﬁssion showed that ﬁssion
increased the likelihood of a mutant lineage becoming ﬁxed in the epithelium.
Crypt ﬁssion is the primary mechanism for expansion of colorectal adenomas
(PRESTON et al., 2003), and correspondingly the incidence of crypts in ﬁssion is
greatly increased in adenomas (WONG et al., 2002; BJERKNES et al., 1997). Therefore,
the normal low rate of crypt ﬁssion, identiﬁed in this thesis, may have evolved as
an anti-tumourigenic mechanism which limits the spread of mutant clones in the
epithelium. Understanding the mechanism responsible for the increase in ﬁssion rate in
neoplastic development may prove vital in developing treatments to restrict the growth
of colorectal adenomas.
Genetic alterations occurring as part of the initial development of sporadic colorectal
adenomas were then examined. Polyps were micro-dissected on a crypt-by-crypt basis,
andthemutationstatusoftheAPCandK-rasgenesineachcryptwasdetermined. K-ras
mutations were found to occur frequently in small adenomas, and many adenomas had
K-ras mutations in every crypt that was genotyped. This suggested that K-ras mutations
may occur very soon after the initiation of tumour growth and rapidly reach ﬁxation in
the adenoma. Alternatively, this data could be interpreted as evidence of pre-tumour
progression, whereby a crypt had acquired a K-ras mutation before APC inactivation
and the subsequent initiation of tumour growth. It was also suggested that speciﬁc
combinations of APC and K-ras mutations tended to be found together, suggesting that
tumourcellswiththesecombinationsarebestowedwithanoptimalselectiveadvantage.
This work has resulted in a better characterisation of the initial clonal expansions in
colorectalcancerdevelopment. Lasercapturemicro-dissection, coupledwithoptimised
sequencing techniques, has been shown to be an efﬁcient tool for investigating the
clonal development of colorectal adenomas. The associations between K-ras and
APC mutations merit further investigation to understand how combinations of speciﬁc
mutation types may deﬁne different pathways of tumorigenesis.
The ﬁnal section of this thesis examined the accumulation of mutations in colorectal
cancers. It had been previously shown that some cancers, with intact mismatch repair206 Chapter 7. Conclusions
machinery, exhibit a low level of microsatellite instability (BOLAND et al., 1998),
and these cancers have been labelled MSI-L. Much research has been focused on
determining whether this apparent low-level of instability is due to an elevated slippage
rate, resulting from an underlying genetic change in the cancer (TOMLINSON et al.,
2002). In this thesis, it was shown that a normal low level of somatic microsatellite
slippage during tumorigenesis will result in a non-negligible degree of slippage in a
cancer. This suggested that the microsatellite slippage observed in the MMR-proﬁcient
cancers was due to random slippage events during the development of the cancer, rather
than an underlying genetic change. Criteria were then suggested which differentiate
between degrees of microsatellite instability in a cancer, and so may be useful for the
identiﬁcation of putative MSI-L cancers. These deﬁnitions will be useful for studying
any association between the putative MSI-L phenotype and clinical or pathological
variables. Finding such an association may have prognostic beneﬁt.
There has been a long running debate as to the relative importance of genetic instability
versus clonal expansion in driving tumour progression (TOMLINSON et al., 1996;
MOOLGAVKAR and LUEBECK, 2003; NOWAK et al., 2002; RAJAGOPALAN et al.,
2003). Genetic instability increases the rate at which new genotypes are produced
in a cancer. When coupled with selection for the ﬁttest clones, an elevated mutation
rate accelerates the process of evolution that occurs in a cancer, and so the time taken
for a normal healthy cell to make the transition to an invasive carcinoma is reduced.
Clonal expansion can have an equivalent effect. Clonal expansion of a cell lineage,
following the initial inactivation of a tumour suppressor gene, produces many cells
which are potential ‘targets’ for further tumorigenic changes. Thus, in a large clone
there are many cells which are susceptible to further tumourigenic mutations, so the
transition from a normal to malignant clone can be rapid. This thesis has looked at the
relative importance of genetic instability and clonal expansion during tumorigenesis.
The study of microsatellite instability in putative MSI-L cancers showed that cancers
can consist of genetically diverse populations of cells, without requiring an elevated
mutation rate to generate diversity. Selection, rather than mutation, may primarily
inﬂuence the spectrum of mutations observed in colorectal adenomas. Mathematical
modelling, as illustrated in this thesis, can reveal cell phenotypes that are selectively207
advantageous, and show whether the observed spectrum of mutations is compatible
with the proposed model of tumour progression.
Future research directions following from the work presented in this thesis have
been suggested at the end of each Chapter. Here, preferred research directions are
summarised.
In Chapter 2, the behaviour of sporadic mutant stem cells in the Drosophila testis
stem cell niche was predicted. These predictions can be readily tested in a suitable
ﬂy model where mutations (such as apc loss) can be induced in the adult ﬂy testis.
Development and testing of these animal models would provide unrivalled insight into
the earliest events in tumorigenesis. These data should be analysed in tandem with a
more sophisticated mathematical than presented in this thesis, describing, in particular,
the behaviours associated with an ageing niche.
In Chapter 3, the role of crypt ﬁssion in the propagation of mutant cells in the human
colon was investigated. Similar analysis, requiring the availability of adequate data,
should be applied to study the rate of crypt or gland expansion in other gastrointestinal
tissues, such as the small intestine or stomach. Developing a stochastic, rather than
deterministic, model of crypt ﬁssion would conﬁrm the results presented here. Such
models could also be used to test the hypothesis that crypt ﬁssion occurs in response
to some (random) intra- or extra-cryptal stimulation, rather being an inevitable event in
the life-cycle of a crypt.
In Chapter 5, the order and timing of APC and K-ras mutations in sporadic colorectal
adenomas was inferred. This work tentatively indicates that APC and K-ras mutations
may not occur independently, in that the type of APC mutation may select for the
presence and possibly type of K-ras mutation. This hypothesis should be evaluated
using mouse models. Mutant mice with different combinations of APC and K-ras
mutations can be generated and compared. The analysis could also be extended to
consider the role of other genes, such as BRAF and p53, in the development of these
sporadic polyps.
In Chapter 6, the degree of genetic diversity at microsatellite loci expected in a cancer
as a result of normal rate of somatic slippage was predicted. Extensions of the approach208 Chapter 7. Conclusions
taken in the chapter should be used to accurately determine somatic MS slippage
rates, and could be used to evaluate the efﬁcacy of panels of MS markers used for
the detection of genetic instability.
In this thesis, it has been shown how mathematical modelling, closely coupled with
laboratory investigation, can be used to produce and test novel, complex hypotheses
about the processes of clonal expansion and tumorigenesis in the human colon. I hope
that mathematical models, as a formalised description of biological theory, will assume
a central role in future attempts to decipher complex biological processes, particularly
tumorigenesis.Bibliography
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8.2 APC sequence
The wild-type sequence of the mRNA of the APC mutator cluster region is displayed
below. SecondroundAPCprimers(identicaltotheAPCSSCPprimers)arehighlighted
in yellow.
 
         tcatctggacaaagcagtaaaaccgaacatatgtcttcaagcagtgagaatacgtccaca  MCR1F 
    3601 ---------+---------+---------+---------+---------+---------+ 3660 
         agtagacctgtttcgtcattttggcttgtatacagaagttcgtcactcttatgcaggtgt 
  
a        S  S  G  Q  S  S  K  T  E  H  M  S  S  S  S  E  N  T  S  T   - 
  
         ccttcatctaatgccaagaggcagaatcagctccatccaagttctgcacagagtagaagt 
    3661 ---------+---------+---------+---------+---------+---------+ 3720 
         ggaagtagattacggttctccgtcttagtcgaggtaggttcaagacgtgtctcatcttca 
  
a        P  S  S  N  A  K  R  Q  N  Q  L  H  P  S  S  A  Q  S  R  S   - 
  
         ggtcagcctcaaaaggctgccacttgcaaagtttcttctattaaccaagaaacaatacag  15G MCR2F  
    3721 ---------+---------+---------+---------+---------+---------+ 3780 
         ccagtcggagttttccgacggtgaacgtttcaaagaagataattggttctttgttatgtc MCR1R 
  
a        G  Q  P  Q  K  A  A  T  C  K  V  S  S  I  N  Q  E  T  I  Q   - 
  
         acttattgtgtagaagatactccaatatgtttttcaagatgtagttcattatcatctttg MCR3F 
    3781 ---------+---------+---------+---------+---------+---------+ 3840 
         tgaataacacatcttctatgaggttatacaaaaagttctacatcaagtaatagtagaaac  15F Rev 
  
a        T  Y  C  V  E  D  T  P  I  C  F  S  R  C  S  S  L  S  S  L   - 
  
         tcatcagctgaagatgaaataggatgtaatcagacgacacaggaagcagattctgctaat 
    3841 ---------+---------+---------+---------+---------+---------+ 3900 
         agtagtcgacttctactttatcctacattagtctgctgtgtccttcgtctaagacgatta MCR2R 
  
a        S  S  A  E  D  E  I  G  C  N  Q  T  T  Q  E  A  D  S  A  N   - 
  
         accctgcaaatagcagaaataaaagaaaagattggaactaggtcagctgaagatcctgtg MCR4F 
    3901 ---------+---------+---------+---------+---------+---------+ 3960 
         tgggacgtttatcgtctttattttcttttctaaccttgatccagtcgacttctaggacac 
  
a        T  L  Q  I  A  E  I  K  E  K  I  G  T  R  S  A  E  D  P  V   - 
  
         agcgaagttccagcagtgtcacagcaccctagaaccaaatccagcagactgcagggttct  
    3961 ---------+---------+---------+---------+---------+---------+ 4020 
         tcgcttcaaggtcgtcacagtgtcgtgggatcttggtttaggtcgtctgacgtcccaaga MCR3R 
  
a        S  E  V  P  A  V  S  Q  H  P  R  T  K  S  S  R  L  Q  G  S   - 
  
         agtttatcttcagaatcagccaggcacaaagctgttgaattttcttcaggagcgaaatct  15H For MCR5F 
    4021 ---------+---------+---------+---------+---------+---------+ 4080 
         tcaaatagaagtcttagtcggtccgtgtttcgacaacttaaaagaagtcctcgctttaga 
  
a        S  L  S  S  E  S  A  R  H  K  A  V  E  F  S  S  G  A  K  S   - 
  
         ccctccaaaagtggtgctcagacacccaaaagtccacctgaacactatgttcaggagacc MCR6F 
    4081 ---------+---------+---------+---------+---------+---------+ 4140 
         gggaggttttcaccacgagtctgtgggttttcaggtggacttgtgatacaagtcctctgg  15G Rev MCR4R 
  
a        P  S  K  S  G  A  Q  T  P  K  S  P  P  E  H  Y  V  Q  E  T   - 
  
         ccactcatgtttagcagatgtacttctgtcagttcacttgatagttttgagagtcgttcg  
    4141 ---------+---------+---------+---------+---------+---------+ 4200 8.2. APC sequence 239
         ggtgagtacaaatcgtctacatgaagacagtcaagtgaactatcaaaactctcagcaagc MCR5R 
  
a        P  L  M  F  S  R  C  T  S  V  S  S  L  D  S  F  E  S  R  S   - 
  
         attgccagctccgttcagagtgaaccatgcagtggaatggtaagtggcattataagcccc MCR7F 
    4201 ---------+---------+---------+---------+---------+---------+ 4260 
         taacggtcgaggcaagtctcacttggtacgtcaccttaccattcaccgtaatattcgggg MCR6R 
  
a        I  A  S  S  V  Q  S  E  P  C  S  G  M  V  S  G  I  I  S  P   - 
  
         agtgatcttccagatagccctggacaaaccatgccaccaagcagaagtaaaacacctcca MCR8F 
    4261 ---------+---------+---------+---------+---------+---------+ 4320 
         tcactagaaggtctatcgggacctgtttggtacggtggttcgtcttcattttgtggaggt 
  
a        S  D  L  P  D  S  P  G  Q  T  M  P  P  S  R  S  K  T  P  P   - 
  
         ccacctcctcaaacagctcaaaccaagcgagaagtacctaaaaataaagcacctactgct MCR9F 
    4321 ---------+---------+---------+---------+---------+---------+ 4380 
         ggtggaggagtttgtcgagtttggttcgctcttcatggatttttatttcgtggatgacga MCR7R 
  
a        P  P  P  Q  T  A  Q  T  K  R  E  V  P  K  N  K  A  P  T  A   - 
  
         gaaaagagagagagtggacctaagcaagctgcagtaaatgctgcagttcagagggtccag  15I For 
    4381 ---------+---------+---------+---------+---------+---------+ 4440 
         cttttctctctctcacctggattcgttcgacgtcatttacgacgtcaagtctcccaggtc MCR8R 
  
a        E  K  R  E  S  G  P  K  Q  A  A  V  N  A  A  V  Q  R  V  Q   - 
  
         gttcttccagatgctgatactttattacattttgccacggaaagtactccagatggattt MCR10F 
    4441 ---------+---------+---------+---------+---------+---------+ 4500 
         caagaaggtctacgactatgaaataatgtaaaacggtgcctttcatgaggtctacctaaa  15H Rev 
  
a        V  L  P  D  A  D  T  L  L  H  F  A  T  E  S  T  P  D  G  F   - 
  
         tcttgttcatccagcctgagtgctctgagcctcgatgagccatttatacagaaagatgtg 
    4501 ---------+---------+---------+---------+---------+---------+ 4560 
         agaacaagtaggtcggactcacgagactcggagctactcggtaaatatgtctttctacac MCR9R 
  
a        S  C  S  S  S  L  S  A  L  S  L  D  E  P  F  I  Q  K  D  V   - 
  
         gaattaagaataatgcctccagttcaggaaaatgacaatgggaatgaaacagaatcagag MCR11F 
    4561 ---------+---------+---------+---------+---------+---------+ 4620 
         cttaattcttattacggaggtcaagtccttttactgttacccttactttgtcttagtctc MCR10R 
  
a        E  L  R  I  M  P  P  V  Q  E  N  D  N  G  N  E  T  E  S  E   - 
  
         cagcctaaagaatcaaatgaaaaccaagagaaagaggcagaaaaaactattgattctgaa 
    4621 ---------+---------+---------+---------+---------+---------+ 4680 
         gtcggatttcttagtttacttttggttctctttctccgtcttttttgataactaagactt 
  
a        Q  P  K  E  S  N  E  N  Q  E  K  E  A  E  K  T  I  D  S  E   - 
  
         aaggacctattagatgattcagatgatgatgatattgaaatactagaagaatgtattatt MCR12F 
    4681 ---------+---------+---------+---------+---------+---------+ 4740 
         ttcctggataatctactaagtctactactactataactttatgatcttcttacataataa MCR 11R 
  
a        K  D  L  L  D  D  S  D  D  D  D  I  E  I  L  E  E  C  I  I   - 240 Chapter 8. Appendices
  
         tctgccatgccaacaaagtcatcacgtaaagcaaaaaagccagcccagactgcttcaaaa  15J For 
    4741 ---------+---------+---------+---------+---------+---------+ 4800 
         agacggtacggttgtttcagtagtgcatttcgttttttcggtcgggtctgacgaagtttt 
  
a        S  A  M  P  T  K  S  S  R  K  A  K  K  P  A  Q  T  A  S  K   - 
  
         ttacctccacctgtggcaaggaaaccaagtcagctgcctgtgtacaaacttctaccatca 
    4801 ---------+---------+---------+---------+---------+---------+ 4860 
         aatggaggtggacaccgttcctttggttcagtcgacggacacatgtttgaagatggtagt MCR12R 
  
a        L  P  P  P  V  A  R  K  P  S  Q  L  P  V  Y  K  L  L  P  S   - 8.3. K-ras sequence 241
8.3 K-ras sequence
The wild-type sequence of the mRNA of the K-ras gene is displayed below. Codons 12
and 13, the two most frequently mutated codons in colorectal cancer are highlighted in
yellow.
atg act gaa tat aaa ctt gtg gta gtt gga gct ggt ggc gta ggc aag agt gcc ttg acg   60 
  M   T   E   Y   K   L   V   V   V   G   A   G   G   V   G   K   S   A   L   T   20 
 
ata cag cta att cag aat cat ttt gtg gac gaa tat gat cca aca ata gag gat tcc tac   120 
  I   Q   L   I   Q   N   H   F   V   D   E   Y   D   P   T   I   E   D   S   Y   40 
 
agg aag caa gta gta att gat gga gaa acc tgt ctc ttg gat att ctc gac aca gca ggt   180 
  R   K   Q   V   V   I   D   G   E   T   C   L   L   D   I   L   D   T   A   G   60 
 
caa gag gag tac agt gca atg agg gac cag tac atg agg act ggg gag ggc ttt ctt tgt   240 
  Q   E   E   Y   S   A   M   R   D   Q   Y   M   R   T   G   E   G   F   L   C   80 
 
gta ttt gcc ata aat aat act aaa tca ttt gaa gat att cac cat tat aga gaa caa att   300 
  V   F   A   I   N   N   T   K   S   F   E   D   I   H   H   Y   R   E   Q   I   100 
 
aaa aga gtt aag gac tct gaa gat gta cct atg gtc cta gta gga aat aaa tgt gat ttg   360 
  K   R   V   K   D   S   E   D   V   P   M   V   L   V   G   N   K   C   D   L   120 
 
cct tct aga aca gta gac aca aaa cag gct cag gac tta gca aga agt tat gga att cct   420 
  P   S   R   T   V   D   T   K   Q   A   Q   D   L   A   R   S   Y   G   I   P   140 
 
ttt att gaa aca tca gca aag aca aga cag ggt gtt gat gat gcc ttc tat aca tta gtt   480 
  F   I   E   T   S   A   K   T   R   Q   G   V   D   D   A   F   Y   T   L   V   160 
 
cga gaa att cga aaa cat aaa gaa aag atg agc aaa gat ggt aaa aag aag aaa aag aag   540 
  R   E   I   R   K   H   K   E   K   M   S   K   D   G   K   K   K   K   K   K   180 
 
tca aag aca aag tgt gta att atg taa                                               567 
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